2026 Annual Meeting | P11 - Poster Session 11

Date Wednesday 04/22/26

Time 11:45 AM - 12:45 PM CDT Add To Calendar

Location McCormick Place West | Hall F

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) General Neurology, Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Sleep, Epilepsy/Clinical Neurophysiology (EEG), Multiple Sclerosis, Child Neurology and Developmental Neurology, Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Infectious Disease, Education, Research, and Methodology, Autoimmune Neurology

CME Available 0.00 CME credit

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM CDT	Abstract	15-001 - Thirty Days, Numerous Connections: The MedSocial30 Challenge and its Influence on Neurologists’ Social Media Presence Dhanya Gorty, MBBS
11:45 AM - 12:45 PM CDT	Abstract	15-002 - Complex Case Conference: Implementation and Evaluation of a Novel Approach to Enhance Inter-specialty Clinical Collaboration within a Department of Neurology Harli Weber, MD
11:45 AM - 12:45 PM CDT	Abstract	15-003 - Unlocking Neurology Education Through Virtual Neurology Escape Room: A Conference Experience Dhanya Gorty, MBBS
11:45 AM - 12:45 PM CDT	Abstract	15-004 - “Friendly Feedback:” Lessons Learned from the Implementation and Evaluation of a Structured Peer Observation and Feedback Program at the American Academy of Neurology (AAN) National Meeting Galina Gheihman, MD
11:45 AM - 12:45 PM CDT	Abstract	15-005 - Neurological Exam Round-robin: Advancing Neurological Examination Skills for Advanced Practice Providers Through an Interactive, Hands-on, Skills-based Workshop Galina Gheihman, MD
11:45 AM - 12:45 PM CDT	Abstract	15-006 - Advanced Practice Provider Fellowship (APP) Growth, Culture, and Curriculum of First to Most Recent Fellow Erin Doan, PhD, RN, NP
11:45 AM - 12:45 PM CDT	Abstract	15-007 - Delivering a Diagnosis of Functional Neurological Disorder without Formal Training? A Cross-sectional Study on the Experience of Neurology Faculty Aimen Vanood, MD
11:45 AM - 12:45 PM CDT	Abstract	15-008 - Neurology Fellowship Transition to Practice Curriculum – A Needs Assessment Kathryn Zuchowski, MD
11:45 AM - 12:45 PM CDT	Abstract	15-009 - How to Fund Your Fellowship: a Time-driven Activity-based Costing Paradigm for Sustainable Neurology Subspecialty Training Marinos G. Sotiropoulos, MD
11:45 AM - 12:45 PM CDT	Abstract	15-010 - “Writing for Publication” (W4P): Three-year Implementation and Evaluation of a Seminar-style Longitudinal Course in Scientific Writing for Academic Neurology Galina Gheihman, MD
11:45 AM - 12:45 PM CDT	Abstract	15-011 - Leading the Future: A Neurology Webinar Series for Chief Resident Development Arielle M. Kurzweil, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	15-012 - From Presentation to Publication: Rates of Publication of Neurology Education-related Abstracts Asif Doja, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	15-013 - Evolving Interest in Neurology as a Preferred Specialty in the Residency Match: Insights from 2007 to 2024 Samaya Kallepalli
11:45 AM - 12:45 PM CDT	Abstract	15-014 - Shaping the Ideal Preliminary Year: A Qualitative Study of Neurology Program Directors on Internal Medicine Training for New Residents Connor Patterson
11:45 AM - 12:45 PM CDT	Abstract	15-015 - Nationwide Analysis of Program Directors in ACGME-accredited Adult Neurology Residency Programs Yohan Kim, DO
11:45 AM - 12:45 PM CDT	Abstract	15-016 - Neuropalliative Care Education: A National Survey of Neurology Program Directors Eileen Harrigan, MD
11:45 AM - 12:45 PM CDT	Abstract	15-017 - Improving Genetics Knowledge in Neurology Residency Education: Insights from a National Survey and Pilot Curriculum Cynthia Peng, MD
11:45 AM - 12:45 PM CDT	Abstract	15-018 - Stakeholder Perspectives on Building, Supporting, & Sustaining Clinician Educator Tracks in Neurology Residency: An Explorative Qualitative Study Hend Heikal
11:45 AM - 12:45 PM CDT	Abstract	15-019 - The State of Telestroke Education in Vascular Neurology Fellowships: Current Practices and Future Directions Nikita Chhabra, DO
11:45 AM - 12:45 PM CDT	Abstract	15-020 - Neurophobia in Low- and Middle-income Countries (LMICs): Burden and Implications for Neurology Care and Research – A Systematic Review Oladotun V. Olalusi, MBBS
11:45 AM - 12:45 PM CDT	Abstract	9-001 - Characteristics and Treatment Patterns of Patients With Myasthenia Gravis: A Retrospective, Real-world Analysis of a United States Claims Database Stephen W. Yeung, DO
11:45 AM - 12:45 PM CDT	Abstract	9-002 - Assessing Glucocorticoid Associated Toxicity in Myasthenia Gravis Using the Glucocorticoid Toxicity Index Marie Beaudin, MD
11:45 AM - 12:45 PM CDT	Abstract	9-003 - Patient Satisfaction With Ravulizumab Treatment for Generalized Myasthenia Gravis (gMG) in the United States (US) Chelsea Shugars, MD
11:45 AM - 12:45 PM CDT	Abstract	9-004 - Rescue Treatment of Inebilizumab in Refractory Myasthenia Gravis: A Case Report Qilong Jiang
11:45 AM - 12:45 PM CDT	Abstract	9-005 - Use of Biologic Therapy in Seropositive Generalized Myasthenia Gravis in a Single Cohort Anne Taylor, MD
11:45 AM - 12:45 PM CDT	Abstract	9-006 - From Onset to Remission: Predictors of Trajectory and Personalized Risk in a Large French Myasthenia Gravis Cohort Edoardo Malfatti, MD
11:45 AM - 12:45 PM CDT	Abstract	9-007 - Real-world Biologics in Generalized Myasthenia Gravis: Evidence for Reduced Hospitalization Rates Joao Vitor Mahler, MD
11:45 AM - 12:45 PM CDT	Abstract	9-008 - Self-reported Clinical Characteristics of a U.S. Generalized Myasthenia Gravis Population Treated With Standard of Care Therapy: Results From a Real-world Patient Survey Jacqueline Pesa
11:45 AM - 12:45 PM CDT	Abstract	9-009 - Bioequivalence and Effectiveness of Auto-Injector-Delivered, Self-administered Zilucoplan Compared With Pre-filled Syringe Mary Petrulis, MD
11:45 AM - 12:45 PM CDT	Abstract	9-010 - Rituximab Combined With Plasma Exchange as Induction Therapy for Patients With Generalized Myasthenia María T. Alba Isasi, MD
11:45 AM - 12:45 PM CDT	Abstract	9-011 - FcRn Inhibitors in gMG: Leveraging Continuing Education to Bridge Gaps in Clinical Practice Emily Scully
11:45 AM - 12:45 PM CDT	Abstract	9-012 - Evaluating the Effects of Therapeutic Goals in Myasthenia Gravis: A Systematic Review and Meta-analysis Angela T. Remuzgo-Cabezas, Medical Student
11:45 AM - 12:45 PM CDT	Abstract	9-013 - Treatment Patterns of Biologic Therapies in a Real-world United States Myasthenia Gravis Population: A Claims Data Analysis Lesley-Ann 9. Miller-Wilson, PhD
11:45 AM - 12:45 PM CDT	Abstract	9-014 - Missed Opportunities for Pharmacist Intervention Among Medicare Fee-for-Service Beneficiaries With Myasthenia Gravis: A Real-world Claims Analysis Judith Thompson, PhD
11:45 AM - 12:45 PM CDT	Abstract	9-015 - Synergistic Clinical Improvement in a Refractory AChR-positive Non-thymomatous Generalized Myasthenia Gravis Patient Treated With Concurrent Zilucoplan and Rozanolixizumab Miao Iris Wei, MD, PhD
11:45 AM - 12:45 PM CDT	Abstract	9-016 - The Efficacy of Eculizumab for Long-term Ventilator-dependent and Postoperative Crisis in Refractory Thymoma-associated Myasthenia Gravis: Two Case Reports Yu Wu
11:45 AM - 12:45 PM CDT	Abstract	9-017 - Impact on Healthcare Resource Utilization in Early Initiators of Ravulizumab or Efgartigimod for Treatment of Generalized Myasthenia Gravis in the U.S.A. Riley J. Snook, MD
11:45 AM - 12:45 PM CDT	Abstract	9-018 - Efficacy and Safety of Efgartigimod in Myasthenia Gravis: A Systematic Review and Meta-analysis of Different Antibody Subtypes Basant Lashin, MD
11:45 AM - 12:45 PM CDT	Abstract	9-019 - Comparing the Safety and Efficacy of Myasthenia Gravis Treatments: A Bayesian Network Meta-analysis Accounting for Inconsistencies in Trial Designs and Populations Bhaskar Roy, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	9-020 - Assessing Efgartigimod Dosing Patterns and Myasthenia Gravis Activities of Daily Living Outcomes in Clinical Practice: Results From a Large Patient Support Program Database in the United States Pushpa Narayanaswami, MD, MBBS, FAAN
11:45 AM - 12:45 PM CDT	Abstract	9-021 - High Rates of Myasthenia Gravis Exacerbations in Individuals With Pre-existing Myasthenia Gravis Exposed to Immune Checkpoint Inhibitors Irena Dujmovic Basuroski, MD, PhD
11:45 AM - 12:45 PM CDT	Abstract	3-001 - Clinical Characteristics of Neuroinvasive West Nile Virus Infection in a Setting of Normal Neuroimaging: A Case Report and a Review of the Literature Vera Nemsadze, MD
11:45 AM - 12:45 PM CDT	Abstract	3-002 - Novel MRI Findings in Fulminant West Nile Neuroinvasive Disease Mimicking Guillain–Barré Syndrome Evan Mooney, MD
11:45 AM - 12:45 PM CDT	Abstract	3-003 - Seizing the Diagnosis: A Rare Case of Fatal West Nile Virus Ventriculitis Matthew Cobler-Lichter, MD
11:45 AM - 12:45 PM CDT	Abstract	3-004 - West Nile Virus Meningoencephalitis Presenting with Seizures in an Immunosuppressed Patient Jagjot Singh, MBBS
11:45 AM - 12:45 PM CDT	Abstract	3-005 - Antibody Negative West Nile Virus Encephalitis in a Patient on Anti-CD20 Therapy for Multiple Sclerosis Thomas Draper, MD
11:45 AM - 12:45 PM CDT	Abstract	3-006 - Diffuse Cerebral Microhemorrhages in West Nile Virus Neuroinvasive Disease: A Case Report Lauren Hinkley
11:45 AM - 12:45 PM CDT	Abstract	3-008 - A Novel Case of West Nile Virus Rhombencephalitis Complicated by Obstructive Hydrocephalus Ryan Bean, DO
11:45 AM - 12:45 PM CDT	Abstract	3-009 - Atypical Presentation of West Nile Encephalitis in an Immunosuppressed Patient: A Diagnostic Challenge Samhitha Rai
11:45 AM - 12:45 PM CDT	Abstract	3-010 - Neuroinvasive West Nile Virus Mimicking Polio: A Case Report Christopher Blaine, MD
11:45 AM - 12:45 PM CDT	Abstract	3-011 - Neuroinvasive West Nile: Epidemiology & Fatal Encephalitis Series from Chicago, Summer 2025 Jon Klein, MD
11:45 AM - 12:45 PM CDT	Abstract	3-012 - Anti-CD20 Therapies Associated With Severe West Nile Neuroinvasive Disease Joyce A. Jimenez Zambrano, MD
11:45 AM - 12:45 PM CDT	Abstract	3-013 - Fatal Neuroinvasive West Nile Virus Encephalitis Cases in Elderly Immunocompromised Patients in Chicago, IL, Summer 2025 Adriana N. Sari, MD
11:45 AM - 12:45 PM CDT	Abstract	3-014 - West Nile Virus Meningoencephalitis Exacerbating Ocular Myasthenia Gravis and Facial Nerve Palsy Ayla Barakat, MD
11:45 AM - 12:45 PM CDT	Abstract	3-015 - Focal Limb Weakness Without Encephalopathy: An Atypical Presentation of West Nile Virus Rajesh Burela, DO
11:45 AM - 12:45 PM CDT	Abstract	12-001 - Nanoparticle-based Antioxidant Strategies for Neurodegenerative Disorders: A PRISMA-guided Systematic Review in Progress Farhan Memon, MBBS
11:45 AM - 12:45 PM CDT	Abstract	12-002 - The Brain Gym: A Community Multimodal Stimulation Program for People with Mild Cognitive Impairment and Dementia in Matanzas, Cuba. Preliminary Report Camelia Valhuerdi Porto, MD
11:45 AM - 12:45 PM CDT	Abstract	12-003 - Disconnection in Facial Perception: A Tract-based Analysis of Reported Prosopometamorphopsia Cases (1947-2025) Shweta Kalita, MD
11:45 AM - 12:45 PM CDT	Abstract	12-004 - Young-onset Sporadic Creutzfeldt-Jakob Disease with Long Survival: Two Cases of the MM2-thalamic Variant Dylan F. Del Papa, MD
11:45 AM - 12:45 PM CDT	Abstract	12-005 - Rapidly Progressive Dementia with Neuropsychiatric Symptoms, Rigidity, Tremor, and Myoclonus: A Case Report Yohan Kim, DO
11:45 AM - 12:45 PM CDT	Abstract	12-006 - The Great Imitator Meets the Rapid Terminator: Coexistence of Neurosyphilis and Creutzfeldt-Jakob Disease Presenting as Rapidly Progressive Dementia Nishtha Gupta, MD
11:45 AM - 12:45 PM CDT	Abstract	12-007 - A Case of Sporadic Creutzfeldt-Jakob Disease with a Long Survival Period of 17 Months Nhan Ly, MD
11:45 AM - 12:45 PM CDT	Abstract	12-008 - A Case of Genetic Creutzfeldt-Jakob Disease (CJD) E200K-129M Mutation Manifesting with Refractory Seizures Kate Arner, MD
11:45 AM - 12:45 PM CDT	Abstract	12-009 - Perspectives on Presymptomatic Genetic Testing in Families Affected by Genetic Creutzfeldt-Jakob Disease: A Survey-based Study Nurit Omer, MD
11:45 AM - 12:45 PM CDT	Abstract	12-010 - Revisiting Creutzfeldt–Jakob Disease as a Diagnostic Challenge: A Case-based and Systematic Analysis of Alzheimer’s Disease Mimics Anas M. Elgenidi, MD
11:45 AM - 12:45 PM CDT	Abstract	12-011 - Delusional Parasitosis: A Systematic Review of Cases Margarita I. Chuquin
11:45 AM - 12:45 PM CDT	Abstract	12-012 - Psychiatric Manifestations due to Cerebral Cavernous Malformation in the Caudate Nucleus Ting Huai Shi, DO
11:45 AM - 12:45 PM CDT	Abstract	12-013 - Atypical Presentation of Balint Syndrome in a Patient with Right-sided Occipital-temporal Infarcts: A Case Report Syeda Safiya Hussaini, MD
11:45 AM - 12:45 PM CDT	Abstract	6-001 - A Survival Analysis of Beta-blocker Administration for Cardiovascular Disease in Patients With Glioblastoma Joshua Hanlon, MS
11:45 AM - 12:45 PM CDT	Abstract	6-003 - Safety and Efficacy of Sodium Fluoresceine in Vestibular Schwannoma, 55 Consecutive Cases Abdullah Serhan, MD
11:45 AM - 12:45 PM CDT	Abstract	6-004 - Dormancy in IDH-mutant Gliomas: A Retrospective 2D and 3D Analysis Before and After Resection Shariq M. Zaman
11:45 AM - 12:45 PM CDT	Abstract	6-005 - Emergent Neurosurgical Intervention for Intracranial Tumors at a Tertiary Referral Center: A 20-year Descriptive Cohort (2004–2024) Hyo Bin You
11:45 AM - 12:45 PM CDT	Abstract	6-006 - Fluorescein-guided Surgery in Brain Tumors: A Systematic Review and Meta-analysis Abdullah Serhan, MD
11:45 AM - 12:45 PM CDT	Abstract	6-007 - Comparative Cost-benefit Analysis of Laser Interstitial Thermal Therapy and Bevacizumab for Cranial Radiation Necrosis Yugant Khand, MBBS, DiMM
11:45 AM - 12:45 PM CDT	Abstract	6-008 - Redefining Landmarks: The Petrosal Process of the Sphenoid Bone and its Implications in Endoscopic Endonasal Skull Base Surgery Vania Amani, BSc Student
11:45 AM - 12:45 PM CDT	Abstract	6-009 - Treatment-related Adverse Events in Clinical Trials of Oncolytic Virus Therapies for Primary CNS Tumors: A Systematic Review Woo Sik Kim
11:45 AM - 12:45 PM CDT	Abstract	6-010 - DOC1021 Cell-based Immunotherapy in Combination With Standard Chemoradiation for Adjuvant Therapy of Glioblastoma: Early Results From an Expanded Access Protocol of a Phase I Trial Jay-Jiguang Zhu, MD, PhD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	6-011 - CAR T-cell Therapy in Glioblastoma: A Systematic Review and Meta-analysis of Clinical Trials Barbara Antonia D. Talah, Medical Student
11:45 AM - 12:45 PM CDT	Abstract	7-001 - A Phase 1, Open-label, Exploratory, Fixed-sequence, Pharmacokinetic Single Ascending Dose Study of IVL3004 Versus VIVITROL® (Naltrexone) Long-acting Injectable (LAI) in Healthy Subjects Slgirim Lee
11:45 AM - 12:45 PM CDT	Abstract	7-002 - Neuroprotective Effects of Tirzepatide: A Scoping Review of Preclinical and Clinical Evidence YASMIN NEGEDA, MD
11:45 AM - 12:45 PM CDT	Abstract	7-003 - Long-Term 30-Month Results of N-Acetyl-L-Leucine for Niemann-Pick Disease Type C Michael Strupp, MD, DO, FAAN
11:45 AM - 12:45 PM CDT	Abstract	7-004 - Results from a Global Phase 3 Trial (IB1001-303) Evaluating N-acetyl-L-leucine in Ataxia-telangiectasia Marc C. Patterson, MD, FRACP, FAAN
11:45 AM - 12:45 PM CDT	Abstract	7-005 - Real-world Benefits and Tolerability of Trofinetide for the Treatment of Adults with Rett Syndrome: the LOTUS Study Louise Cosand, PhD
11:45 AM - 12:45 PM CDT	Abstract	7-006 - The IVIg–TNK Paradox: Immunologic Modulation of Thrombolysis: Evaluating the IVIG–TNK Relationship Mamadou Diallo, MD
11:45 AM - 12:45 PM CDT	Abstract	7-007 - Efficacy of Combination Therapy of Donepezil and Memantine in the Treatment of Alzheimer's Disease: A Systematic Review and Meta-analysis Khawaja M. Hassan
11:45 AM - 12:45 PM CDT	Abstract	7-009 - SYT-510, the Clinical Candidate of First-in-class Selective Endocannabinoid Reuptake Inhibitors, Demonstrated Efficacy in Preclinical Models of Anxiety, Spasticity, Seizure, Pain and Neuroinflammation Rhianne Scicluna, PhD
11:45 AM - 12:45 PM CDT	Abstract	7-010 - Establishing Primary Structure Comparability Between ABP-450 (probotulinumtoxinA) and OnabotulinumtoxinA (Botox®) to Support Biosimilarity Chad Oh
11:45 AM - 12:45 PM CDT	Abstract	7-011 - Baclofen Toxicity Presenting as Generalized Myoclonus and Choreoathetosis Without Altered Consciousness in the Setting of Acute-on-chronic Kidney Disease Shivaansh Aggarwal, MD
11:45 AM - 12:45 PM CDT	Abstract	7-012 - Clinical Presentations and Treatment of Baclofen Toxicity and Withdrawal: A Systematic Review Junaid H. Siddiqui, MD
11:45 AM - 12:45 PM CDT	Abstract	7-013 - Top Line Results of the Phase 1b, Open-label, Multiple Ascending Dose Proof of Concept Study of the PIKfyve Inhibitor VRG50635 in Familial and Sporadic Amyotrophic Lateral Sclerosis Diego Cadavid, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	1-001 - IVIG-Related Hypercoagulability vs PMP-Mediated Thrombosis in Evans Syndrome Developing Bilateral Thalamic Strokes Jose F. Ortega Tola, MD
11:45 AM - 12:45 PM CDT	Abstract	1-003 - Anti–GABA-B Receptor Encephalitis with Startle Myoclonus as a Paraneoplastic Manifestation of Small-cell Lung Cancer: A Case Report Valentina I. Roa Forster
11:45 AM - 12:45 PM CDT	Abstract	1-004 - GFAP Astrocytopathy Presenting as Rhombo-meningoencephalitis with Initial Negative Antibody Testing Sina Aghili-Mehrizi, MD
11:45 AM - 12:45 PM CDT	Abstract	1-005 - A Swiss Cheese Approach to Immunotherapy in Autoimmune Encephalitis : Concurrent Blockade of Multiple Steps in the Autoimmune Pathway Tejas S. Lal
11:45 AM - 12:45 PM CDT	Abstract	1-006 - Paraneoplastic Encephalomyelitis Caused By A Pancreatic Well-differentiated Neuroendocrine Tumor Twila Gaston, MD
11:45 AM - 12:45 PM CDT	Abstract	1-007 - Concurrent Serotonin Toxicity and CRMP5-associated Autoimmune Encephalitis: Diagnostic Challenges in a Complex Neurotoxic-autoimmune Overlap Veronica L. Torres, MD
11:45 AM - 12:45 PM CDT	Abstract	1-008 - Plasma Exchange as Rescue Immunotherapy in Severe LGI-1 Encephalitis: A Case Report Anne M. Islam
11:45 AM - 12:45 PM CDT	Abstract	1-009 - The Sleep Thief: A Complex Presentation of Anti-IGLON5 Disease Trisha Chatterjee, MD
11:45 AM - 12:45 PM CDT	Abstract	1-010 - LGI1 Encephalitis Masquerading as Creutzfeldt-Jakob Disease – A Diagnostic Challenge: Case Report Rohan S. Joshi, MD
11:45 AM - 12:45 PM CDT	Abstract	1-011 - Refractory Partial Status Epilepticus in the Setting of Anti-GAD65 Autoimmune Encephalitis in an 18-Year-Old Female with an MRI Contraindication: A Case Report Lilla S. Simon, MD
11:45 AM - 12:45 PM CDT	Abstract	1-012 - Anti-Hu Limbic Encephalitis Induced by Checkpoint Inhibitor Alex Cabe, DO
11:45 AM - 12:45 PM CDT	Abstract	18-001 - Maternal B-cell Depletion and the Maternal-infant Dyad: Prospectively Collected Effects on Maternal Multiple Sclerosis Disease Control and Newborn Growth, Development and Infections Riley Bove, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	18-002 - Pregnancy and Infant Outcomes in Women With Relapsing Multiple Sclerosis Following Exposure to Ofatumumab: Latest Evidence From the PRIM Study Ruth Dobson
11:45 AM - 12:45 PM CDT	Abstract	18-003 - Cesarean Sections Prior to 39 Weeks Among Pregnant Patients With Multiple Sclerosis Sana Desai, MD Student
11:45 AM - 12:45 PM CDT	Abstract	18-004 - Women With Multiple Sclerosis: Fear No MS Relapse Following Assisted Reproduction Techniques Mohamed Ibrahim A. Mohamed, MD
11:45 AM - 12:45 PM CDT	Abstract	18-005 - Cervical Spinal Cord Atrophy in Multiple Sclerosis: Age, Sex, and Hormonal Status Nur Neyal
11:45 AM - 12:45 PM CDT	Abstract	18-006 - Forecasting the Future of MS-related Mortality: Trends in Comorbid Contributors and Sex Differences, 1999-2030 Syed Ijlal Ahmed, MD, MBBS
11:45 AM - 12:45 PM CDT	Abstract	18-007 - Cognitive Concerns in Women With MS at Menopause: Patient-identified Care Gaps Min Ji Kim, BA
11:45 AM - 12:45 PM CDT	Abstract	18-008 - Preserved Cognition With Multiple Sclerosis at Age 60: Association With Sex-specific Lifespan Factors Denisse Morales-Rodriguez
11:45 AM - 12:45 PM CDT	Abstract	18-009 - The Pill Leaves Fewer Disability Traces and Holds no Association With Future Multiple Sclerosis Risk: Evidence From a Systematic Review and Meta-analysis Rana S. Abdelhafiz
11:45 AM - 12:45 PM CDT	Abstract	10-001 - Azetukalner, a Novel, Potent KV7 Channel Opener, in Adults with Focal Epilepsy: ≥42-Month Interim Analysis of the Ongoing 7-year X-TOLE Open-label Extension Jacqueline French, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	10-002 - Phase 1, Open-label, Fixed-sequence, Bidirectional, Pharmacokinetic (PK) Drug-drug Interaction (DDI) Study Between Cannabidiol (CBD) and Cenobamate (CNB) in Healthy Adult Participants Arjun Vijan, PhD
11:45 AM - 12:45 PM CDT	Abstract	10-003 - Vormatrigine Rapidly Reduces Seizures in Adults with Treatment-resistant Epilepsy: Results from the RADIANT Study Karl Hansen
11:45 AM - 12:45 PM CDT	Abstract	10-004 - Primary Results of the 12-month Open-label Extension of the Phase 1b/2a PACIFIC Trial of Bexicaserin for the Treatment of Seizures in Participants with Developmental and Epileptic Encephalopathies Demonstrates Long-term Safety, Tolerability, and Efficacy Johannes R. Streffer, MD
11:45 AM - 12:45 PM CDT	Abstract	10-005 - Long-term Efficacy of Adjunctive Cenobamate: Open-label Extension of a Randomized Clinical Study in a Multinational Asian Population Louis Ferrari
11:45 AM - 12:45 PM CDT	Abstract	10-006 - Phase 3 EPIC (EPIlepsy Cell Therapy) Clinical Trial Design: NRTX-1001 GABAergic Interneuron Cell Therapy for the Treatment of Drug-resistant Mesial Temporal Lobe Epilepsy (MTLE) Jessica Roland, PhD
11:45 AM - 12:45 PM CDT	Abstract	10-007 - A Phase 1 Single-dose Bioavailability Study of an Oral Cenobamate Suspension Formulation Andrea Robinson, PhD
11:45 AM - 12:45 PM CDT	Abstract	10-008 - Updates from the First-in-human Phase 1 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of Vormatrigine in Healthy Participants Karl Hansen
11:45 AM - 12:45 PM CDT	Abstract	10-009 - EMERALD: A Phase 3, Randomized, Multi-center, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Relutrigine in Participants with Developmental and Epileptic Encephalopathies Samata Kamireddy, MD
11:45 AM - 12:45 PM CDT	Abstract	10-010 - Efficacy and Safety of Relutrigine in Pediatric Participants with SCN2A- and SCN8A-related Developmental and Epileptic Encephalopathies: Pivotal EMBOLD Cohort 2 Study Samata Kamireddy, MD
11:45 AM - 12:45 PM CDT	Abstract	4-001 - Ischemic versus Hemorrhagic Stroke in CADASIL Patients Joshua Grube
11:45 AM - 12:45 PM CDT	Abstract	4-002 - Analyzing the Epidemiologic Mortality Trends Among Patients with Comorbid Alzheimer’s Disease and Cerebrovascular Disease in the United States from 1999 to 2024: Insights from the CDC WONDER Database Daniel Isaza Pierotti, MD, MCSO
11:45 AM - 12:45 PM CDT	Abstract	4-003 - Hospital Outcomes of Patients with Small-vessel Stroke: A National Inpatient Sample Analysis, 2016 to 2021 Harendra Kumar
11:45 AM - 12:45 PM CDT	Abstract	4-004 - Association Between High-grade Carotid Stenosis and Cognitive Function: A Systematic Review and Meta-analysis Mahmoud Afia, MBBCh
11:45 AM - 12:45 PM CDT	Abstract	4-005 - Predictors of Acute Stroke in Delirious COVID-19 Patients: A Retrospective Study Abdullah Serhan, MD
11:45 AM - 12:45 PM CDT	Abstract	4-006 - Socioeconomic Disparities in Acute Stroke Care at a Safety-net Hospital: A Retrospective Cohort Study Christina Banat
11:45 AM - 12:45 PM CDT	Abstract	4-007 - National Analysis of Financial Distress in Adults with Cardiovascular and Cerebrovascular Conditions Soonmyung Hwang
11:45 AM - 12:45 PM CDT	Abstract	4-008 - Burden and Temporal Trends of Ischemic Stroke in South Asia, 1990–2023: Insights from the Global Burden of Disease Study 2023 Shahbaz Khan, Medical Student
11:45 AM - 12:45 PM CDT	Abstract	4-009 - Gender Disparities in Clinical Presentation and In-hospital Outcomes Among Hispanic Patients with Anterior Ischemic Stroke Carlos A. Rodríguez Alarcón, MD
11:45 AM - 12:45 PM CDT	Abstract	4-010 - Trends, Disparities, and Forecasting of Transient Ischemic Attack-related Mortality Among the Elderly: A 21-Year Retrospective Analysis Sara Zakris
11:45 AM - 12:45 PM CDT	Abstract	4-011 - National Trends in Ischemic Brain Injury and Cardiac Arrest Related Mortality in The United States from 1999–2024 : Insights From The CDC WONDER Database Sakina Shaikh
11:45 AM - 12:45 PM CDT	Abstract	4-012 - Epidemiology of Stroke in Pakistan and its Provinces, 1990-2021: Findings from the Global Burden of Disease Study 2021 Dhyey Sidhpura, MD
11:45 AM - 12:45 PM CDT	Abstract	4-014 - Stroke Hospitalization Rates Increased in Brazilian Adults While Remaining Stable Among the Elderly (2010-2024) Rebeca O. Silva, Student
11:45 AM - 12:45 PM CDT	Abstract	4-015 - Hypertension-Associated Stroke: Exploring Long-term Mortality Trends in the United States Sudheendra Lakshman Chintha, MD
11:45 AM - 12:45 PM CDT	Abstract	4-016 - Impact of Celebrity Stroke Disclosures: Online Trends and Public Awareness Radhika Patel
11:45 AM - 12:45 PM CDT	Abstract	4-017 - Neurological Outcomes in Cerebral Venous Sinus Thrombosis-an Observational Study Sankar P. Gorthi, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	4-018 - Antiphospholipid Syndrome and Ischemic Stroke: Racial and Socioeconomic Disparities in Mortality, Hospitalization, and Healthcare Costs AlDana J. Al-Khalaf
11:45 AM - 12:45 PM CDT	Abstract	4-019 - A Systematic Review and Pooled Analysis of Cases with Blood Transfusion-induced Posterior Reversible Encephalopathy Syndrome and/or Reversible Cerebral Vasoconstriction Syndrome Yazan Nouh, MD
11:45 AM - 12:45 PM CDT	Abstract	4-020 - Socioeconomic and Racial Disparities in Stimulant Drug Use-associated Stroke: Trends in Mortality, Hospitalization, and Resource Use Muhammad Ahmed, MD
11:45 AM - 12:45 PM CDT	Abstract	4-022 - Unmasking Atrial Cardiopathy: A Systematic Review and Meta-analysis of Left Atrial Strain Implicated in Embolic Stroke of Undetermined Source Sangharsha Thapa, MD
11:45 AM - 12:45 PM CDT	Abstract	19-001 - Neurofibromatosis and Multiple Sclerosis Under Cladribine Therapy: An Illustrative Unique Case and Systematic Review Oscar E. Gutierrez Trevino, MD
11:45 AM - 12:45 PM CDT	Abstract	19-002 - CAR-T Cell Therapy for Multiple Sclerosis: A Systematic Review of Emerging Clinical, Safety, and Biomarker Evidence Daniel V. De Siqueira Lima, Jr., MD
11:45 AM - 12:45 PM CDT	Abstract	19-003 - Safety Comparison of Teriflunomide and Next-generation BTK Inhibitors in Relapsing Multiple Sclerosis: Network Meta-analysis of Randomized Controlled Trials Meet Kachhadia, MBBS
11:45 AM - 12:45 PM CDT	Abstract	19-004 - Efficacy of Cognitive Behavioural Therapy on Fatigue in Persons With Multiple Sclerosis: A Systematic Review and Meta-analysis Anita Alizadeh
11:45 AM - 12:45 PM CDT	Abstract	19-005 - Opdualag-induced Central Nervous System Demyelination Mimicking Multiple Sclerosis: A Case Report Anusha Khawaja, MD
11:45 AM - 12:45 PM CDT	Abstract	19-006 - Clinical, Radiological, and Laboratory Features of Tumefactive Demyelinating Lesions Esra Gursoy
11:45 AM - 12:45 PM CDT	Abstract	19-008 - Rural vs Urban Use of Complementary and Alternative Medicine in Multiple Sclerosis Suryaa Gupta
11:45 AM - 12:45 PM CDT	Abstract	19-009 - Acute Worsening of Facial Weakness as a Presenting Symptom of Multiple Sclerosis in a Young Woman With Facioscapulohumeral Muscular Dystrophy (FSHD)- A Case Report Bakhtawar Ahmad, MBBS
11:45 AM - 12:45 PM CDT	Abstract	19-010 - Global and Cell-Type-Specific Gene Expression With Ozanimod, a S1P1 Modulator, in Multiple Sclerosis (MS) Fiona Samson
11:45 AM - 12:45 PM CDT	Abstract	13-001 - Rising Mortality Burden of Atrial Fibrillation and Parkinson’s Disease among Adults in the United States: A 24-year National Trend Analysis, 2000-2023 Muhammad Inam Ul Haq, MD, MBBS
11:45 AM - 12:45 PM CDT	Abstract	13-002 - E326K GBA Polymorphism is Associated with Clinical and Pathological Features of Synucleinopathy in the Absence of Overt Parkinson’s Disease or Lewy Body Dementia Moriah R. Arnold
11:45 AM - 12:45 PM CDT	Abstract	13-003 - A Pilot Myocardial MIBG Scintigraphy Study in Prodromal and Overt Dementia with Lewy Bodies Toji Miyagawa, MD, PhD
11:45 AM - 12:45 PM CDT	Abstract	13-004 - Neuronal ??-Synucleinopathy Distribution Within the Hippocampal Circuit Correlates with Microglial Activity in the CA2 Hippocampal Subfield of Lewy Body Dementia Patients Esteban Luna, MD, PhD
11:45 AM - 12:45 PM CDT	Abstract	13-006 - Response Trajectories of Patients with Parkinson’s Disease Psychosis Treated with Pimavanserin: An Exploratory Cluster Analysis Greg Brunson, PharmD
11:45 AM - 12:45 PM CDT	Abstract	13-007 - Impact of Baseline Sleep Disturbances on Pimavanserin Response in Parkinson’s Disease Psychosis: A Post Hoc Analysis Lambros Chrones, MD
11:45 AM - 12:45 PM CDT	Abstract	13-008 - Brief Estimate of Seconds Test: A New Paradigm for Evaluation of Time Perception in Parkinson's Disease Hannah Branstetter, MD
11:45 AM - 12:45 PM CDT	Abstract	13-009 - Preliminary Evidence that Neflamapimod has a Beneficial Effect on Basal Forebrain Atrophy Assessed by MRI in Dementia with Lewy Bodies John Alam
11:45 AM - 12:45 PM CDT	Abstract	13-010 - Association of Microinfarcts and Amyloid CoPathology with Cognitive Performance in Lewy Body Dementia Patrick Stancu, MD
11:45 AM - 12:45 PM CDT	Abstract	13-011 - Autopsy Validation of Biomarker-derived Biological Classifications in Lewy Body Disease Shannon Y. Chiu, MD, MSc
11:45 AM - 12:45 PM CDT	Abstract	13-012 - EEG-based Machine Learning Models for Early Detection of Dementia with Lewy Bodies in Isolated REM Sleep Behavior Disorder: A Scoping Review Mahmoud T. Hefnawy, MD
11:45 AM - 12:45 PM CDT	Abstract	13-013 - Multimodal Biomarkers of Prodromal Neurodegeneration: Integrating Speech, Alpha-synuclein, and Smell in RBD Saeid Sadeghian, MD
11:45 AM - 12:45 PM CDT	Abstract	5-001 - Advanced Cardiac Imaging Improves Diagnostic Yield and Management in ESUS: A Single-center Study Anastasiia Strelkova, MD
11:45 AM - 12:45 PM CDT	Abstract	5-002 - Length of Stay and Mortality of Patients with Intracerebral Hemorrhage in a Tertiary Center in the Dominican Republic: A Single Center Analysis. Ryna Then, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	5-003 - Unilateral Hemorrhagic Presentation of Amyloid Beta-related Angiitis: Expanding the Spectrum of Inflammatory Cerebral Amyloid Angiopathy Nidhila Masha, MD
11:45 AM - 12:45 PM CDT	Abstract	5-004 - Intracranial Hemorrhage A Rare Complication Secondary to Cerebrospinal Fluid Leak Post Spine Surgery Naser Haj Aissa, MBBS
11:45 AM - 12:45 PM CDT	Abstract	5-005 - Ruptured Anterior Inferior Cerebellar Artery (AICA) Aneurysm Presenting with Cranial Nerve Deficits: Case report and Management Overview Boris Kobilja, MD
11:45 AM - 12:45 PM CDT	Abstract	5-006 - Socioeconomic and Behavioral Determinants of Cerebral Venous Thrombosis: Associations Between Insurance, Smoking, and Regional Distribution Anshal Vyas
11:45 AM - 12:45 PM CDT	Abstract	5-007 - Cerebral Venous Thrombosis as Initial Manifestation of Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia with Secondary Antiphospholipid Syndrome: A Case Report Daniel F. Guijo, MD
11:45 AM - 12:45 PM CDT	Abstract	5-008 - Spinal Dural Arteriovenous Fistula with Radiological Features Of Longitudinally Extensive Transverse Myelitis Kin Mun Lau, MD
11:45 AM - 12:45 PM CDT	Abstract	5-009 - When Lightning Strikes Twice: Acute Ischemic Stroke and Intracranial Hemorrhage in a Patient with Candida Endocarditis Justine Chee, MD
11:45 AM - 12:45 PM CDT	Abstract	5-010 - Saddled With A Fistula; A Rare Case Of Spinal Dural AVF In An 81 Year Old Equestrian Joshua Fernandez
11:45 AM - 12:45 PM CDT	Abstract	5-011 - Managing Antithrombotic Treatment in Intracerebral Hemorrhage and Ischemic Stroke due to Cerebral Amyloid Angiopathy with Supporting Pathology: A Case Report Charlene Bustamante, MD
11:45 AM - 12:45 PM CDT	Abstract	5-012 - Needle in a Haystack: The Elusive CSF-venous Fistula Sathvik S. Shastry, MD
11:45 AM - 12:45 PM CDT	Abstract	5-013 - Machine Learning for Outcome Prediction and Rehabilitation in Hemorrhagic Stroke: Systematic Review SAI VENKATA MANOJ KOTHARU, MBBS
11:45 AM - 12:45 PM CDT	Abstract	5-014 - Diffuse Cerebral Microhemorrhages Following Intrathecal Nivolumab: A Case Report of a Rare Immune Checkpoint Inhibitor Neurotoxicity Tuqa Asedi, MD
11:45 AM - 12:45 PM CDT	Abstract	5-015 - Spontaneous Lobar Intracranial Hemorrhage Leading to Diagnosis of Streptococcus Sanguinis Endocarditis Ashwath Ravisankar, MD
11:45 AM - 12:45 PM CDT	Abstract	5-016 - Prognostic Value of Inflammatory Cytokines (IL-6, TNF-a, CRP) in Predicting Functional Outcome After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis Usama Abbas, MBBS
11:45 AM - 12:45 PM CDT	Abstract	5-017 - When Low Iron Strikes: A Rare Case of Cerebral Venous Sinus Thrombosis Triggered by Severe Iron Deficiency Anemia Adrian J. Diaz, DO
11:45 AM - 12:45 PM CDT	Abstract	5-018 - Concurrent Subdural Hemorrhage, Arteriovenous Fistula, and Dural Venous Sinus Thrombosis in a Patient with Myeloproliferative Disorder Michael V. Hood-Julien, MD
11:45 AM - 12:45 PM CDT	Abstract	5-019 - Neurological Deterioration in Intracerebral Haemorrhage at 72 Hours: A Prospective Observational Study FAYE A. SHAIKH III, MD
11:45 AM - 12:45 PM CDT	Abstract	5-021 - Preadmission retirement is associated with abnormal communication after hemorrhagic stroke Nikhil V. Avadhani, BA
11:45 AM - 12:45 PM CDT	Abstract	5-022 - The association between abnormal communication and neuropsychiatric outcomes after hemorrhagic stroke Nikhil V. Avadhani, BA
11:45 AM - 12:45 PM CDT	Abstract	16-001 - Emerging Mechanisms in Restless Legs Syndrome: Revisiting the Pathophysiology Over the Past 10 Years to Summarize Current Evidence on the Pathophysiology of Restless Legs Syndrome (RLS) Published Over the Past Decade (2015–2025) Tanya Baker, DO
11:45 AM - 12:45 PM CDT	Abstract	16-002 - Belly Dancer Dyskinesia in Pregnancy: A case report and literature review on a rare hyperkinetic disorder. Shiv K. Jha, MBBS
11:45 AM - 12:45 PM CDT	Abstract	16-003 - Huntington's Chorea Presenting with Atypical Parkinsonian Features: A Diagnostic Dilemma Praveen Nandha Kumar Pitchan Velammal, MBBS
11:45 AM - 12:45 PM CDT	Abstract	16-004 - Uncommon Movements in a Rare Syndrome: Adult-Onset Dystonia in 5p deletion Dhruv Bansal, MBBS, MRCP UK
11:45 AM - 12:45 PM CDT	Abstract	16-005 - Harvard Biomarkers Study 2.0: A Longitudinal Multi-modal Platform for Biomarker Discovery in Parkinson’s Disease and Related Disorders Daniel N. El Kodsi, PhD
11:45 AM - 12:45 PM CDT	Abstract	16-006 - Epidemiology of Sepsis-related Mortality in Parkinson Disease: A 25-year Analysis of U.S. Death Certificate Data Minahil Zaheer, MBBS
11:45 AM - 12:45 PM CDT	Abstract	16-007 - Reliability of Scoring Transforms of Wearable Sensor Signals in People with Parkinson’s Disease James R. Brasic, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	16-008 - Predicting REM Sleep Behavior Disorder in Early Parkinson's Disease using Graph Theory-enhanced Resting-state fMRI Analysis Alfonso Enrique Martinez Nunez, MD
11:45 AM - 12:45 PM CDT	Abstract	16-009 - Assessing Large Language Models as Multimodal Reasoning Engines for Parkinson's Disease Detection Mallikarjun Verma
11:45 AM - 12:45 PM CDT	Abstract	16-010 - Levodopa-responsive Early-onset Parkinsonism in a Patient with PPP2R5D-related Neurodevelopmental Disorder Ignacio J. Keller Sarmiento, MD
11:45 AM - 12:45 PM CDT	Abstract	16-011 - Decoding Parkinson’s Disease through Network Metrics of Inertial Sensor Data: A Machine Learning approach Salvatore Mazzeo
11:45 AM - 12:45 PM CDT	Abstract	16-012 - Association Between Plasma Alpha-synuclein and Non-motor Symptoms in Parkinson’s Disease: A Systematic Review and Meta-analysis Sama Almasri, MBBS
11:45 AM - 12:45 PM CDT	Abstract	16-014 - A Pathogenic Heterozygous Mutation Affecting ATP13A2 in Parkinson's Disease Anna Thomsen, MD
11:45 AM - 12:45 PM CDT	Abstract	16-015 - Higher Overall and DBS-Specific Genetic Variant Yield in the South Florida PD GENEration Cohort Priyanka Atit, DO
11:45 AM - 12:45 PM CDT	Abstract	2-001 - Diverse Neurological Manifestations in Neuro-Behcet’s Disease: A Case Series William R. Meador, MD
11:45 AM - 12:45 PM CDT	Abstract	2-002 - Area Postrema Syndrome: A New Paradigm in the Neurological Manifestation of Antiphospholipid Syndrome Veronica M. Andrade
11:45 AM - 12:45 PM CDT	Abstract	2-003 - Case Report: Highlighting the Classic Neuroimaging Features of Neuro-Behçet’s Disease and Dramatic Clinical-radiological Response to Immunosuppressive Treatment with Infliximab Hesamoldin Khodadadi Chamgordani, MD
11:45 AM - 12:45 PM CDT	Abstract	2-004 - A Long Cord and Short Circuit: Concurrent Central and Peripheral Nervous System Involvement in ANCA-associated Vasculitis Presenting as Longitudinally Extensive Myelitis Hannah W. Austin, MD
11:45 AM - 12:45 PM CDT	Abstract	2-005 - Microscopic Polyangiitis with a Twist: A Rare Case of CRAO and Brainstem Infarction Govind S. Mann, MBBS
11:45 AM - 12:45 PM CDT	Abstract	2-006 - MPO-ANCA Associated Vasculitis Following Intravesical BCG Therapy: A Novel Case Report Nikash Shankar, MD
11:45 AM - 12:45 PM CDT	Abstract	2-007 - Recurrent Cerebellitis in a Patient with Lupus Tina Bastin
11:45 AM - 12:45 PM CDT	Abstract	2-008 - Unmasking Sjögren’s Syndrome: Recurrent Facial Palsy as a Presenting Symptom Deya'a I. Alasmar, MD
11:45 AM - 12:45 PM CDT	Abstract	2-009 - A Dangerous Chameleon: A Case Report of Rheumatoid Central Nervous System Vasculitis Ping-Hao Yang, MD
11:45 AM - 12:45 PM CDT	Abstract	2-011 - Rheumatoid Meningitis: Clinical, Radiological, and Therapeutic Insights from a Complex Case Report Dante O. Oropeza Velazquez, Jr.
11:45 AM - 12:45 PM CDT	Abstract	2-012 - Mononeuritis Multiplex as a Manifestation of Small-Vessel Vasculitis: A Diagnostic Challenge Ereny Mikhael, MD
11:45 AM - 12:45 PM CDT	Abstract	2-013 - Integrating Autoantibody Profiles and Disease Activity for the Prediction of Neuropsychiatric Involvement in Systemic Lupus Erythematosus Nicole J. Al Alam Rabie
11:45 AM - 12:45 PM CDT	Abstract	2-014 - Systematic Review Unraveling the Complexities of Transverse Myelitis in Primary Antiphospholipid Syndrome: A Call for Predictive Biomarkers and Personalized Therapeutics Gelanys Castro Tejada, MD
11:45 AM - 12:45 PM CDT	Abstract	17-001 - The Association Between Parkinson's Patients' Development of Peripheral Neuropathy While on Chronic Carbidopa/Levodopa Treatment Mehar Durah, DO
11:45 AM - 12:45 PM CDT	Abstract	17-002 - Development of a Scale for Psychosis in Parkinson’s Disease: The Movement Disorders Society- Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS) Michelle H. Tosin, PhD, RN
11:45 AM - 12:45 PM CDT	Abstract	17-003 - Psychomotor Vigilance in Lewy Body Diseases: Comparative Performance and Association With Core Features Razan Hallak, MD
11:45 AM - 12:45 PM CDT	Abstract	17-004 - Inverse Association Between Parkinson’s Disease and Rheumatoid Arthritis: A Meta-analysis of Observational Studies Theres Alexander
11:45 AM - 12:45 PM CDT	Abstract	17-005 - Handwriting as a Quantitative Biomarker in Motor-Cognitive Neurological Disorders: A Systematic Review Umika S. Paul
11:45 AM - 12:45 PM CDT	Abstract	17-007 - Square Wave Jerk in De Novo Idiopathic Parkinson's Disease: Insights into the Dynamic Overshoot Subtype Hyun Sung Kim, MD
11:45 AM - 12:45 PM CDT	Abstract	17-008 - Pendular Hemi–See-Saw Nystagmus With Oculopalatal Tremor: Case Report and Systematic Review Fiorella E. Rivas Sarmiento, Dra
11:45 AM - 12:45 PM CDT	Abstract	17-009 - Downbeat Nystagmus in Association With the Dorsal Midbrain Syndrome Lea Saab, MD
11:45 AM - 12:45 PM CDT	Abstract	17-010 - Prevalence and Prognostic Significance of Autoantibody Profiles in Progression of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis Ginger Kwak, BS
11:45 AM - 12:45 PM CDT	Abstract	17-011 - When Dangerous HINTS is not so Dangerous: A Pitfall in Idiopathic Sudden Sensorineural Hearing Loss With Vertigo Hyun Sung Kim, MD
11:45 AM - 12:45 PM CDT	Abstract	17-012 - Effectiveness of Prism Therapy Versus Botulinum Toxin Injection in the Management of Sixth Cranial Nerve Palsy: A Systematic Review and Meta-analysis Areej Riaz, MBBS
11:45 AM - 12:45 PM CDT	Abstract	17-013 - Atypical Variant of GQ1 Antibody Syndrome: Ophthalmoplegia Without Sensory Ataxia, a Diagnostic Challenge Diana M. Riaño, MD
11:45 AM - 12:45 PM CDT	Abstract	17-014 - Secondary BPPV After Vestibular Neuritis, Don’t Miss It! Claire Allen, MD
11:45 AM - 12:45 PM CDT	Abstract	17-015 - "Why do I Keep Falling?" A Case of Vestibular Agnosia Kaitlyn E. Druyor, DO
11:45 AM - 12:45 PM CDT	Abstract	17-016 - Spontaneous Episodic Vertigo: Consider Vertebral Artery Compression Syndrome as a Differential Diagnosis Vishal G. Pawar, MBBS, DNB
11:45 AM - 12:45 PM CDT	Abstract	17-017 - A Case of Acute Vestibular Syndrome With a "Peripheral" HINTS+ Exam Despite a Central Vascular Etiology David Sandlin, MD, PhD
11:45 AM - 12:45 PM CDT	Abstract	11-001 - Status Epilepticus-related Demographic and Temporal Mortality Trends in the United States from 1999 to 2024: Insights from the CDC WONDER Database Anosh John, MBBS
11:45 AM - 12:45 PM CDT	Abstract	11-002 - The “Hope, Hesitancy, and Hard Truths” Survey: A Patient and Provider Perspective on Epilepsy Treatment Pavel Klein, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	11-003 - Emergency Department Presentations and Inpatient Outcomes Following Epilepsy Consultation: A Retrospective Analysis at a Tertiary Academic Center Diji Johnson, MBBS
11:45 AM - 12:45 PM CDT	Abstract	11-004 - Outcomes of Centro-median (CM) Thalamic Nucleus Stimulation by DBS vs RNS Device for Refractory Epilepsy Ryan Dahl, MD
11:45 AM - 12:45 PM CDT	Abstract	11-006 - Burnout Among U.S. Epilepsy Physicians: A National Survey of Prevalence and Predictors Brin Freund, MD
11:45 AM - 12:45 PM CDT	Abstract	11-007 - Determinants of Refractory Course and Outcomes in Adult Status Epilepticus at a Regional Center Curtis A. Amankwah, MD
11:45 AM - 12:45 PM CDT	Abstract	11-009 - Impact of magnetoencephalography (MEG) on clinical decision making in surgical epilepsy evaluations Christopher Phillips, MD
11:45 AM - 12:45 PM CDT	Abstract	11-010 - Patterns of Drop Seizure Outcome after Corpus Callosotomy in Children Alexander Yucht
11:45 AM - 12:45 PM CDT	Abstract	20-001 - Prevalence of Obesity in Multiple Sclerosis: Insights from Large-scale Real-world EHR Data Karim Borei
11:45 AM - 12:45 PM CDT	Abstract	20-002 - Trends in Mortality from Multiple Sclerosis With Sepsis as a Contributing Cause in the United States, 1999–2020: A Multiple Cause of Death Analysis Tirath Patel
11:45 AM - 12:45 PM CDT	Abstract	20-003 - Age Gap as a Biomarker of Neurodegeneration and Functional Decline in Multiple Sclerosis: Insights into Racial Differences Anas Z. Nourelden, MD
11:45 AM - 12:45 PM CDT	Abstract	20-004 - Features of Pediatric Multiple Sclerosis: Demographics, Phenotypes, and Treatments in a Cohort of 139 Patients at a Tertiary Center Benjamin M. Greenberg, MD, FAAN
11:45 AM - 12:45 PM CDT	Abstract	20-005 - Changes in Age at Death of People With Multiple Sclerosis in the United States: Sex-based Disparities,1999-2023 Keara Kennedy
11:45 AM - 12:45 PM CDT	Abstract	20-006 - Gut Microbiota Composition in Ukrainian Patients With Multiple Sclerosis and Associations With Disease-modifying Therapy Kateryna Potapova, MD
11:45 AM - 12:45 PM CDT	Abstract	20-007 - Tumefactive Lesions as Debut of Multiple Sclerosis Ana P. Sieben Samek, Jr., MD
11:45 AM - 12:45 PM CDT	Abstract	20-008 - Prevalence of Depression in Multiple Sclerosis in Latin America and the Caribbean: A Systematic Review and Meta-analysis Meiling M. Carbajal Galarza, MD
11:45 AM - 12:45 PM CDT	Abstract	20-009 - Analysis of the Correlation Between the Prevalence of Multiple Sclerosis and Food Habits/Lifestyle in Brazilian Capitals Valéria A. Salas
11:45 AM - 12:45 PM CDT	Abstract	20-010 - Assessing the Educational Impact of the Brain Health Masterclass in Multiple Sclerosis Care Bryan D. Clements II, DO
11:45 AM - 12:45 PM CDT	Abstract	20-011 - The Case for Familial Multiple Sclerosis in Von Hippel-Lindau Disease Konrad Kubicki, MD
11:45 AM - 12:45 PM CDT	Abstract	20-012 - Predictors of Cognitive Stability in Multiple Sclerosis: A Longitudinal Analysis Mahsa Mohajery, MD
11:45 AM - 12:45 PM CDT	Abstract	14-001 - Does Treatment for Insomnia Improve Sleep State Misperception? Dinesh Kumar
11:45 AM - 12:45 PM CDT	Abstract	14-002 - The Battle after Hours: Improving Detection of Bedtime Procrastination in Military Members Thomas Pelkmann, MD
11:45 AM - 12:45 PM CDT	Abstract	14-003 - Effectiveness of Transcranial Alternating Current Stimulation (tACS) in Patients Having Insomnia Symptoms: A Systematic Review and Meta-analysis Muhammad Moiz Javed, MD
11:45 AM - 12:45 PM CDT	Abstract	14-004 - Medical Cannabis for the Treatment of Insomnia: A Cochrane Systematic Review and Meta-analysis Lucia Belen Varela
11:45 AM - 12:45 PM CDT	Abstract	14-005 - Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS®) Improves Sleep Quality in Adults With Insomnia Jacob J. Shawwa
11:45 AM - 12:45 PM CDT	Abstract	14-006 - Circadian-Informed Analysis of Sleep Disruptions in Traumatic Brain Injury: Insights from Wearable Monitoring and Sleep Deprivation Angeliki Pollatou
11:45 AM - 12:45 PM CDT	Abstract	14-007 - The Impact of Anxiety on Subjective and Objective Wakefulness in Warfighters With Insomnia Claire M. Akard
11:45 AM - 12:45 PM CDT	Abstract	14-008 - Is Melatonin Safe? Effects of Short- and Long-term Exposure in Young Rats on Behavioral and Neurochemical Parameters in Adulthood TAIS L. DENICOL, MD
11:45 AM - 12:45 PM CDT	Abstract	14-009 - Non-invasive Brain Stimulation and Light-based Therapies for Sleep Dysregulation in Major Depressive Disorder: Evidence From a Parameter-stratified Network Meta-analysis of Randomized Controlled Trials SAI VENKATA MANOJ KOTHARU, MBBS
11:45 AM - 12:45 PM CDT	Abstract	14-010 - Once-nightly Pregabalin for Co-occurring Nightmares, Nonrestorative Sleep, and Headaches: A Case Series James Bates, Medical Student
11:45 AM - 12:45 PM CDT	Abstract	14-011 - Obstructive Sleep Apnea and Its Effects on Cerebrovascular Accident Risk Zoe Wilson
11:45 AM - 12:45 PM CDT	Abstract	8-001 - Our Experience with Combination Therapy and it’s Outcomes in Pediatric Subacute Sclerosing Panencephalitis: A Retrospective Case Series Bagath Srinivasan Balaji, MBBS
11:45 AM - 12:45 PM CDT	Abstract	8-002 - Real-world Practice and Early Outcomes of Hypoxic-ischaemic Encephalopathy: A Three-year Experience from a Tertiary Neonatal Unit Danyal Khan, MBBS
11:45 AM - 12:45 PM CDT	Abstract	8-003 - Neuroinflammatory Biomarkers in Autism Spectrum Disorder: A Systematic Review and Meta-analysis Mariana Letícia d. Maximiano, MD
11:45 AM - 12:45 PM CDT	Abstract	8-004 - Treatment of Fulminant Cerebellitis with Tocilizumab Liz C. Ballinger, MD, PhD
11:45 AM - 12:45 PM CDT	Abstract	8-005 - Tocilizumab as a Rescue Therapy for Acute Necrotizing Encephalopathy – Experience from A Tertiary Care Pediatric Neurology Unit in Western India. Ananya Talukdar
11:45 AM - 12:45 PM CDT	Abstract	8-007 - Hidden in Plain Sight: A Case Report of Incidental Sphenoid Sinusitis Unmasking Secondary Headache Suriya Subramanian, MD
11:45 AM - 12:45 PM CDT	Abstract	8-008 - Idiopathic Pediatric Oculomotor Nerve Palsy: Diagnostic Challenges and Therapeutic Response Tobias Kremsmayer, MS
11:45 AM - 12:45 PM CDT	Abstract	8-009 - HSV Encephalitis: Non-classical PCR Results with a Classical Clinical Presentation in a 5-year Old Girl Victoria Mazo, MD
11:45 AM - 12:45 PM CDT	Abstract	8-010 - Efficacy of Iron and Magnesium Supplementation as First-line Treatment for Pediatric Tic Disorders Allison Przekop, DO
11:45 AM - 12:45 PM CDT	Abstract	8-011 - Real-world Adverse Event Profile and Comorbidity Index in Children and Adolescents with Tourette Syndrome (TS) Treated with Dopamine D2 Receptor Antagonists David A. Isaacs, MD

Faculty Disclosures
Christopher Goetz, MD, FAAN	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Patricia K. Coyle, MD, FAAN	Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Mark G. Malkin, MD, FAAN	Dr. Malkin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Malkin has received publishing royalties from a publication relating to health care.
Eric R. Eggenberger, DO, FAAN	Dr. Eggenberger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Welch-Allyn. Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illinois Institute of Technology (IITT). Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Stephen L. Hauser, MD	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Joseph F. Quinn, MD, FAAN	Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Marc C. Patterson, MD, FRACP, FAAN	Dr. Patterson has received personal compensation for serving as an employee of IntraBio. The institution of Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme /KemPharm/Zevra. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azafaros. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IntraBio. Dr. Patterson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. Dr. Patterson has or had stock in IntraBio. The institution of Dr. Patterson has received research support from Glycomine. The institution of Dr. Patterson has received research support from Orphazyme /KemPharm/Zevra. The institution of Dr. Patterson has received research support from Idorsia. The institution of Dr. Patterson has received research support from Shire-Takeda. Dr. Patterson has received publishing royalties from a publication relating to health care. Dr. Patterson has received publishing royalties from a publication relating to health care.
Nabih Ramadan, MD, FAAN	Dr. Ramadan has nothing to disclose.
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
James F. Howard, Jr., MD, FAAN	Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx . Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron Pharmaceuticals. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Howard has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN (Horizon Therapeutics). Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Ltd. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck EMD Serono. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for H. Lundbeck A/S. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seismic Therapeutics. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Biopharma. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Academic CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PeerView CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Platform Q CME. Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MJH LifeSci. Dr. Howard has or had stock in Johnson & Johnson dividends.Dr. Howard has or had stock in Pfizer dividends. An immediate family member of Dr. Howard has or had stock in GlaxoSmithKline dividends.Dr. Howard has or had stock in Bristol Myer Squbb dividends.Dr. Howard has or had stock in AbbieVie Inc. The institution of Dr. Howard has received research support from Alexion Pharmaceuticals. The institution of Dr. Howard has received research support from argenx . The institution of Dr. Howard has received research support from UCB Biosciences. The institution of Dr. Howard has received research support from NIH. The institution of Dr. Howard has received research support from Centers for Disease Control/Research Triangle Institute. The institution of Dr. Howard has received research support from Cartestian Therapeutics. The institution of Dr. Howard has received research support from NMD Pharma. The institution of Dr. Howard has received research support from Ad Scientiam. The institution of Dr. Howard has received research support from Merck EMD Serono. Dr. Howard has a non-compensated relationship as a Scientific Advisiory Board member, Committee member with Myasthenia Gravis Foundation of America that is relevant to AAN interests or activities. Dr. Howard has a non-compensated relationship as a Committee member with American Assoc Neuromuscular and Electrodiagnostic Medicine that is relevant to AAN interests or activities.
Fenwick T. Nichols III, MD, FAAN	Dr. Nichols has nothing to disclose.
David S. Liebeskind, MD, FAAN	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Gil I. Wolfe, MD, FAAN	Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Vinay Chaudhry, MD, FAAN	Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care. Dr. Chaudhry has received intellectual property interests from a discovery or technology relating to health care.
Orhun H. Kantarci, MD	Dr. Kantarci has nothing to disclose.
Yunxia Wang, MD, FAAN	Dr. Wang has nothing to disclose.
Stephen N. Gomperts, MD, PhD, FAAN	Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cowen. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bob's Last Stand. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus Boston. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Expert connect. Dr. Gomperts has received personal compensation in the range of $0-$499 for serving as a Consultant for Mosaic. Dr. Gomperts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jannsen. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from LBDA. The institution of Dr. Gomperts has received research support from DOD/CDMRP. The institution of Dr. Gomperts has received research support from FFFPRI. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from MJFF. The institution of Dr. Gomperts has received research support from NIH. The institution of Dr. Gomperts has received research support from NIH. Dr. Gomperts has received intellectual property interests from a discovery or technology relating to health care.
Jennifer G. Goldman, MD, MS, FAAN	Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation Scientific Advisory Board. The institution of Dr. Goldman has received research support from Michael J. Fox Foundation. The institution of Dr. Goldman has received research support from Parkinson's Foundation.
Kottil W. Rammohan, MD	Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Rammohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Rammohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. The institution of Dr. Rammohan has received research support from Genentech. The institution of Dr. Rammohan has received research support from Genzyme. The institution of Dr. Rammohan has received research support from EMD Serono. The institution of Dr. Rammohan has received research support from Alexion.
Janet C. Rucker, MD	Dr. Rucker has nothing to disclose.
Annette M. Langer-Gould, MD, PhD	An immediate family member of Dr. Langer-Gould has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of American Thoracic Society. The institution of Dr. Langer-Gould has received research support from PCORI. The institution of an immediate family member of Dr. Langer-Gould has received research support from PCORI, ARQ, NIH. Dr. Langer-Gould has a non-compensated relationship as a Voting Member with ICER CTAF Panel that is relevant to AAN interests or activities.
Erika Driver-Dunckley, MD, FAAN	Dr. Driver-Dunckley has nothing to disclose.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Howard L. Geyer, MD, PhD	Dr. Geyer has received publishing royalties from a publication relating to health care.
Shawn M. Smith, MD	Dr. Smith has nothing to disclose.
Jacinda B. Sampson, MD, PhD	Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
Bruce A. Cree, MD, PhD, MAS, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Erik K. St. Louis, MD	The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Orrin Devinsky, MD, FAAN	Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
David D. Song, MD, PhD	Dr. Song has nothing to disclose.
Donald Gilbert, MD, FAAN	Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex Biosciences. The institution of Dr. Gilbert has received research support from PTC Therapeutics. The institution of Dr. Gilbert has received research support from Department of Defense. The institution of Dr. Gilbert has received research support from Quince Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Robert A. Gross, MD, PhD, FAAN	Dr. Gross has received publishing royalties from a publication relating to health care.
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
Anette E. Schrag, MD	Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer ingelheim. Dr. Schrag has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. The institution of Dr. Schrag has received research support from NIHR, EU, Parkinson's UK, MDS.
Brett C. Meyer, MD	Dr. Meyer has received personal compensation in the range of $0-$499 for serving as a Consultant for Sevaro Health. An immediate family member of Dr. Meyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chiesi.
Catherine Cho, MD	Dr. Cho has nothing to disclose.
Carlos Singer, MD	Dr. Singer has nothing to disclose.
Farrah J. Mateen, MD, PhD, FAAN	Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
George J. Hutton, MD, FAAN	Dr. Hutton has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Autoimmunity Biologic Solutions, Inc.. The institution of Dr. Hutton has received research support from Biogen. The institution of Dr. Hutton has received research support from Genentech. The institution of Dr. Hutton has received research support from Genzyme.
Hossam H. AbdelSalam, MD, FAAN	Dr. AbdelSalam has nothing to disclose.
Babak Boroojerdi, MD	Dr. Boroojerdi has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boroojerdi has stock in UCB Biosciences.
Ratna K. Bhavaraju-Sanka, MD, FAAN	Dr. Bhavaraju-Sanka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Bhavaraju-Sanka has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen.
Maria P. Amato, PhD	Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Javier Pagonabarraga	Javier Pagonabarraga has nothing to disclose.
Jennifer A. Frontera, MD	Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician Education Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Alberto Cifelli	No disclosure on file
Pushpa Narayanaswami, MD, MBBS, FAAN	Dr. Narayanaswami has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for UCB. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx USA. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD pharma. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD-Serono (Merck usa). Dr. Narayanaswami has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Immuneabs. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta-Bio. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Narayanaswami has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vor Bio. Dr. Narayanaswami has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Muscle and Nerve, Wiley. Dr. Narayanaswami has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Narayanaswami has or had stock in Dr. Reddys laboratories.Dr. Narayanaswami has or had stock in Doximity. The institution of Dr. Narayanaswami has received research support from Alexion. The institution of Dr. Narayanaswami has received research support from NIH. The institution of Dr. Narayanaswami has received research support from Argenx. The institution of Dr. Narayanaswami has received research support from Cabaletta Bio. Dr. Narayanaswami has received publishing royalties from a publication relating to health care. Dr. Narayanaswami has a non-compensated relationship as a Member, Finance Committee with AANEM that is relevant to AAN interests or activities.
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Devin L. Brown, MD, FAAN	The institution of Dr. Brown has received research support from NIH.
Elaine C. Wirrell, MD, FAAN	Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Fen Bao	Fen Bao has nothing to disclose.
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Chad Carlson, MD, FAAN	Dr. Carlson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with US Department of Justice.
Holly A. Shill, MD, FAAN	Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Sami L. Khella, MD, FAAN	Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos.
Violaine Plante-Bordeneuve, MD	Dr. Plante-Bordeneuve has nothing to disclose.
Ricardo A. Maselli, MD	Dr. Maselli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARGENX. Dr. Maselli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst.
Thomas Beach	Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Frederick E. Munschauer III, MD, FAAN	Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Dina Jacobs, MD	Dr. Jacobs has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/EMD Serono. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharmaceuticals. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for William Blair &Company . Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . The institution of Dr. Jacobs has received research support from Roche/Genentech .
Anthony Reder, MD	Dr. Reder has nothing to disclose.
John Papatriantafyllou, MD	Dr. Papatriantafyllou has nothing to disclose.
Khalil Ali, MD	Dr. Ali has nothing to disclose.
Seung-Han Lee, MD, PhD	Dr. Lee has nothing to disclose.
Sandra Vukusic, MD	The institution of Dr. Vukusic has received research support from Biogen. The institution of Dr. Vukusic has received research support from Janssen. The institution of Dr. Vukusic has received research support from Merck. The institution of Dr. Vukusic has received research support from Novartis. The institution of Dr. Vukusic has received research support from Roche.
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Scott Przybelski	Scott Przybelski has nothing to disclose.
Diego Cadavid, MD, FAAN	Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Owen A. Ross, PhD	Dr. Ross has nothing to disclose.
Martin Brodie	Martin Brodie has nothing to disclose.
Emilio Perucca	Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SKB Life Sciences. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharma. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN Therapeutics. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sun Pharma. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Xenon Pharma. Emilio Perucca has received publishing royalties from a publication relating to health care. Emilio Perucca has received publishing royalties from a publication relating to health care.
Deanna Saylor, MD, MHS, FAAN	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from American Academy of Neurology. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Gene H. Barnett, MD	Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical. Dr. Barnett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Monteris Medical.
William O. Tatum IV, DO, FAAN	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Robin R. Lincoln	Robin R. Lincoln has nothing to disclose.
Heather Adams	The institution of Heather Adams has received research support from Current: NIH; Past: Abeona; Batten Research Alliance; American University Centers on Disabilities. An immediate family member of Heather Adams has received publishing royalties from a publication relating to health care. Heather Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Critical Path Institute.
Timothy E. Lotze, MD, FAAN	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
David G. Vossler, MD, FAAN	Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals. Dr. Vossler has received publishing royalties from a publication relating to health care.
Dinesh Kumar	Dinesh Kumar has received personal compensation for serving as an employee of Eisai Inc.
Leonard van den Berg, MD	The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Michael Strupp, MD, DO, FAAN	Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has or had stock in IntraBio.
Hiba A. Haider, MD	Dr. Haider has received publishing royalties from a publication relating to health care. Dr. Haider has received publishing royalties from a publication relating to health care.
Sigmund H. Hsu, MD	No disclosure on file
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Khashayar Dashtipour, MD, PhD	Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acadia. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for kyowa kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal . Dr. Dashtipour has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for neurocrine . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for teva. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for abbvie. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for kyowa Kirin . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for amneal . Dr. Dashtipour has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Dashtipour has received research support from Abbvie. The institution of Dr. Dashtipour has received research support from ipsen. The institution of Dr. Dashtipour has received research support from amneal.
Alain Creange	Alain Creange has nothing to disclose.
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Darin Zahuranec, MD, MS	The institution of Dr. Zahuranec has received research support from NIH.
J. Douglas Miles, MD, PhD, FAAN	Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Tracey A. Milligan, MD, FAAN	Dr. Milligan has received publishing royalties from a publication relating to health care.
Bhupendra O. Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ER Squibb (Bristol Myer Squibb). Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizone. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyne. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Khatri has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seronoe. Dr. Khatri has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for E.R. Squibb. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutic. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx US. The institution of Dr. Khatri has received research support from Biogen.
Hector R. Martinez, MD	Dr. Martinez has nothing to disclose.
Marios Hadjivassiliou	Marios Hadjivassiliou has nothing to disclose.
Khalid I. El-Salem, MD, FAAN	Dr. El-Salem has nothing to disclose.
Roland G. Henry, PhD	Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
Rebecca Spain, MD, MSPH, FAAN	Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Lakshmi N. Ranganathan, MD, PhD, FAAN	Dr. Ranganathan has nothing to disclose.
Leonel Cantu-Martinez, MD	Dr. Cantu-Martinez has nothing to disclose.
Kinga Tomczak, MD, PhD	Dr. Tomczak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Tomczak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Emalex Biosciences, Inc.. Dr. Tomczak has received personal compensation in the range of $0-$499 for serving as a Consultant for Frazier Life Sciences. Dr. Tomczak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Tomczak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tomczak has received personal compensation in the range of $0-$499 for serving as a Consultant for Health Advances. Dr. Tomczak has received personal compensation in the range of $0-$499 for serving as a Consultant for Alpha Sights. Dr. Tomczak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Expert Connect. Dr. Tomczak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex Biosciences, Inc.. The institution of Dr. Tomczak has received research support from Emalex Biosciences, Inc.. The institution of Dr. Tomczak has received research support from Noema Pharma.
Hamada H. Altalib, DO	The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
Allison Przekop, DO	Dr. Przekop has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Przekop has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acadia.
Srikanth Muppidi, MD, FAAN	Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Jeremy Moeller, MD, FAAN	Dr. Moeller has received publishing royalties from a publication relating to health care.
Daniel O. Claassen, MD, FAAN	Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Michigan. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics . Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from CHDI.
Melissa Brock	Melissa Brock has nothing to disclose.
Refujia Gomez	Refujia Gomez has nothing to disclose.
David Irwin, MD	The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Edoardo Malfatti, MD	Dr. Malfatti has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark therapeutics. Dr. Malfatti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from Spark Therapeutics. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from ANR.
Albert Saiz	Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Afsaneh Shirani, MD, FAAN	Dr. Shirani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics.
Madhu Soni, MD, FAAN	Dr. Soni has received personal compensation in the range of $500-$4,999 for serving as a Physician Lead (Honorarium) in Women Leading in Neurology Program with American Academy of Neurology.
Michael K. Hehir II, MD	Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Hehir has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum- American Academy of Neurology. Dr. Hehir has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Hehir has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. Hehir has received research support from University of Vermont Medical Center.
Richard J. Nowak, MD	Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janseen . The institution of Dr. Nowak has received research support from UCB. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Janseen. The institution of Dr. Nowak has received research support from Immunovant . The institution of Dr. Nowak has received research support from argenx. The institution of Dr. Nowak has received research support from Amgen. Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Deborah Gelinas, MD	Dr. Gelinas has received personal compensation for serving as an employee of argenx. Dr. Gelinas has stock in argenx.
Flavia Nelson, MD	Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis.
Pavel Klein, MD, FAAN	The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Ricardo Roda, MD, PhD	Dr. Roda has nothing to disclose.
Deepak S. Nair, MD	Dr. Nair has nothing to disclose.
Augusto A. Miravalle, MD, FAAN	Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
Lily Wong-Kisiel, MD, FAAN	Dr. Wong-Kisiel has nothing to disclose.
Ryan Hays, MD, MBA, FAES, FAAN	Dr. Hays has nothing to disclose.
Carly Siskind, MS	Ms. Siskind has nothing to disclose.
Randall L. Woltjer	Randall L. Woltjer has nothing to disclose.
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Gustavo A. Patino, MD, PhD	Dr. Patino has nothing to disclose.
Daniel Weintraub	Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Matthew T. Hoerth, MD, FAAN	Dr. Hoerth has a non-compensated relationship as a Epilepsy.com Editorial Board member with the Epilepsy Foundation of America that is relevant to AAN interests or activities.
Tomoko Kitago, MD	Dr. Kitago has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MindMaze. The institution of Dr. Kitago has received research support from American Speech-Language Hearing Foundation. The institution of Dr. Kitago has received research support from National Institutes of Health.
Margaret Moline	Margaret Moline has received personal compensation for serving as an employee of EISAI, INC.. Margaret Moline has received intellectual property interests from a discovery or technology relating to health care. Margaret Moline has received personal compensation in the range of $0-$499 for serving as a review, loan repayment program with NIH.
Dimitri Krainc, MD, PhD	Dr. Krainc has nothing to disclose.
Jacqueline Bernard, MD, FAAN	Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2ND MD. Dr. Bernard has received publishing royalties from a publication relating to health care.
Alice Chen-Plotkin, MD	Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Educational Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Megan Donohue, MD	Dr. Donohue has nothing to disclose.
Antonio Gil-Nagel, MD	Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $0-$499 for serving as a Consultant for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI . Dr. Gil-Nagel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GW Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC Therapeutics . Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Gil-Nagel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix . The institution of Dr. Gil-Nagel has received research support from Jazz Pharmaceuticals. The institution of Dr. Gil-Nagel has received research support from PTC Therapeutics. The institution of Dr. Gil-Nagel has received research support from Zogenix. The institution of Dr. Gil-Nagel has received research support from Agencia Estatal Innovacion.
Eugenio M. Guevara, MD	Dr. Guevara has nothing to disclose.
David E. Kahn, MD	An immediate family member of Dr. Kahn has received personal compensation for serving as an employee of Essai.
Chafic Y. Karam, MD	Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied therapeutics. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intellia. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex.
George Karkanias, PhD	Dr. Karkanias has received personal compensation for serving as an employee of Emalex Biosciences, Inc.
Vikram Khurana, MD, PhD	Dr. Khurana has received personal compensation for serving as an employee of DaCapo BrainScience. An immediate family member of Dr. Khurana has received personal compensation for serving as an employee of Arbor Therapeutics. Dr. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda Pharmaceuticals. Dr. Khurana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Khurana has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DaCapo Brainscience. Dr. Khurana has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. Dr. Khurana has stock in DaCapo Brainscience. The institution of Dr. Khurana has received research support from Sanofi. The institution of Dr. Khurana has received research support from Janssen. The institution of Dr. Khurana has received research support from Biohaven. The institution of Dr. Khurana has received research support from Tiziana Life Sciences. Dr. Khurana has received intellectual property interests from a discovery or technology relating to health care.
Ngoc Minh D. Le, MD	Dr. Le has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Le has stock in Neurona Therapeutics.
Corneliu C. Luca, MD	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Rohit A. Marawar, MD, FAAN	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Sokratis Papageorgiou, MD	Dr. Papageorgiou has nothing to disclose.
George M. Plotkin, MD, PhD	The institution of Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic.
Christopher Schwarz	The institution of Christopher Schwarz has received research support from NIH.
Joshua Tobin, MD, FAAN	An immediate family member of Dr. Tobin has received personal compensation for serving as an employee of Amgen. Dr. Tobin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tobin has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Yessar M. Hussain, MD	The institution of Dr. Hussain has received research support from Alnylam Pharma.
Yakov Isakov, DO	Dr. Isakov has nothing to disclose.
Nada G. Abou Fayssal, MD, FAAN	Dr. Abou Fayssal has nothing to disclose.
Arun R. Antony, MD	Dr. Antony has nothing to disclose.
Christine Belden	Christine Belden has nothing to disclose.
Brian Berman, MD, MS, FAAN	The institution of Dr. Berman has received research support from Dystonia Medical Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health. The institution of Dr. Berman has received research support from Neurocrine Biosciences. The institution of Dr. Berman has received research support from Benign Essential Blepharospasm Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Rima N. El-Abassi, MD	Dr. El-Abassi has nothing to disclose.
Xuan Feng, PhD	The institution of Dr. Feng has received research support from BMS.
Adham Kamel, MD	Dr. Kamel has nothing to disclose.
Kristen M. Krysko, MD	Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Krysko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Krysko has received research support from MS Society of Canda. The institution of Dr. Krysko has received research support from Roche.
Maria I. Leite, MD	The institution of Dr. Leite has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon / Amgen. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Leite has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela/Horizon/Amgen. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Leite has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Leite has received research support from Non-Profit Organization - Myaware. The institution of Dr. Leite has received research support from UCB - Ra Pharma. The institution of Dr. Leite has received research support from Non-Profit Organization - Muscular Dystrophy UK.
Aaron Lord, MD	Dr. Lord has nothing to disclose.
Henry P. Moore, MD	Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Cormac A. O'Donovan, MD	Dr. O'Donovan has nothing to disclose.
Roger J. Porter, MD, FAAN	Dr. Porter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axonis. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bright MInds Bioscience. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobah. Dr. Porter has received publishing royalties from a publication relating to health care.
Liana Rosenthal, MD	Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Pharmaceuticals. Dr. Rosenthal has received research support from NIH. Dr. Rosenthal has received research support from Gordon and Marilyn Macklin Foundation. Dr. Rosenthal has received research support from The Daniel B. and Florence E. Green Foundation. Dr. Rosenthal has received research support from National Ataxia Foundation. Dr. Rosenthal has received research support from Michael J. Fox Foundation. Dr. Rosenthal has received research support from Pfizer. Dr. Rosenthal has received research support from Biohaven Pharmaceuticals. Dr. Rosenthal has a non-compensated relationship as a Medical Director, ex-officio Member of the Board with National Ataxia Foundation that is relevant to AAN interests or activities.
Roberto E. Sanchez, MD	Dr. Sanchez has nothing to disclose.
Christopher A. Scheiner, MD, PhD	Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx Pharmaceuticals. Dr. Scheiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansssen. Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for CSL Behring . Dr. Scheiner has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals . Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Scheiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Scheiner has received research support from Alexion Pharmaceuticals .
James Stark, MD, FAAN	Dr. Stark has nothing to disclose.
Camilo Toro, MD, FAAN	Dr. Toro has received personal compensation in the range of $100,000-$499,999 for serving as a TORO with NIH/IRP.
Armistead Williams III, MD	Dr. Williams has nothing to disclose.
Jay-Jiguang Zhu, MD, PhD, FAAN	The institution of Dr. Zhu has received research support from Novocure, Inc. The institution of Dr. Zhu has received research support from ABM Therapeutics Corporation . The institution of Dr. Zhu has received research support from Chimerix Inc.
Douglas M. Smith, MD	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pyros Pharma. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher-Smith. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Thomas M. Hemmen, MD, PhD	Dr. Hemmen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck & Co. Dr. Hemmen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. The institution of Dr. Hemmen has received research support from NIH.
Bassem I. Yamout, MD, FAAN	Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Asif Doja, MD, FAAN	Dr. Doja has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Education . Dr. Doja has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for the CMPA. Dr. Doja has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Integra . Dr. Doja has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Connect Care .
Michael J. Howell, MD, FAAN	The institution of Dr. Howell has received research support from National Institutes of Health. Dr. Howell has received publishing royalties from a publication relating to health care.
Haatem M. Reda, MD	Dr. Reda has nothing to disclose.
Katherine C. Nickels, MD, FAAN	Dr. Nickels has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ApotheCom Associates, LLC- Longboard. Dr. Nickels has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Med Learning Group. Dr. Nickels has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape Education. The institution of Dr. Nickels has received research support from Neurocrine Biosciences, Inc. The institution of Dr. Nickels has received research support from Stoke Therapeutics. Dr. Nickels has received personal compensation in the range of $500-$4,999 for serving as a Faculty with J. Kiffin Penry Educational Programs.
Vikram Bhise, MD	Dr. Bhise has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharmaceuticals. The institution of Dr. Bhise has received research support from Horizon Blue Cross Blue Shield.
Amy K. Guzik, MD, FAAN	Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Rebecca L. Hurst, MD	Dr. Hurst has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Paul Wilkinson law firm.
Shruti P. Agnihotri, MD	An immediate family member of Dr. Agnihotri has stock in Pfizer. The institution of Dr. Agnihotri has received research support from Roche/ Genentech.
David Bearden, MD	Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Bearden has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms.
John Probasco, MD, FAAN	Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech.
Sanjay Pandey, MD	Dr. Pandey has nothing to disclose.
Oluwadamilola O. Ojo, MD	Dr. Ojo has nothing to disclose.
Raghav Govindarajan, MD, FAAN	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Irena Dujmovic Basuroski, MD, PhD	The institution of Dr. Dujmovic Basuroski has received research support from Alexion Pharmaceuticals, Inc. The institution of Dr. Dujmovic Basuroski has received research support from Biogen MA Inc. The institution of Dr. Dujmovic Basuroski has received research support from EMD Serono Research and Development Institute, Inc . The institution of Dr. Dujmovic Basuroski has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Dujmovic Basuroski has received research support from The Bodford Family Transverse Myelitis Center Fund. The institution of Dr. Dujmovic Basuroski has received research support from CorEvitas, LLC. The institution of Dr. Dujmovic Basuroski has received research support from Novartis. The institution of Dr. Dujmovic Basuroski has received research support from Ad Scientiam. Dr. Dujmovic Basuroski has received personal compensation in the range of $0-$499 for serving as a Travel -related expenses to attend clinical trial investigator meeting with Novartis. Dr. Dujmovic Basuroski has received personal compensation in the range of $500-$4,999 for serving as a International Clinical Consortium Member, Travel -related expenses to attend the meeting with The Guthy-Jackson Charitable Foundation.
Lana Harder, PhD	Dr. Harder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals.
Vikram Prabhu	Vikram Prabhu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zeiss.
Francisco A. Rodriguez Leal, MD	Dr. Rodriguez Leal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Rodriguez Leal has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Rodriguez Leal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Tamara Shiner	Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli lilly. Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tamara Shiner has received research support from MJFF.
Sasha Alick-Lindstrom, MD, MPH FACNS, FAES, FAAN	Dr. Alick-Lindstrom has nothing to disclose.
Said R. Beydoun, MD, FAAN	Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Beydoun has received research support from Abcuro. The institution of Dr. Beydoun has received research support from Sean Healy & AMG Center for ALS. The institution of Dr. Beydoun has received research support from Regeneron. The institution of Dr. Beydoun has received research support from RemeGen. The institution of Dr. Beydoun has received research support from Sanofi. The institution of Dr. Beydoun has received research support from Novartis.
Ryna Then, MD, FAAN	Dr. Then has nothing to disclose.
Jocelyn Y. Cheng, MD, FAAN	Dr. Cheng has received personal compensation for serving as an employee of Eisai Inc.
Carla E. Santiago-Martinez	Ms. Santiago-Martinez has nothing to disclose.
Matthew Brock, MD	Dr. Brock has received research support from Department of Defense, Defense Health Program, Congressionally Directed Medical Research Programs.
Cornelia Drees, MD	Dr. Drees has nothing to disclose.
Amber Mitchell, MD	Dr. Mitchell has nothing to disclose.
Matthew J. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Kyowa Kirin. The institution of Dr. Barrett has received research support from NIH.
Yolanda Blanco Morgado, MD	Dr. Blanco Morgado has nothing to disclose.
Jessica H. Goldstein, MD, FAAN	Dr. Goldstein has nothing to disclose.
Sara Llufriu	Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merci. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbot. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Ariol Labrada, MD	Dr. Labrada has nothing to disclose.
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Tiago Mestre, MD, MSC	Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CHDI. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Mestre has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mestre has received research support from CIHR. The institution of Dr. Mestre has received research support from Ontario Research Fund. The institution of Dr. Mestre has received research support from MJFF. The institution of Dr. Mestre has received research support from Parkinson Canada. The institution of Dr. Mestre has received research support from University of Ottawa/PRC.
Tuan H. Vu, MD	Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VOR. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR. The institution of Dr. Vu has received research support from NMD Pharma. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with AcademicCME. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with CMEO. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with PER. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Faculty with MedLive.
Nataliya Ternopolska, MD	Dr. Ternopolska has nothing to disclose.
Ge Xiong, MD	The institution of Dr. Xiong has received research support from Argenx.
Kara R. Melmed, MD	Dr. Melmed has nothing to disclose.
Joome Suh, MD	Dr. Suh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Suh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx.
Annapoorna Bhat, MD	Dr. Bhat has nothing to disclose.
Ingrid E. Scheffer, MBBS, PhD, FRACP, AO	Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals, Inc. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Longboard Pharmaceuticals . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bellberry Ltd. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Einstein Visiting Fellowship. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Akumentis. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Biocodex. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Chiesi . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Travel/Conference/Speaker honoraria with Stoke Therapeutics. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Zuellig Pharma Inc.. Dr. Scheffer has a non-compensated relationship as a Trial Investigator with Anavex Life Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerecin that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cereval Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Biohaven Ltd. that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Scientific Advisory Board, Trial investigator with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with EpiMinder Inc that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with ES-Therapeutics that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Bright Minds Biosciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Marinus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neurocrine BioSciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neuren Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Praxis Precision Medicines that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator, Scientific Advisory Board with Takeda Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Xenon Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Zogenix that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epileptic Disorders that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Progress in Epileptic Disorders series that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with The Lancet Neurology that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Australian Academy of Health and Medical Sciences that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Royal Society (Australia). that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Shanghai Zhimeng Biopharma that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with SK Life Science that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Supernus Pharmaceuticals that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with UCB Biopharma SRL that is relevant to AAN interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Ultragenyx that is relevant to AAN interests or activities.
Arielle M. Kurzweil, MD, FAAN	Dr. Kurzweil has nothing to disclose.
Noam Epstein, MD	Dr. Epstein has received personal compensation for serving as an employee of Praxis Precision Medicines.
Erin M. Feinstein, DO	Dr. Feinstein has nothing to disclose.
Rony Dekermenjian, MD	Dr. Dekermenjian has nothing to disclose.
Amelia K. Adcock, MD	The institution of an immediate family member of Dr. Adcock has received research support from NIH.
Muhammad Taimur A. Malik, MD	Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. The institution of Dr. Malik has received research support from National MS Society .
Ricardo Alonso	Ricardo Alonso has nothing to disclose.
Benjamin H. Brinkmann, PhD	Dr. Brinkmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. The institution of Dr. Brinkmann has received research support from Neurelis Inc. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care.
Ziv Gan-Or, MD, PhD	Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Gan-Or has received personal compensation in the range of $0-$499 for serving as a Consultant for Lighthouse. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Handl Therapeutics. Dr. Gan-Or has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial Biotech.
Amrita Amanda D. Vuppala, MD	Dr. Vuppala has nothing to disclose.
Michael W. Ruff, MD	Dr. Ruff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Radmetrix. Dr. Ruff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Ruff has received intellectual property interests from a discovery or technology relating to health care.
Veronica E. Santini, MD, MA, FAAN	Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion NeuroStim, Inc. The institution of Dr. Santini has received research support from MeiraGTx, LLC. The institution of Dr. Santini has received research support from Ono Pharmaceuticals. The institution of Dr. Santini has received research support from Lundbeck. The institution of Dr. Santini has received research support from American Parkinson Disease Association. The institution of Dr. Santini has received research support from Mission MSA. The institution of Dr. Santini has received research support from CurePSP. The institution of Dr. Santini has received research support from Parkinson Foundation. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with American Academy of Neurology. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a course director and for committee responsibilities with International Parkinson and Movement Disorders Society. Dr. Santini has received personal compensation in the range of $0-$499 for serving as a invited speaker with Parkinson Study Group. Dr. Santini has received personal compensation in the range of $500-$4,999 for serving as a data safety monitoring board with NIH.
Nuri Jacoby, MD, FAAN	Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for N/A.
James R. Brasic, MD, FAAN	Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Image Guided Therapy Research Institute. Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for One World, Inc.. Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Society of Nuclear Medicine and Molecular Imaging. Dr. Brasic has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multidisciplinary Digital Publishing Institute. Dr. Brasic has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Gerson Lehman Group, Inc..
J. H. Harvey, DO	Dr. Harvey has received personal compensation for serving as an employee of Neuralogix. Dr. Harvey has received personal compensation for serving as an employee of Integris . Dr. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Harvey has stock in Epiminder.
Ciro Ramos Estebanez, MD, PhD, MBA, FAAN	The institution of Dr. Ramos Estebanez has received research support from NIH. Dr. Ramos Estebanez has received intellectual property interests from a discovery or technology relating to health care.
Royya F. Modir, MD	Dr. Modir has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medtronic .
Jose L. Torres, MD	Dr. Torres has nothing to disclose.
Philip Van Damme	The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for QurAlis. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for VectorY. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NRG Therapeutics. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van Damme has received research support from CSL Behring.
Kunal Agrawal, MD	Dr. Agrawal has nothing to disclose.
David A. Isaacs, MD	The institution of Dr. Isaacs has received research support from NIH NINDS. The institution of Dr. Isaacs has received research support from Teva Branded Pharmaceutical Products, R&D, Inc.. The institution of Dr. Isaacs has received research support from Emalex Biosciences, Inc. Dr. Isaacs has received personal compensation in the range of $0-$499 for serving as a attendee at the annual meeting for Center of Excellence Directors with Tourette Association of America. Dr. Isaacs has a non-compensated relationship as a research collaborator with Emalex Biosciences, Inc that is relevant to AAN interests or activities.
Scott M. Belliston, DO	Dr. Belliston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Shamik Bhattacharyya, MD, FAAN	Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLambda. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bhattacharyya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bhattacharyya has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Bhattacharyya has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Merck. The institution of Dr. Bhattacharyya has received research support from Alexion Pharmaceuticals. The institution of Dr. Bhattacharyya has received research support from National Institute of Health. The institution of Dr. Bhattacharyya has received research support from UCB. The institution of Dr. Bhattacharyya has received research support from Genentech. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care. Dr. Bhattacharyya has received publishing royalties from a publication relating to health care.
Anza B. Memon, MD, FAAN	Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inlightened. Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research. Dr. Memon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutic . The institution of Dr. Memon has received research support from Genentech. The institution of Dr. Memon has received research support from TG Therapeutics.
Sharon Stoll, DO	Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for roche Genentech. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi/genzyme. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Stoll has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for alexion. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono . Dr. Stoll has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. Dr. Stoll has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Stoll has stock in BeCare Link LLC. Dr. Stoll has stock in Global Consult MS .
Ahmed M. Yassin, MD	Dr. Yassin has nothing to disclose.
Alexander J. Gill, MD, PhD	Dr. Gill has received personal compensation for serving as an employee of Novartis Pharmaceuticals Corporation. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medical Logix, LLC. Dr. Gill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Health Union, LLC . Dr. Gill has received research support from National Multiple Sclerosis Society. Dr. Gill has a non-compensated relationship as a President, Treasurer, and Member of Board of Directors with Autoimmune Neurology Research Consortium, Inc. that is relevant to AAN interests or activities.
Bhaskar Roy, MD, FAAN	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Roy has or had stock in Cabaletta bio. .Dr. Roy has or had stock in Pfizer.Dr. Roy has or had stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
Michelle P. Lin, CRC	Dr. Lin has nothing to disclose.
Sankar P. Gorthi, MD, FAAN	Dr. Gorthi has nothing to disclose.
Benjamin R. Claytor, MD	Dr. Claytor has nothing to disclose.
Cuiping Chen	Cuiping Chen has stock in Jazz Pharmacenticals.
Geidy Serrano	Geidy Serrano has nothing to disclose.
Muhammad Ahmed, MD	Dr. Ahmed has nothing to disclose.
Nitin Tandon	Nitin Tandon has stock in BrainDynamics. The institution of Nitin Tandon has received research support from NIH.
Prasanna Venkatesan Eswaradass, MD	Dr. Eswaradass has nothing to disclose.
Ruth Dobson	The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Ruth Dobson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis . Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz. Ruth Dobson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Epionex. The institution of Ruth Dobson has received research support from NMSS. The institution of Ruth Dobson has received research support from MS Society UK . The institution of Ruth Dobson has received research support from BMA Foundation . The institution of Ruth Dobson has received research support from Biogen . The institution of Ruth Dobson has received research support from Merck . The institution of Ruth Dobson has received research support from Horne Family Charitable Trust . The institution of Ruth Dobson has received research support from MRC. The institution of Ruth Dobson has received research support from NIHR. Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape . Ruth Dobson has received personal compensation in the range of $0-$499 for serving as a Speaker with Limbus. Ruth Dobson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Neurology Academy .
Raymond Rosales	Dr. Rosales has nothing to disclose.
Shyamal Mehta, MD, PhD, FAAN	Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharma. Dr. Mehta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CNS Ratings.
John D. Hixson, MD	Dr. Hixson has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Hixson has received personal compensation for serving as an employee of Nile Ai. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NextSense Inc.. Dr. Hixson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seer Medical. Dr. Hixson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Epilepsy Study Consortium.
David E. Mandelbaum, MD, PhD, FAAN	Dr. Mandelbaum has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms and insurance companies. Dr. Mandelbaum has received personal compensation in the range of $500-$4,999 for serving as a consultant with Best Doctors.
William R. Meador, MD	Dr. Meador has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for ForensisGroup. The institution of Dr. Meador has received research support from PCORI. The institution of Dr. Meador has received research support from ROCHE/GENENTECH.
Koto Ishida, MD, FAAN	Dr. Ishida has received publishing royalties from a publication relating to health care.
Sunita N. Misra, MD	Dr. Misra has received personal compensation for serving as an employee of SK Life Science, Inc. An immediate family member of Dr. Misra has received personal compensation for serving as an employee of Neurocrine Biosciences.
Jenny Linnoila, MD, PhD	Dr. Linnoila has received personal compensation in the range of $10,000-$49,999 for serving as a expert respondent on autoimmune encephalitis with U.S. government/DHHS/Vaccine Injury Compensation Program.
Chantale O. Branson, MD, MSCR, FAAN	Dr. Branson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Branson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Paul E. Youssef, DO	Dr. Youssef has nothing to disclose.
Surabhi Ranjan, MD	Dr. Ranjan has nothing to disclose.
Danielle S. Shpiner, MD	An immediate family member of Dr. Shpiner has received personal compensation for serving as an employee of University of Miami. Dr. Shpiner has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Mission MSA. The institution of Dr. Shpiner has received research support from American Parkinson's Disease Association. The institution of Dr. Shpiner has received research support from CurePSP. The institution of Dr. Shpiner has received research support from Parkinson's Foundation. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Parkinson's Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Medtronic that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Boston Scientific that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbott that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Abbvie that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Ipsen that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Amneal that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Michael J. Fox Foundation that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a CoC Medical Director with CurePSP that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a COE Medical Director with Mission MSA that is relevant to AAN interests or activities. Dr. Shpiner has a non-compensated relationship as a Fellowship Co-Director with Merz that is relevant to AAN interests or activities.
Salman Al Jerdi, MD	Dr. Al Jerdi has nothing to disclose.
Katherine Fu, MD	Dr. Fu has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology: Neurology Journal . Dr. Fu has received research support from American Academy of Neurology. Dr. Fu has received personal compensation in the range of $0-$499 for serving as a Edmond J. Safra Fellowship Reviewer with The Michael J. Fox Foundation.
Paula Barreras, MD	Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from American Academy of Neurology.
J. Kent Werner, Jr., MD, PhD	Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has or had stock in Cogentis Therapeutics.Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics.
Alexandra C. Simpson, MD	Dr. Simpson has received research support from National MS Society.
Giovanna Manzano, MD	Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx.
Shailee S. Shah, MD	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Alyssa Nylander, MD, PhD	Dr. Nylander has nothing to disclose.
Marie Beaudin, MD	Dr. Beaudin has nothing to disclose.
Nadine Knowles	Nadine Knowles has received personal compensation for serving as an employee of Lundbeck. Nadine Knowles has received personal compensation for serving as an employee of Longboard Pharmaceuticals, inc.
Cynthia X. Wang, MD	Dr. Wang has nothing to disclose.
Daniel R. Gold, DO	Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer . Dr. Gold has received publishing royalties from a publication relating to health care.
Ayman Alboudi, MD	Dr. Alboudi has nothing to disclose.
Linda Laux, MD	Dr. Laux has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Laux has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex.
Eric Segal, MD	Dr. Segal has received personal compensation for serving as an employee of Lundbeck. Dr. Segal has received personal compensation for serving as an employee of Eisai. Dr. Segal has received personal compensation for serving as an employee of Neurelis. Dr. Segal has received personal compensation for serving as an employee of Zogenix. Dr. Segal has received personal compensation for serving as an employee of Aquestive. Dr. Segal has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Segal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwhich Bioscience. Dr. Segal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Nirali Vora, MD	Dr. Vora has nothing to disclose.
Marc Kamin, MD	Dr. Kamin has received personal compensation for serving as an employee of SK LIFE SCIENCE INC.
Timothy Cunniff, PharmD	Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Junaid H. Siddiqui, MD	Dr. Siddiqui has nothing to disclose.
Christopher T. Doughty, MD	Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurometrix. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Doughty has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Doughty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TD Securities. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Adler¦Cohen¦Harvey¦Wakeman¦Guekguezian, LLP. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gidley, Sarli & Marusak, LLP. Dr. Doughty has received research support from NINDS/NeuroNEXT. Dr. Doughty has received research support from AstraZeneca. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a Grant Advisory Board Member with Dysimmune Diseases Foundation. Dr. Doughty has received personal compensation in the range of $500-$4,999 for serving as a CME Lecturer with Oakstone Publishing.
Syed A. Shah, MD	Dr. Shah has nothing to disclose.
Jason H. Margolesky, MD, FAAN	Dr. Margolesky has nothing to disclose.
Richa Tripathi, MD	Dr. Tripathi has nothing to disclose.
Amr H. Ewida, MD	Dr. Ewida has nothing to disclose.
Fadar O. Otite, MD	Dr. Otite has nothing to disclose.
Elina Zakin, MD, FAAN	The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Laura K. Stein, MD, MPH	The institution of Dr. Stein has received research support from American Heart Association.
Jacob C. Rube, MD	Dr. Rube has nothing to disclose.
Yi Li, MD	The institution of Dr. Li has received research support from AES. The institution of Dr. Li has received research support from NIH.
Edison Vasquez, MD	Dr. VASQUEZ has nothing to disclose.
Donnie K. Starnes II, MD	Dr. Starnes has nothing to disclose.
Fawad Yousuf, MBBS	Dr. Yousuf has nothing to disclose.
Noa Bregman	Noa Bregman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison. The institution of Noa Bregman has received research support from Ionis pharmaceuticals.
Anibal Chertcoff	Anibal Chertcoff has nothing to disclose.
Julie A. Fields, PhD	The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute.
Cecilia Pita	Cecilia Pita has nothing to disclose.
Shane Raines	Shane Raines has received personal compensation for serving as an employee of 2b Analytics, LLC.
Jessica B. Smith, MPH	Ms. Smith has nothing to disclose.
Stephen Wanaski, PhD	Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has or had stock in Paragon Biosciences.Dr. Wanaski has or had stock in Emalex Biosciences.
Kalyan Yarraguntla, MD	Dr. Yarraguntla has nothing to disclose.
Meabh O'Hare, MD	Dr. O'Hare has nothing to disclose.
Victor Abler, DO	Dr. Abler has stock in Acadia Pharmaceuticals .
Michael Bowley, MD	Dr. Bowley has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for DeLUCA, WEIZENBAUM, BARRY & REVENS, LTD.. Dr. Bowley has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hamilton Weber LLC.
Brian Lundstrom, MD, PhD	The institution of Dr. Lundstrom has received research support from Medtronic. Dr. Lundstrom has a non-compensated relationship as a Consultant with Cadence Neuroscience that is relevant to AAN interests or activities.
Gamaleldin M. Osman, MD	Dr. Osman has nothing to disclose.
Lauren Tardo, MD	Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NeurologyLive. Dr. Tardo has received personal compensation in the range of $500-$4,999 for serving as a consultant with CanDoMS. Dr. Tardo has a non-compensated relationship as a Tardo with The MOG Project that is relevant to AAN interests or activities.
Nicholas Lannen, MD	Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech. Dr. Lannen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for TG Therapeutics. Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon Theraputics.
Alexander Doyle, MD	Dr. Doyle has nothing to disclose.
Steven T. Bellows, MD	The institution of Dr. Bellows has received research support from Takeda Pharmaceuticals. The institution of Dr. Bellows has received research support from Sage Therapeutics. The institution of Dr. Bellows has received research support from Bukwang Pharmaceutical . The institution of Dr. Bellows has received research support from AbbVie.
Leila Darki, MD, FAAN	Dr. Darki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partner. Dr. Darki has received personal compensation in the range of $0-$499 for serving as a Consultant for Guide point Global. Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Global Access Meetings. Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx . Dr. Darki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx.
Eugenia Martinez-Hernandez, MD	Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. The institution of Dr. Martinez-Hernandez has received research support from Fundacio La Caixa. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings and speaker honoraria with UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria and attending meetings with Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with CSL Behring.
Joshua Wong, MD	The institution of Dr. Wong has received research support from NIH.
Danny Samkutty, MD	Dr. Samkutty has nothing to disclose.
Ahmed Negida, MD, PhD	Dr. Negida has nothing to disclose.
Shannon Y. Chiu, MD, MSc	Dr. Chiu has received research support from NIH.
Daniel Shalev	Mr. Shalev has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Hospice and Palliative Medicine. Mr. Shalev has received research support from Weill cornell. The institution of Mr. Shalev has received research support from National Institute of Aging. The institution of Mr. Shalev has received research support from National Institute of Mental health .
Erie Gonzalez Gutierrez, MD	Dr. Gonzalez Gutierrez has nothing to disclose.
Toji Miyagawa, MD, PhD	Dr. Miyagawa has nothing to disclose.
Alexandra R. Balshi	Ms. Balshi has nothing to disclose.
Nsser Abdelall, MD	Dr. Abdelall has nothing to disclose.
Ali M. Al-Salahat, MBBS	Dr. Al-Salahat has nothing to disclose.
Carrie Li, MD	Dr. Li has nothing to disclose.
Adriana N. Sari, MD	Dr. Sari has nothing to disclose.
Brian Stamm, MD	Dr. Stamm has received personal compensation in the range of $10,000-$49,999 for serving as a Physician with Veterans Health Administration.
Anthony L. Fine, MD	The institution of Dr. Fine has received research support from Neurocrine Biosciences. The institution of Dr. Fine has received research support from American Board of Psychiatry and Neurology.
Kristin M. Galetta, MD	Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS.
Burcu Zeydan, MD	The institution of Dr. Zeydan has received research support from National Institutes of Health.
Negar Moheb, MD	Dr. Moheb has nothing to disclose.
Ting Zhou, MD	Dr. Zhou has nothing to disclose.
Irfan S. Sheikh, MD	Dr. Sheikh has nothing to disclose.
Rahul Guha, MD	Dr. Guha has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Experienced Neurology Consulting.
Ranier G. Reyes, MD	Dr. Reyes has nothing to disclose.
Faten El Ammar, MD	Dr. El Ammar has nothing to disclose.
Nikita Shukla, MD	The institution of Dr. Shukla has received research support from Roche.
Zhiyv Niu, PhD, FACMG	Zhiyv Niu has nothing to disclose.
Salman Assad, MD, MBBS	Dr. Assad has nothing to disclose.
Jonathan Krett, MD	Dr. Krett has nothing to disclose.
Angelica Rivera Cruz, MD	Dr. Rivera Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Rivera Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharmaceutical. Dr. Rivera Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life Science.
Reza Bavarsad Shahripour, MD	Dr. Bavarsad Shahripour has nothing to disclose.
Muhammad Adeel Saleemi, MBBS	The institution of Dr. Saleemi has received research support from NIH.
Bradley Lega, MD	The institution of Bradley Lega has received research support from NIH.
Olga Selioutski, DO	The institution of Dr. Selioutski has received research support from NIH.
James V. Nguyen, MD, MEd	Dr. Nguyen has nothing to disclose.
Sarah Marmol, MD	Dr. Marmol has nothing to disclose.
Brin Freund, MD	Dr. Freund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Freund has received research support from Mayo Clinic.
Iffat Ara Suchita, MD	Dr. Suchita has nothing to disclose.
Leah P. Dickstein, MD	Dr. Dickstein has nothing to disclose.
Shannon Anderson, PA, DAAN	Mrs. Anderson has nothing to disclose.
Susan L. Scarberry, MD, FAAN	Dr. Scarberry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Scarberry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich. Dr. Scarberry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenix. Dr. Scarberry has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Scarberry has received research support from Sanofi Genzyme.
Peter C. Mabie, MD	Dr. Mabie has nothing to disclose.
Piero Parchi, MD, PhD	The institution of Dr. Parchi has received research support from Ministero della Salute, ITA. The institution of Dr. Parchi has received research support from Ministero della Ricerca. The institution of Dr. Parchi has received research support from Ministero della Salute.
Neelam Goyal, MD, FAAN	Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Kristen Fisher, DO	Dr. Fisher has nothing to disclose.
Timothy J. Harrigan	Mr. Harrigan has nothing to disclose.
Casey S. Albin, MD, FAAN	Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from American Academy of Neurology. Dr. Albin has received publishing royalties from a publication relating to health care.
Tyler Kaplan, MD	Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono . Dr. Kaplan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave Biosciences. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Kaplan has received personal compensation in the range of $100,000-$499,999 for serving as a Speaker with EMD Serono. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with Amgen. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with TG Therapeutis. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with Biogen.
Sarah R. Durica, MD	An immediate family member of Dr. Durica has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Federal Aviation Administration.
Jeffrey Gluckstein, MD	Dr. Gluckstein has nothing to disclose.
Rachel J. Gottlieb-Smith, MD, MHPE	The institution of Dr. Gottlieb-Smith has received research support from American Board of Psychiatry and Neurology.
Haoming Pang, MD	Dr. Pang has nothing to disclose.
Roberto Alejandro Cruz, MD	The institution of Dr. Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. The institution of Dr. Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. The institution of Dr. Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AMGEN. The institution of Dr. Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion.
Nicholas S. Streicher, MD	Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovent. Dr. Streicher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Streicher has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Streicher has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion.
Shuvro Roy, MD	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Roy has received research support from The Siegel Rare Neuroimmune Association.
Emma M. Loebel, MD	Ms. Loebel has nothing to disclose.
Lauryn Hemminger	Dr. Hemminger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Ahmad Mahadeen, MD	Dr. Mahadeen has nothing to disclose.
Amir A. Mbonde, MD	Dr. Mbonde has nothing to disclose.
Louis Ferrari	Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
Diogo Haddad Santos, MD	Dr. Haddad Santos has nothing to disclose.
Adam Karp, MD	Dr. Karp has nothing to disclose.
Aimen Vanood, MD	Dr. Vanood has nothing to disclose.
Joyce A. Jimenez Zambrano, MD	Dr. Jimenez Zambrano has nothing to disclose.
Casey J. Judge, DO	Dr. Judge has nothing to disclose.
Mariyam Humayun, MD	Dr. Humayun has nothing to disclose.
David E. Hale, Jr., MD	Dr. Hale has nothing to disclose.
Carlos Alva-Diaz	Carlos Alva-Diaz has nothing to disclose.
Patricia Chandler	Patricia Chandler has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Patricia Chandler has stock in Jazz Pharmaceuticals.
Katie Robinson, PhD	Dr. Robinson has nothing to disclose.
Milimo Mweemba	Milimo Mweemba has nothing to disclose.
Parul Agarwal	Parul Agarwal has nothing to disclose.
Leah K. Forsberg, PhD	Ms. Forsberg has nothing to disclose.
Pelekelo Kabundula	Pelekelo Kabundula has nothing to disclose.
Esau G. Mbewe	Esau G. Mbewe has received research support from Research was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number K23NS117310. .
Irina Podkorytova	Irina Podkorytova has nothing to disclose.
Maria Sepúlveda	No disclosure on file
Erick Tarula, MD	Dr. Tarula has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WellFleet RX.
Anna Goodheart, MD	The institution of Dr. Goodheart has received research support from American Academy of Neurology.
Cole A. Harrington, MD, PhD	Dr. Harrington has nothing to disclose.
Jennifer Axelband, DO	Dr. Axelband has nothing to disclose.
Sang Kun Lee, MD	Prof. Lee has nothing to disclose.
Riley J. Snook, MD	Dr. Snook has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Snook has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Snook has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Saba Ahmad, MD	Dr. Ahmad has nothing to disclose.
Gregory N. Beatch, PhD	Dr. Beatch has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Beatch has stock in Xenon Pharmaceuticals Inc. Dr. Beatch has received intellectual property interests from a discovery or technology relating to health care.
Margaret L. McDermott, MD	Dr. McDermott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Cardiology. Dr. McDermott has received personal compensation in the range of $500-$4,999 for serving as a Expert Reviewer with Michigan LARA. Dr. McDermott has a non-compensated relationship as a Consultant with Mitovation that is relevant to AAN interests or activities.
Pawan K. Singh, MD	Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier Pharmaceuticals.
Kyle A. Wuthrich, DO	Dr. Wuthrich has nothing to disclose.
Elizabeth Silbermann, MD	Dr. Silbermann has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Silbermann has received research support from VA.
Parichita Choudhury, MD	The institution of Dr. Choudhury has received research support from Lewy Body Dementia Association. The institution of Dr. Choudhury has received research support from Arizona Alzheimer's Consortium.
Linda Nguyen, MD, PhD	Dr. Nguyen has nothing to disclose.
Judy Dawod, MD	Dr. Dawod has nothing to disclose.
Zahari Tchopev, MD	Dr. Tchopev has nothing to disclose.
Chaitanya Medicherla, MD	Dr. Medicherla has nothing to disclose.
Mattia Rosso, MD	Dr. Rosso has nothing to disclose.
Rani Priyanka Vasireddy, MBBS	Dr. Vasireddy has nothing to disclose.
Valerie Jeanneret Lopez, MD	Dr. Jeanneret Lopez has nothing to disclose.
Alexander Sandweiss, MD, PhD	Dr. Sandweiss has nothing to disclose.
Rebecca J. Levy, MD	Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. An immediate family member of Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for SRB Hawaii Law LLC. An immediate family member of Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wisner Baum LLP. The institution of Dr. Levy has received research support from CNCDP-K12. The institution of Dr. Levy has received research support from NINDS.
Nabeela Nathoo, MD, PhD	Dr. Nathoo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Sarah Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Live.
Amanda M. Yaworski, MD	Dr. Yaworski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Yaworski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Yaworski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Celeste R. Camargo, MD	Dr. Camargo has nothing to disclose.
Charles Saad, MD	An immediate family member of Dr. Saad has received personal compensation for serving as an employee of Stryker. An immediate family member of Dr. Saad has received intellectual property interests from a discovery or technology relating to health care.
Mar Guasp, MD	Dr. Guasp has nothing to disclose.
Constanza Luzon	Constanza Luzon has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Constanza Luzon has stock in Xenon Pharmaceuticals.
Salvatore Mazzeo	Mr. Mazzeo has nothing to disclose.
Takamichi Yamamoto, MD, PhD, FAES	Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Dr. Yamamoto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Daiichi-Sankyo.
Daniella A. Bustamante, MD	Dr. Bustamante has nothing to disclose.
Samantha R. Cencer, DO	Dr. Cencer has nothing to disclose.
Alice Tang, MBBS	Dr. Tang has received personal compensation for serving as an employee of Third Rock Ventures.
Niccolo Mencacci, MD, PhD	The institution of Dr. Mencacci has received research support from NIH.
Isha Snehal, MBBS	Dr. Snehal has nothing to disclose.
Galina Gheihman, MD	Dr. Gheihman has nothing to disclose.
Jennifer R. Cheng, NP	The institution of an immediate family member of Ms. Cheng has received research support from NIH.
Anne G. Douglas, MD	Dr. Douglas has nothing to disclose.
Ian Walker, MD	Dr. Walker has nothing to disclose.
Chelsea Shugars, MD	Dr. Shugars has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Shugars has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Shugars has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MTPA.
Denis T. Balaban, MD	Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Infucare. Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedLive. The institution of Dr. Balaban has received research support from ArgenX.
Sarah C. Parauda, MD	Dr. Parauda has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Panter, Panter & Sampedro.
Marinos G. Sotiropoulos, MD	Dr. Sotiropoulos has or had stock in Moderna.Dr. Sotiropoulos has or had stock in Ikena Oncology.Dr. Sotiropoulos has or had stock in Cassava Sciences.Dr. Sotiropoulos has or had stock in Biogen.Dr. Sotiropoulos has or had stock in Tiziana Life Sciences.Dr. Sotiropoulos has received publishing royalties from a publication relating to health care.
Eileen Harrigan, MD	Dr. Harrigan has nothing to disclose.
Mahsa Mohajery, MD	Dr. Mohajery has nothing to disclose.
Chloe S. Sader, PharmD	Chloe Sader has received personal compensation for serving as an employee of Alexion. Chloe Sader has received stock or an ownership interest from Alexion.
Dylan F. Del Papa, MD	Dr. Del Papa has nothing to disclose.
Alfonso Enrique Martinez Nunez, MD	Dr. Martinez Nunez has nothing to disclose.
Sadia Waheed, MBBS	Dr. Waheed has nothing to disclose.
David Landzberg, MD	Dr. Landzberg has nothing to disclose.
Bryan D. Clements II, DO	Dr. Clements has nothing to disclose.
Harneel S. Saini, DO	Dr. Saini has nothing to disclose.
Jorge E. Patino Murillas, MD	Dr. Patino Murillas has nothing to disclose.
Andrew Morrison, MD	Dr. Morrison has nothing to disclose.
Holly Elser, MD, PhD	Dr. Elser has nothing to disclose.
Cory R. Nicholas, PhD	Dr. Nicholas has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Nicholas has stock in Neurona Therapeutics. Dr. Nicholas has received intellectual property interests from a discovery or technology relating to health care.
Catherine Priest, PhD	Catherine Priest has received personal compensation for serving as an employee of Neurona Therapeutics. Catherine Priest has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. The institution of Catherine Priest has received research support from CIRM.
Luis Fuentealba	Luis Fuentealba has nothing to disclose.
JOSELYN ELIZABETH MIÑO ZAMBRANO, MD	Dr. MIÑO ZAMBRANO has nothing to disclose.
Valentine Jehl	Valentine Jehl has received personal compensation for serving as an employee of Novartis Pharma AG. Valentine Jehl has stock in Novartis. Pharma AG.
Margaret Naclerio, PA	Ms. Naclerio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB.
Jaclyn Martindale, DO, FAAN	Dr. Martindale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Dr. Martindale has received research support from Tourette Association of America. The institution of Dr. Martindale has received research support from American Board of Neurology and Psychiatry.
Cory K. Dodson, MD	Dr. Dodson has nothing to disclose.
Daniel Talmasov, MD	Dr. Talmasov has received personal compensation in the range of $0-$499 for serving as a Consultant for SpearBio.
Virginia DeLasHeras	Virginia DeLasHeras has received personal compensation for serving as an employee of NOVARTIS.
Kathryn Zuchowski, MD	Dr. Zuchowski has received personal compensation in the range of $500-$4,999 for serving as a QOD and Neuro SAE question writer with American Academy of Neurology.
Stephanie Gandelman, MD	Dr. Gandelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gandelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Dr. Gandelman has received research support from Alexion Pharmaceuticals.
Brian Emmert, Jr., MD	Dr. Emmert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zynx. Dr. Emmert has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Aquifer.
Maulik Kantawala, MD	Dr. Kantawala has nothing to disclose.
Manu Jokela	Manu Jokela has nothing to disclose.
Danielle Kei Pua, MD	Dr. Pua has nothing to disclose.
Mays Khweileh, Jr., MD	Dr. Khweileh has nothing to disclose.
Konrad Kubicki, MD	Dr. Kubicki has nothing to disclose.
Muhammed Ikbal Arvas, MD	Dr. Arvas has nothing to disclose.
Ricardo Murguia Fuentes, MD	Dr. Murguia Fuentes has nothing to disclose.
Christian A. Sam, MD	Dr. Sam has nothing to disclose.
Maxime Jean, MD, PhD	Dr. Jean has nothing to disclose.
Oladotun V. Olalusi, MBBS	Dr. Olalusi has nothing to disclose.
Ajay Banga, DO	Dr. Banga has nothing to disclose.
Yoji Hoshina, MD	Dr. Hoshina has nothing to disclose.
Dror Shir, MD	Dr. Shir has nothing to disclose.
Yoona Lee, MD	Dr. Lee has nothing to disclose.
Gopikrishnan Unnikrishnan	Gopikrishnan Unnikrishnan has nothing to disclose.
Michelle H. Tosin, PhD, RN	Dr. Tosin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuraLight . The institution of Dr. Tosin has received research support from International Parkinson and Movement Disorders Society. Dr. Tosin has received personal compensation in the range of $500-$4,999 for serving as a Consultant with International Parkinson and Movement Disorders Society.
Marina Bershteyn	Marina Bershteyn has received personal compensation for serving as an employee of Neurona therapeutics. Marina Bershteyn has stock in Neurona therapeutics. Marina Bershteyn has received intellectual property interests from a discovery or technology relating to health care.
Yves Maury	Yves Maury has received personal compensation for serving as an employee of Neurona Therapeutics. Yves Maury has stock in Neurona therapeutics.
Andrew Krystal	Andrew Krystal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome Therapeutics, Abbvie, Big Health, Eisai, Evecxia, Harmony Biosciences, Idorsia, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Neurocrine Biosciences, Neumora, Neurawell, Otsuka Pharmaceuticals, Sage, Takeda. Andrew Krystal has stock in Neurawell, Big Health. The institution of Andrew Krystal has received research support from Alkermes; Janssen Pharmaceuticals, Axsome Pharmaceutics, Attune, Eisai, Harmony, Neumora; Neurocrine Biosciences, Reveal Biosensors, The Ray and Dagmar Dolby Family Fund, Weill Institute for Neurosciences, and the National Institutes of Health.
Hakmook Kang	Hakmook Kang has nothing to disclose.
Kimberly Gokoffski	Kimberly Gokoffski has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Kimberly Gokoffski has received research support from NIH. The institution of Kimberly Gokoffski has received research support from ARPA-H. The institution of Kimberly Gokoffski has received research support from DOD. The institution of Kimberly Gokoffski has received research support from Research to Prevent Blindness.
Matthew Feldman, MD	Dr. Feldman has nothing to disclose.
Bethany Zanrucha	Bethany Zanrucha has stock in IntraBio. Bethany Zanrucha has stock in Sarepta.
Sudheeran Kannoth	The institution of Sudheeran Kannoth has received research support from ICMR.
Vivek K. Nambiar, DM	Dr. Nambiar has nothing to disclose.
Udit U. Saraf, MD, MBBS	Dr. Saraf has nothing to disclose.
Annamma Mathai	Annamma Mathai has nothing to disclose.
Nur Neyal	Dr. Neyal has nothing to disclose.
Matthew Roberts, MD	Dr. Roberts has nothing to disclose.
Cynthia Qi	Cynthia Qi has received personal compensation for serving as an employee of argenx.
Shirin Sadeghpour, MD	Dr. Sadeghpour has nothing to disclose.
Yuriy Edwards, MD, PhD	Dr. Edwards has received personal compensation for serving as an employee of Immunovant. Dr. Edwards has stock in Immunovant.
Cattien N. Phan, DO	Dr. Phan has nothing to disclose.
Holly Cohan, MD, PhD	An immediate family member of Dr. Cohan has received personal compensation for serving as an employee of Gateway Institute for Brain Research.
Joseph R. Geraghty, MD, PhD	Dr. Geraghty has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Stroke and Cerebrovascular Diseases. Dr. Geraghty has received publishing royalties from a publication relating to health care.
Ciaran Considine, PhD	Dr. Considine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MDisrupt. Dr. Considine has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Park Dietz & Associates. The institution of Dr. Considine has received research support from NIH. The institution of Dr. Considine has received research support from DoD. The institution of Dr. Considine has received research support from Acadia Pharmaceuticals.
Valentina Quintana, Jr., MD	Dr. Quintana has nothing to disclose.
Alexander Buslov, MD	Dr. Buslov has nothing to disclose.
Jordan Carrier, MD	Dr. CARRIER has nothing to disclose.
Bakhtawar Ahmad, MBBS	Dr. Ahmad has nothing to disclose.
Brian Sacks, DO	Dr. Sacks has nothing to disclose.
Ajay Menon, MD	Dr. Menon has nothing to disclose.
Davis L. Ewbank, DO	Dr. Ewbank has nothing to disclose.
Benjamin Brush, MD	Dr. Brush has nothing to disclose.
Alina Ivaniuk, MD	Dr. Ivaniuk has nothing to disclose.
Kelley Del Real	Kelley Dalby has received personal compensation for serving as an employee of Praxis Precision Medicines. Kelley Dalby has stock in Praxis Precision Medicines. Kelley Dalby has stock in RogCon.
Nikhil Modak, MD	Dr. Modak has nothing to disclose.
Mattia Wruble, MD	The institution of Dr. Wruble has received research support from Alexion. The institution of Dr. Wruble has received research support from Roche.
María Paula Aguilera Peña, MD	María Paula Aguilera Peña, MD has nothing to disclose.
Brendan Huang, MD	Dr. Huang has nothing to disclose.
Valentina Velasco	Miss Velasco has nothing to disclose.
Poojith Nuthalapati, MD	Mr. Nuthalapati has nothing to disclose.
Lamees H. Alzyoud, MD	Dr. Alzyoud has nothing to disclose.
Joao Vitor Mahler, MD	Dr. Mahler has received research support from The Sumaira Foundation.
Sathvik S. Shastry, MD	Dr. Shastry has nothing to disclose.
Avinash S. Kolli, MD	Dr. Kolli has nothing to disclose.
Nikash Shankar, MD	Dr. Shankar has nothing to disclose.
Adel Hijazi, MD	Mr. Hijazi has nothing to disclose.
Tatiana T. Bremova-Ertl, MD, PhD	Dr. Bremova-Ertl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrabio. The institution of Dr. Bremova-Ertl has received research support from InnoSuisse. Dr. Bremova-Ertl has received research support from Baasch-Medicus.
Nicole Sukkarieh, MD	Dr. Sukkarieh has nothing to disclose.
Sai Kumar Reddy Pasya, MD, MBBS	Dr. Pasya has nothing to disclose.
Hesamoldin Khodadadi Chamgordani, MD	Dr. Khodadadi Chamgordani has nothing to disclose.
Jose F. Ortega Tola, MD	Dr. Ortega Tola has nothing to disclose.
Shayan Marsia, MBBS	Dr. Marsia has nothing to disclose.
Jamir Pitton Rissardo, MD	Dr. Pitton Rissardo has nothing to disclose.
Soonmyung Hwang	Mr. Hwang has nothing to disclose.
Soroush Kakawand, MD	Dr. Kakawand has nothing to disclose.
Nitai Mukhopadhyay	Nitai Mukhopadhyay has nothing to disclose.
Jacqueline Pesa	Jacqueline Pesa has received personal compensation for serving as an employee of Johnson and Johnson.
Vijaykumar Vashi	Vijaykumar Vashi has nothing to disclose.
Mahmoud T. Hefnawy, MD	Dr. Hefnawy has nothing to disclose.
Emily Scully	Emily Scully has nothing to disclose.
Andres Felipe Cardenas Cruz, Jr., MD	Dr. Cardenas Cruz has nothing to disclose.
Cecilia Tremblay	Cecilia Tremblay has nothing to disclose.
Mahmoud Elkhooly, MD	Dr. Elkhooly has nothing to disclose.
Shweta Kalita, MD	Dr. Kalita has nothing to disclose.
Amit Akula	Amit Akula has nothing to disclose.
Presley M. Gruezo, Jr.	Mr. Gruezo has nothing to disclose.
Margaret Gopaul, PhD	Dr. Gopaul has nothing to disclose.
Henry Jacotin	Henry Jacotin has received personal compensation for serving as an employee of Praxis Precision Medicines. Henry Jacotin has stock in Praxis Precision Medicines. Henry Jacotin has stock in Clover Health. Henry Jacotin has stock in Certara. Henry Jacotin has stock in Takeda. Henry Jacotin has received personal compensation in the range of $500,000-$999,999 for serving as a VP Clinical Development and Pharmacovigilance with Praxis Precision Medicines.
Shane Poole	Shane Poole has nothing to disclose.
Jonathon Lebovitz	Jonathon Lebovitz has stock in Vesalio NeuroVascular.
Linker E. Viñan Paucar, Sr.	Mr. Viñan Paucar has nothing to disclose.
Taylor Fields	Taylor Fields has received personal compensation for serving as an employee of IntraBio Inc. Taylor Fields has stock in IntraBio. Taylor Fields has received intellectual property interests from a discovery or technology relating to health care.
Gregor Gibson	Mr. Gibson has nothing to disclose.
Tiffany Cooper	Tiffany Cooper has nothing to disclose.
Meagan Harms	Meagan Harms has nothing to disclose.
Jenny Qian	Jenny Qian has nothing to disclose.
Kyriakos Martakis	Kyriakos Martakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eversana.
Christopher Kenney	No disclosure on file
Marcio Souza	Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.
Nishtha Gupta, MD	Dr. Gupta has nothing to disclose.
Hannah Silverman	Ms. Silverman has nothing to disclose.
Deepa Dongarwar	Deepa Dongarwar has nothing to disclose.
Andrew Wolf, MD	The institution of Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Wolf has received research support from Genentech. The institution of Dr. Wolf has received research support from Rocky Mountain MS Center. The institution of Dr. Wolf has received research support from Michael J. Fox Foundation. The institution of Dr. Wolf has received research support from Sanofi. The institution of Dr. Wolf has received research support from Alexion. The institution of Dr. Wolf has received research support from Novartis. The institution of Dr. Wolf has received research support from TG Therapeutics. The institution of Dr. Wolf has received research support from BMS. Dr. Wolf has received publishing royalties from a publication relating to health care. Dr. Wolf has received publishing royalties from a publication relating to health care. Dr. Wolf has received personal compensation in the range of $0-$499 for serving as a Speaker with Rocky Mountain MS Center. Dr. Wolf has a non-compensated relationship as a Board Member with Autoimmune Neurology Research Consortium that is relevant to AAN interests or activities.
Matt Jefferson	Matt Jefferson has received personal compensation for serving as an employee of argenx. Matt Jefferson has stock in argenx.
Gautam Banik	Gautam Banik has received personal compensation for serving as an employee of Neurona Therapeutics.
Alessandro Bulfone, MD	Dr. Bulfone has received personal compensation for serving as an employee of Neurona Therapeutics Inc.
Brianna Feld	Brianna Feld has received personal compensation for serving as an employee of Neurona Therapeutics.
Ji-Hye Jung	Ji-Hye Jung has nothing to disclose.
Rose Larios, PhD	Dr. Larios has received personal compensation for serving as an employee of Neurona Therapeutics.
Seonok Lee	Seonok Lee has received personal compensation for serving as an employee of Neurona Therapeutics.
Sheri Madrid	Mrs. Madrid has nothing to disclose.
Erika L. Weil, MD	Dr. Weil has nothing to disclose.
Jigisha Thakkar, MD	Dr. Thakkar has nothing to disclose.
John Paul Aboubechara, MD, PhD	Dr. Aboubechara has nothing to disclose.
Rachel Caplan, MD	Dr. Caplan has nothing to disclose.
Megan Sniecinski	Megan Sniecinski has received personal compensation for serving as an employee of Praxis Precision Medicines. Megan Sniecinski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Praxis Precision Medicines.
Esteban Luna, MD, PhD	Dr. Luna has nothing to disclose.
Isabella Strozzi, MD	Dr. Strozzi has nothing to disclose.
Manali S. Sheth, MD	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Kristen Watkins, MD	Dr. Watkins has nothing to disclose.
May Zin Myint, MBBS	Dr. Myint has nothing to disclose.
Thomas Pelkmann, MD	Dr. Pelkmann has nothing to disclose.
Nupur Lala, MD	Dr. Lala has nothing to disclose.
Kaitlyn Palmer, MD	Dr. Palmer has nothing to disclose.
Derek A. Wainwright, PhD	Prof. Wainwright has nothing to disclose.
Yugant Khand, MBBS, DiMM	Dr. Khand has nothing to disclose.
Yohan Kim, DO	Dr. Kim has nothing to disclose.
Edward Lee	Edward Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Edward Lee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Rainwater Foundation. Edward Lee has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for South Texas ADRC. Edward Lee has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for 1Florida ADRC. The institution of Edward Lee has received research support from NIH. The institution of Edward Lee has received research support from Delaware Community Foundation. The institution of Edward Lee has received research support from Chan Zuckerberg Institute. Edward Lee has received intellectual property interests from a discovery or technology relating to health care. Edward Lee has received personal compensation in the range of $0-$499 for serving as a Speaker (travel) with Chan Zuckerber Institute. Edward Lee has received personal compensation in the range of $0-$499 for serving as a Speaker (travel) with ALS Network. Edward Lee has received personal compensation in the range of $0-$499 for serving as a Speaker (travel) with Academic Institutions & Universities. Edward Lee has received personal compensation in the range of $0-$499 for serving as a Speaker (travel) with Gordon Research Conferences.
Victoria Mazo, MD	Dr. Mazo has nothing to disclose.
Seerat Sachdeva, MD	Dr. Sachdeva has nothing to disclose.
Daniel V. De Siqueira Lima, Jr., MD	Dr. De Siqueira Lima has nothing to disclose.
Sathya S. Narasimhan, MBBS	Dr. Narasimhan has nothing to disclose.
Rajesh Burela, DO	Dr. Burela has nothing to disclose.
Sakhi A. Bhansali, MD	Dr. Bhansali has nothing to disclose.
Amanda R. Sellers, MD	Dr. Sellers has nothing to disclose.
Thomas Draper, MD	Dr. Draper has nothing to disclose.
Sean Montgomery, MD	Dr. Montgomery has nothing to disclose.
Hannah W. Austin, MD	Dr. Austin has nothing to disclose.
Carlos A. Rodríguez Alarcón, MD	Dr. Rodríguez Alarcón has nothing to disclose.
Savio Batista, MD	Mr. Batista has nothing to disclose.
Fatemeh Sadeghifar, MD	Dr. Sadeghifar has nothing to disclose.
Prashanth Rajarajan, MD, PhD	Dr. Rajarajan has nothing to disclose.
Miao Iris Wei, MD, PhD	Dr. Wei has nothing to disclose.
Abdelwahab A. Elshourbagy	Mr. Elshourbagy has nothing to disclose.
Shiv K. Jha, MBBS	Dr. Jha has nothing to disclose.
Yousef A. Hawas	Mr. Hawas has a non-compensated relationship as a Faculty with American Academy of Neurology Institution (AANI); NeuroBytes: Medical Students Series that is relevant to AAN interests or activities.
Manuel Hernandez	Manuel Hernandez has nothing to disclose.
David Penn	David Penn has nothing to disclose.
Christoper A. Alarcon Ruiz, MD	Dr. Alarcon Ruiz has received research support from Universidad Científica del Sur.
Daniel E. Kaufman	Mr. Kaufman has nothing to disclose.
Jaan Nandwani	Miss Nandwani has nothing to disclose.
Karen Yee, PhD	Dr. Yee has received personal compensation for serving as an employee of Alexion. Dr. Yee has stock in Alexion. Dr. Yee has stock in Takeda.
Michael Blackowicz, PhD	Dr. Blackowicz has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Dr. Blackowicz has stock in Alexion Pharmaceuticals.
Louis Jackson, PharmD	Dr. Jackson has received personal compensation for serving as an employee of Johnson and Johnson.
Lambros Chrones, MD	Dr. Chrones has received personal compensation for serving as an employee of Acadia Pharmaceuticals.
Jeffrey Yu, PhD	Dr. Yu has received personal compensation for serving as an employee of Alexion. Dr. Yu has stock in AstraZeneca.
Emaan Fawad, Other	Miss Fawad has nothing to disclose.
Fajar Fawad, Other	Miss Fawad has nothing to disclose.
Mamadou Diallo, MD	Dr. Diallo has nothing to disclose.
Madiha Qureshi, MD	Dr. Qureshi has nothing to disclose.
Harli Weber, MD	Ms. Weber has nothing to disclose.
Brooke Honzel	Ms. Honzel has nothing to disclose.
Maria de Los Angeles Alvarez Falcon	Ms. Alvarez Falcon has nothing to disclose.
Juletsy M. Moreira Alcivar, MD	Miss Moreira Alcivar has nothing to disclose.
Danny J. Japon	Mr. Japon has nothing to disclose.
Sangharsha Thapa, MD	Dr. Thapa has nothing to disclose.
Sarah Atkinson	Sarah Atkinson has received personal compensation for serving as an employee of Emalex Biosciences. Sarah Atkinson has received personal compensation for serving as an employee of World Wide Clinical Trials.
Francisco de Moraes	Francisco de Moraes has nothing to disclose.
Ryan Rilinger	Mr. Rilinger has nothing to disclose.
Sadeen Eid	Sadeen Eid has nothing to disclose.
Mohamed Abouzid	Mohamed Abouzid has nothing to disclose.
Yoav Piura, MD	Dr. Piura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Piura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Ariel Nowicki	Ms. Nowicki has nothing to disclose.
Hannah Connolly	Hannah Connolly has nothing to disclose.
ZL Liaquat	ZL Liaquat has nothing to disclose.
Hafiz M. Maaz	Mr. Maaz has nothing to disclose.
Irving G. Calisaya-Madariaga, Sr.	Mr. Calisaya-Madariaga has nothing to disclose.
Adam M. Abdallah	Adam M. Abdallah has nothing to disclose.
Lucia Belen Varela	Lucia Belen Varela has nothing to disclose.
Lucila Hernandez	Lucila Hernandez has nothing to disclose.
Claudia Cano	Claudia Cano has nothing to disclose.
Ayushi D. Balan	Miss Balan has nothing to disclose.
Silvia Vargas Parra	Silvia Vargas Parra has nothing to disclose.
Sangam Shah	Dr. Shah has nothing to disclose.
Dhanya Gorty, MBBS	Dr. Gorty has nothing to disclose.
Dabbara V. Ramana	Mr. Ramana has nothing to disclose.
Eumorphia DELICHA	Eumorphia DELICHA has nothing to disclose.
Philip Chan	Philip Chan has nothing to disclose.
Muddana Nikhilesh	Muddana Nikhilesh has nothing to disclose.
Muhammad Sohaib, MBBS	Mr. Sohaib has nothing to disclose.
Hossam T. Ali, MD	Dr. Ali has nothing to disclose.
José Felipe Lacerda Fernandes	José Felipe Lacerda Fernandes has nothing to disclose.
Gerardo M. Luna-Peralta	Mr. Luna-Peralta has nothing to disclose.
Meena Thevarkalam	Meena Thevarkalam has nothing to disclose.
Kai Miller	Kai Miller has nothing to disclose.
Stephanie Hsu	Stephanie Hsu has nothing to disclose.
Rohit Menon	Rohit Menon has received personal compensation for serving as an employee of ZS Associates.
Tia Kowal	Tia Kowal has received personal compensation for serving as an employee of Neurona Tharapeutics. Tia Kowal has received personal compensation in the range of $100,000-$499,999 for serving as a Scientist with Neurona Theraputics.
Sonja Kriks	Sonja Kriks has received personal compensation for serving as an employee of Neurona Therapeutics. Sonja Kriks has stock in Neurona Therapeutics. Sonja Kriks has received intellectual property interests from a discovery or technology relating to health care.
Colleen O'Connell	Colleen O'Connell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma. Colleen O'Connell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Colleen O'Connell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Colleen O'Connell has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MT PHarma. The institution of Colleen O'Connell has received research support from Biogen. The institution of Colleen O'Connell has received research support from Calico. The institution of Colleen O'Connell has received research support from Praxis Spinal Cord Institute. The institution of Colleen O'Connell has received research support from Verge. Colleen O'Connell has a non-compensated relationship as a Steering Committee with World Rehabilitation Alliance that is relevant to AAN interests or activities.
Gursant Atwal	Gursant Atwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aesculap.
Priyanka Atit, DO	Dr. Atit has nothing to disclose.
Kangni Xiao, MD	Dr. Xiao has nothing to disclose.
Anna Bashmakov, DO	Dr. Bashmakov has nothing to disclose.
Randall Kaye	Dr. Kaye has received personal compensation for serving as an employee of Longboard Pharma. Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Kaye has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Nervgen.
Syed H. Inam, MD	Dr. Inam has nothing to disclose.
Lisa M. Townsend, NP	Ms. Townsend has nothing to disclose.
Lyndsey Babcock, MD	Dr. Babcock has nothing to disclose.
Judith Thompson, PhD	Dr. Thompson has received personal compensation for serving as an employee of UCB, Inc. Dr. Thompson has or had stock in UCB, Inc.
Atika Paracha, MBBS	Dr. Paracha has nothing to disclose.
Emma Weiskopf, MD	Dr. Weiskopf has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. Dr. Weiskopf has stock in Alexion Astrazeneca Rare Disease.
Amy Poindexter, NP	Ms. Poindexter has nothing to disclose.
Byron D. Cheon, MD	Dr. Cheon has nothing to disclose.
Muneeb Ahmad Muneer	Mr. Muneer has nothing to disclose.
Lesley-Ann 9. Miller-Wilson, PhD	Dr. Miller-Wilson has received personal compensation for serving as an employee of Immunovant Inc. Dr. Miller-Wilson has or had stock in Immunovant Inc..
Nicole Betor	Nicole Betor has received personal compensation for serving as an employee of Avalere Health.
Meiling M. Carbajal Galarza, MD	Miss Carbajal Galarza has nothing to disclose.
Nicole Baldwin, MD	Dr. Baldwin has received personal compensation in the range of $500-$4,999 for serving as a volunteer international neurology instructor with CMDA, MAP International, and INMED (NGOs).
Sue Park	Miss Park has nothing to disclose.
Syed Ijlal Ahmed, MD, MBBS	Dr. Ahmed has nothing to disclose.
Samhitha Rai	Miss Rai has nothing to disclose.
Lauren Hinkley	Miss Hinkley has nothing to disclose.
Tuqa Asedi, MD	Dr. Asedi has nothing to disclose.
Samuel J. Steuart	Mr. Steuart has nothing to disclose.
Nabihah Kabir, MD	Dr. Kabir has nothing to disclose.
Rajesh C. Sachdeo, MD	Dr. Sachdeo has nothing to disclose.
Pentti Tienari, MD, PhD	Dr. Tienari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck GmBH. Dr. Tienari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tienari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. The institution of Dr. Tienari has received research support from Helsinki University Hospital. The institution of Dr. Tienari has received research support from Sigrid Juselius Foundation. The institution of Dr. Tienari has received research support from Maze Therapeutics. The institution of Dr. Tienari has received research support from Verge genomics. The institution of Dr. Tienari has received research support from University of Helsinki. The institution of Dr. Tienari has received research support from Private donor. Dr. Tienari has received intellectual property interests from a discovery or technology relating to health care.
Joanna Haas	Joanna Haas has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Vergegenomics . Joanna Haas has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nimbus Therapeutics . Joanna Haas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for X4 Pharmaceuticals.
Yvan Mercader, MD	Dr. Mercader has nothing to disclose.
Dante B. Oropeza Canto, MD	Dr. Oropeza Canto has nothing to disclose.
David Sandlin, MD, PhD	Dr. Sandlin has nothing to disclose.
Jared M. Davis, MD	Dr. Davis has nothing to disclose.
John Alam	John Alam has received personal compensation for serving as an employee of CervoMed. John Alam has or had stock in CervoMed.
Manher Joshi, MD	Dr. Joshi has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Joshi has stock in Atara Biotherapeutics.
Isaac Ng	Mr. Ng has nothing to disclose.
Karim Makhoul, Sr., MD	Dr. Makhoul has nothing to disclose.
SUIQIANG ZHU	No disclosure on file
Naser Haj Aissa, MBBS	Dr. Haj Aissa has nothing to disclose.
Rong Ye, MD, PhD	Dr. Ye has nothing to disclose.
Dhruv Bansal, MBBS, MRCP UK	Dr. Bansal has nothing to disclose.
Harendra Kumar	Mr. Kumar has nothing to disclose.
Janelle Raymond, PhD	Dr. Schafer has received personal compensation for serving as an employee of IntraBio. Dr. Schafer has stock in Amylyx Pharmaceuticals .
Elianet Fonseca, MD	Dr. Fonseca has nothing to disclose.
Monika Mikolajczak, MD	Dr. Mikolajczak has nothing to disclose.
Christopher Phillips, MD	Dr. Phillips has nothing to disclose.
Tiffany Hu, MD	Dr. Hu has nothing to disclose.
Boris Kobilja, MD	Dr. Kobilja has nothing to disclose.
Andrea Thurler, NP	Dr. Thurler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Focus Medical.
Sai Krishna Vallamchetla, MBBS	Mr. Vallamchetla has nothing to disclose.
Pooja Bhandari, MD	Dr. Bhandari has nothing to disclose.
Adrian J. Diaz, DO	Dr. Diaz has nothing to disclose.
Anil Abeyewickreme, MD, PhD	Dr. Abeyewickreme has received personal compensation for serving as an employee of Novartis Pharmaceuticals.
Anika Pruthi	Ms. Pruthi has nothing to disclose.
Kajal Patel, MD	Dr. Patel has nothing to disclose.
Valéria A. Salas	Mrs. Salas has nothing to disclose.
Anna Thomsen, MD	Dr. Thomsen has nothing to disclose.
Haitham O. Alhazaimeh	Mr. Alhazaimeh has nothing to disclose.
Pranav J. Mehta	Mr. Mehta has nothing to disclose.
Sreehari Dinesh, MD	Dr. Dinesh has nothing to disclose.
Hyo Bin You	Mr. You has received personal compensation for serving as an employee of Dasion.AI. Mr. You has received personal compensation for serving as an employee of IXL Learning.
Genesis Polanco Jerez, MD	Dr. Polanco Jerez has nothing to disclose.
Annika Anderson	Miss Anderson has nothing to disclose.
Shravani Khisti	Ms. Khisti has nothing to disclose.
Mohamed Ibrahim A. Mohamed, MD	Mr. Mohamed has nothing to disclose.
Abdallah Khatatbeh, MD	Dr. Khatatbeh has nothing to disclose.
Ana Leticia Fornari Caprara, MD	Dr. Fornari Caprara has nothing to disclose.
Lea Saab, MD	Dr. Saab has nothing to disclose.
Haia Hazim, DO	Dr. Hazim has nothing to disclose.
Ashwath Ravisankar, MD	Dr. Ravisankar has nothing to disclose.
Muhammad Tayyab Muzaffar Chaychi, MD	Muhammad Tayyab Muzaffar Chaychi, MD has nothing to disclose.
Shivaansh Aggarwal, MD	Shivaansh Aggarwal, MD has nothing to disclose.
Rebeca O. Silva, Student	Miss Silva has nothing to disclose.
Sufyan Shahid, MBBS	Mr. Shahid has nothing to disclose.
FNU Kalpina, MBBS	Dr. Ramesh has nothing to disclose.
Azka Ijaz, MBBS	Miss Ijaz has nothing to disclose.
Tejas S. Lal	Mr. Lal has nothing to disclose.
Sophia Ahmed, MBBS	Miss Ahmed has nothing to disclose.
Diji Johnson, MBBS	Dr. Johnson has nothing to disclose.
Ken Uchino, MD	Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Lindsay A. Horton, MD	Dr. Horton has nothing to disclose.
Rodica Di Lorenzo, MD	Dr. Di Lorenzo has nothing to disclose.
Stephen W. Yeung, DO	Dr. Yeung has received personal compensation for serving as an employee of Novartis.
Chad Oh	Chad Oh has nothing to disclose.
Samhita Panda, MD, DM	Dr. Panda has nothing to disclose.
Camelia Valhuerdi Porto, MD	Dr. Valhuerdi Porto has nothing to disclose.
Sama Almasri, MBBS	Dr. Almasri has nothing to disclose.
Sarbesh Tiwari	Sarbesh Tiwari has nothing to disclose.
Johannes R. Streffer, MD	Dr. Streffer has received personal compensation for serving as an employee of H. Lundbeck A/S. Dr. Streffer has or had stock in H. Lundbeck A/S.
BIANCA OLIVEIRA, MD	Dr. OLIVEIRA has nothing to disclose.
Chintan Shah	An immediate family member of Chintan Shah has received personal compensation for serving as an employee of Pfizer, Inc. Chintan Shah has stock in Penumbra, Inc.
Maricruz Velazquez, MD	Dr. Velazquez has nothing to disclose.
Muhammad Inam Ul Haq, MD, MBBS	Dr. Inam Ul Haq has nothing to disclose.
Anusha Khawaja, MD	Dr. Khawaja has nothing to disclose.
TAIS L. DENICOL, MD	Miss DENICOL has nothing to disclose.
Wajeeh Hassan, MBBS	Mr. Hassan has nothing to disclose.
Praveen Nandha Kumar Pitchan Velammal, MBBS	Dr. Pitchan Velammal has nothing to disclose.
Ananya Talukdar	Ms. Talukdar has nothing to disclose.
Kensuke Kawai, MD, PhD	Prof. Kawai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Biopharma. Prof. Kawai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Japan. Prof. Kawai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zimmer Biomet. Prof. Kawai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EP Medical. Prof. Kawai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Prof. Kawai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Daiichi-Sankyo.
Minahil Iqbal	Ms. Iqbal has nothing to disclose.
Ian Billington, PhD	Mr. Billington has received personal compensation for serving as an employee of IntraBio Inc. Mr. Billington has stock in IntraBio Inc.
Barbara Antonia D. Talah, Medical Student	Miss Talah has nothing to disclose.
Mohamed El Moslemani, MD	Dr. El Moslemani has nothing to disclose.
Soha R. Dargham, MPH	Miss Dargham has nothing to disclose.
Anderson S. Corin	Mr. Corin has nothing to disclose.
Erjia Cui	Dr. Cui has nothing to disclose.
Jagjot Singh, MBBS	Dr. Singh has nothing to disclose.
Joshua Mahutga, MD, MS	Mr. Mahutga has nothing to disclose.
Nick Corriveau-Lecavalier, PhD	Dr. Corriveau-Lecavalier has nothing to disclose.
Peimin Yu	Dr. Yu has nothing to disclose.
Zhen Hong	Prof. Hong has nothing to disclose.
Victor Guerra-Fernandez, MD	Mr. Guerra-Fernandez has nothing to disclose.
Dong Zhou	Dong Zhou has nothing to disclose.
Jacob J. Shawwa	Mr. Shawwa has nothing to disclose.
Mahima Sriram	Miss Sriram has nothing to disclose.
Muzamil Akhtar, Medical Student	Mr. Akhtar has nothing to disclose.
Anas M. Elgenidi, MD	Dr. Elgenidi has nothing to disclose.
Wagner Rios-Garcia	Mr. Rios-Garcia has nothing to disclose.
Ashwin Swami, MD	Dr. Swami has nothing to disclose.
Anil Tarachandani, PhD	Dr. Tarachandani has received personal compensation for serving as an employee of Verge Genomics. Dr. Tarachandani has stock in Verge Genomics.
Eino Solje, MD, PhD	Prof. Solje has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Prof. Solje has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Solje has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Prof. Solje has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Solje has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Prof. Solje has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Govind S. Mann, MBBS	Dr. Mann has nothing to disclose.
Brian Shook, PhD	Dr. Shook has nothing to disclose.
Ahmed Farid, MD	Dr. Farid has nothing to disclose.
Cristina E. Ramos, MD	Dr. Ramos has nothing to disclose.
Ping-Hao Yang, MD	Dr. Yang has nothing to disclose.
Yoshua Esquenazi, MD	Dr. Esquenazi has nothing to disclose.
Dulari Gupta, MD, MBBS	Dr. Gupta has nothing to disclose.
Luciano Mastronardi, MD	Dr. Mastronardi has nothing to disclose.
Ramanjot Kaur, MBBS	Dr. Kaur has nothing to disclose.
Javeria Javeid	Mrs. Javeid has nothing to disclose.
Areej Javeid	Miss Javeid has nothing to disclose.
Martin J. Schmidt, PhD	Dr. Schmidt has received personal compensation for serving as an employee of Kypha Inc.. Dr. Schmidt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Verge Genomics. Dr. Schmidt has stock in Kypha Inc. Dr. Schmidt has received intellectual property interests from a discovery or technology relating to health care.
Laura Aguilar, MD, PhD	Dr. Aguilar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Diakonos Oncology. An immediate family member of Dr. Aguilar has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Candel Therapeutics. Dr. Aguilar has stock in Candel Therapeutics .
Abdallah Abbas, MD	Dr. Abbas has nothing to disclose.
Ruben van Eijk, MD, PhD	Dr. van Eijk has nothing to disclose.
Eva H. Schumann	Ms. Schumann has received personal compensation for serving as an employee of Diakonos Oncology.
Mia Vu, CRC	Miss Vu has nothing to disclose.
Keenan Ernste	Mr. Ernste has received intellectual property interests from a discovery or technology relating to health care.
Shiva L. Birija, BSc	Miss Birija has nothing to disclose.
Akshar J. Trivedi, MS	Mr. Trivedi has nothing to disclose.
Ivan Alegre-Cordero	Mr. Alegre-Cordero has nothing to disclose.
Vanaja konduri, PhD	Dr. konduri has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Diakonos Oncology. Dr. konduri has stock in Diakonos Oncology. The institution of Dr. konduri has received research support from Diakonos Oncology.
Rodrick C. Zvavanjanja, MD	Dr. Zvavanjanja has nothing to disclose.
Dinesh Kumar	Dr. Kumar has nothing to disclose.
Tabia Shujaat, MBBS	Dr. Shujaat has nothing to disclose.
Irene Choi, PhD	Dr. Choi has received personal compensation for serving as an employee of Verge Genomics. Dr. Choi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Modality AI. Dr. Choi has stock in Nektar Therapeutics. Dr. Choi has stock in Verge Genomics. Dr. Choi has stock in Modality AI.
Puneet V. Singh, MBBS	Dr. Singh has nothing to disclose.
Wei Liu, MD	Ms. Liu has nothing to disclose.
William K. Decker, PhD	Dr. Decker has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Diakonos Oncology Corp.. Dr. Decker has stock in Diakonos Research, Ltd.. The institution of Dr. Decker has received research support from NIH. The institution of Dr. Decker has received research support from ALSF. The institution of Dr. Decker has received research support from Cancer Cures 4 Kids. Dr. Decker has received intellectual property interests from a discovery or technology relating to health care.
Mai Sato, PhD	Dr. Sato has received personal compensation for serving as an employee of ZS Associates.
Rawdah Shakil, MBBS	Ms. Shakil has nothing to disclose.
Atul K. Mallik, MD, PhD	Dr. Mallik has received publishing royalties from a publication relating to health care.
Monika Pandit, MBBS	Dr. Pandit has nothing to disclose.
William T. Raskopf	Mr. Raskopf has nothing to disclose.
Luis F. Leyton Aguilar, MD	Dr. Leyton Aguilar has nothing to disclose.
Kwang-Dong Choi	Prof. Choi has nothing to disclose.
Hyun Sung Kim, MD	Prof. Kim has nothing to disclose.
Yousof Al-Bojoq, Sr., PhD	Dr. Al-Bojoq has nothing to disclose.
Liran Ziegelman, PhD	Dr. Ziegelman has nothing to disclose.
Gianmarco Severa, MD	Dr. Severa has received research support from Généthon, UPEC.
Doaa Ramadan	Doaa Ramadan has nothing to disclose.
Ines Hoffmann, PhD	Dr. Hoffmann has received personal compensation for serving as an employee of Xencor. Dr. Hoffmann has received personal compensation for serving as an employee of Verge Genomics. Dr. Hoffmann has stock in Xencor.
Faris Fayyaz, MBBS	Mr. Fayyaz has nothing to disclose.
Silvia Michelini, MD	Dr. Michelini has nothing to disclose.
Tirath Patel	Mr. Patel has nothing to disclose.
James Bates, Medical Student	Mr. Bates has nothing to disclose.
Bibiana Valhuerdi Porto, MD	Dr. Valhuerdi Porto has nothing to disclose.
Min Ji Kim, BA	Ms. Kim has nothing to disclose.
Dante O. Oropeza Velazquez, Jr.	Dr. Velazquez has nothing to disclose.
Nicole R. Princic, MS	Mrs. Princic has nothing to disclose.
Lincy Lal, PhD	Mrs. Lal has received personal compensation for serving as an employee of Immunovant. Mrs. Lal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with UT School of Public Health.
Anand Kumar, MD	Dr. Kumar has nothing to disclose.
Silvana Frizzo, MD	Dr. Frizzo has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Frizzo has stock in Praxis Precision Medicines.
John Port, MD, PhD	The institution of Prof. Port has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clario.
Charlotte A. Pettersson, MSc	Ms. Pettersson has received personal compensation for serving as an employee of PPD Scandinavia AB, part of Thermo Fisher Scientific.
Firas Dabbous, PhD	Dr. Dabbous has received personal compensation for serving as an employee of Thermofisher Scientific.
William Rowles	Mr. Rowles has nothing to disclose.
Joseph Georges, DO, PhD	Dr. Georges has received intellectual property interests from a discovery or technology relating to health care.
Steven Petrou, FAHMS	Dr. Petrou has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Petrou has stock in Praxis Precision Medicines. The institution of Dr. Petrou has received research support from Praxis Precision Medicines. Dr. Petrou has received intellectual property interests from a discovery or technology relating to health care.
Karl Hansen	Dr. Hansen has received personal compensation for serving as an employee of Praxis Precision Medicines.
María T. Alba Isasi, MD	Dr. Alba Isasi has nothing to disclose.
Siby Gopinath, MD	Dr. Gopinath has nothing to disclose.
Ahmed Sabra, MD	Mr. Sabra has nothing to disclose.
Kevin Barton, MD	Dr. Barton has nothing to disclose.
Jae-Hwan Choi	Jae-Hwan Choi has nothing to disclose.
Karen Espinal	Karen Espinal has nothing to disclose.
Paul Min	No disclosure on file
Cynthia Vernon	Cynthia Vernon has nothing to disclose.
Mariana Letícia d. Maximiano, MD	Dr. Maximiano has nothing to disclose.
Dharit Patel, MD	Mr. Patel has received personal compensation for serving as an employee of Praxis Precision Medicines, Inc..
Hong Sun, MD, PhD	Dr. Sun has nothing to disclose.
Louise Cosand, PhD	Dr. Cosand has received personal compensation for serving as an employee of Acadia Pharmaceuticals Inc. Dr. Cosand has or had stock in Acadia Pharmaceuticals Inc.
Isabella M. Tincher	Ms. Tincher has nothing to disclose.
Sunanjay Bajaj, MD	Dr. Bajaj has nothing to disclose.
Nikita Chhabra, DO	Dr. Chhabra has nothing to disclose.
Kaitlyn E. Druyor, DO	Dr. Druyor has nothing to disclose.
Juliet O. Manu	Ms. Manu has nothing to disclose.
Bagath Srinivasan Balaji, MBBS	Dr. Balaji has nothing to disclose.
Kateryna Potapova, MD	Dr. Potapova has nothing to disclose.
Ana P. Sieben Samek, Jr., MD	Miss Sieben Samek has nothing to disclose.
Shawn J. Bird, MD, FAAN	No disclosure on file
Dean Roller, MD	Dr. Roller has nothing to disclose.
Stavra N. Romas, MD	Dr. Romas has nothing to disclose.
Venka Veerappan, MD, FAAN	Dr. Veerappan has nothing to disclose.
Wendy A. Stewart, MD, PhD, FRCP	No disclosure on file
Behzad Habibi Khameneh, MD	Dr. Habibi Khameneh has nothing to disclose.
Adrienne Castillo, RN	No disclosure on file
Nitin Jain, MD, MBBS, DM	Dr. Jain has nothing to disclose.
Kevin T. Meier, MD	Dr. Meier has nothing to disclose.
Adrienne M. Pan, DO	Dr. Pan has nothing to disclose.
Karla E. Naujoks, PhD	Dr. Becerril has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Becerril has stock in Acadia Pharmaceuticals.
Vikas Patel, MD	Dr. Patel has nothing to disclose.
Esra Gursoy	Esra Gursoy has nothing to disclose.
Cynthia Peng, MD	Dr. Peng has nothing to disclose.
Mary Petrulis, MD	Dr. Petrulis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Dr. Petrulis has received research support from UCB.
Suriya Subramanian, MD	Dr. Subramanian has nothing to disclose.
Jesus Daniel Gutierrez Arratia, MD	Dr. Gutierrez Arratia has nothing to disclose.
Erin Doan, PhD, RN, NP	Dr. Doan has nothing to disclose.
Marissa D'Souza, MD	No disclosure on file
Vishal G. Pawar, MBBS, DNB	Dr. Pawar has nothing to disclose.
Liz C. Ballinger, MD, PhD	Dr. Ballinger has nothing to disclose.
Sachin Gadani, MD, PhD	Dr. Gadani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Gadani has received research support from National MS Society.
Arindra Jayasekara, MD	Dr. Jayasekara has nothing to disclose.
Moriah R. Arnold	Ms. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Srinath Ramanan, MD	Dr. Ramanan has nothing to disclose.
Kyle Hobbs, MD	Dr. Hobbs has nothing to disclose.
Claire Allen, MD	Dr. Allen has nothing to disclose.
Nidhila Masha, MD	Dr. Masha has nothing to disclose.
Nhan Ly, MD	Mr. Ly has nothing to disclose.
Vera Nemsadze, MD	Dr. Nemsadze has nothing to disclose.
Connie Chung, MD	Dr. Chung has nothing to disclose.
Ryan Bean, DO	Dr. Bean has nothing to disclose.
Iwalewa Moninuola, MD	Dr. Moninuola has nothing to disclose.
Biany Santos de Pena, MD	Dr. Santos de Pena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Mesofarma Corporation y Novartis .
Efthalia Angelopoulou	The institution of Mrs. Angelopoulou has received research support from Hellenic Foundation Research and Innovation.
Asante Hatcher, PhD	Dr. Hatcher has received personal compensation for serving as an employee of IntraBio. Dr. Hatcher has stock in IntraBio.
Michael V. Hood-Julien, MD	Dr. Hood-Julien has nothing to disclose.
Mayara S. Marques, MD	Miss Marques has nothing to disclose.
Bryan Tang, DO	Dr. Tang has nothing to disclose.
Mina Baskharoun, MD	Dr. Baskharoun has nothing to disclose.
Razan Hallak, MD	Dr. Hallak has nothing to disclose.
Isheeta Gupta, MBBS	Dr. Gupta has nothing to disclose.
Harshal P. Chorya, MBBS	Mr. Chorya has nothing to disclose.
Curtis A. Amankwah, MD	Dr. Amankwah has nothing to disclose.
Verónica L. Torres-Torres	No disclosure on file
Ming-Chen Tsai, MD	Dr. Tsai has nothing to disclose.
Darina Dinov, DO	Dr. Dinov has nothing to disclose.
Andrea Mastrangelo, MD	Dr. Mastrangelo has nothing to disclose.
Chala R. Riddick, MD	Dr. Riddick has nothing to disclose.
Anthony J. DiCesare, DO	Dr. DiCesare has nothing to disclose.
Joshua Y. Yeo, MBBS	Dr. Yeo has nothing to disclose.
Malak F. Albattah, MD	Dr. Albattah has nothing to disclose.
Talia Watras, MD	Dr. Watras has nothing to disclose.
Wayne Zhong, MD	Dr. Zhong has nothing to disclose.
Casey Manzanero, MD	Dr. Manzanero has nothing to disclose.
Sina Aghili-Mehrizi, MD	Dr. Aghili-Mehrizi has nothing to disclose.
Matthew Cobler-Lichter, MD	Dr. Cobler-Lichter has nothing to disclose.
Amanda Hijazin, MD	Dr. Hijazin has nothing to disclose.
Anna Kaiser, DO	Dr. Kaiser has nothing to disclose.
Ana M. Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Bruno A. Rosario, MD	Dr. Rosario has nothing to disclose.
Ansen Steiner, MD	Dr. Steiner has nothing to disclose.
Fredy G. Gutierrez Munoz, MD	Dr. Gutierrez Munoz has nothing to disclose.
Wajiha Memon, DO	Dr. Memon has nothing to disclose.
Ereny Mikhael, MD	Dr. Mikhael has nothing to disclose.
Thomas J. Pisano, MD, PhD	The institution of Dr. Pisano has received research support from NIH.
Ronny Yip	Dr. Yip has nothing to disclose.
Twila Gaston, MD	Dr. Gaston has nothing to disclose.
Patrick Stancu, MD	Dr. Stancu has nothing to disclose.
Emma K. Vivlamore	Miss Vivlamore has nothing to disclose.
Sheena Hussain	Miss Hussain has nothing to disclose.
Jacob Farris, MD	Dr. Farris has nothing to disclose.
Rikki Chisvin, MD	Dr. Chisvin has nothing to disclose.
Ryan Dahl, MD	Dr. Dahl has nothing to disclose.
Abdirahim Aden, MBChB	Dr. Aden has nothing to disclose.
Joshua Fernandez	Dr. Fernandez has nothing to disclose.
Crystal Eshraghi, MD	Dr. Eshraghi has nothing to disclose.
Hannah Branstetter, MD	Dr. Branstetter has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill Education Inc. Dr. Branstetter has received publishing royalties from a publication relating to health care.
Ella Mengchen Suo, MBBS	Dr. Suo has nothing to disclose.
Sana Hussaini, MD	Dr. Hussaini has nothing to disclose.
Sakina Shaikh	Miss Shaikh has nothing to disclose.
Justiniano O. Zea Quispe, Sr., MD	No disclosure on file
Abdullah H. Almarfadi II	Mr. Almarfadi has nothing to disclose.
Tehshina Mallick, MBBS	Dr. Mallick has nothing to disclose.
Dakota Wilkinson	Ms. Wilkinson has nothing to disclose.
Robert Nebro, PharmD	Dr. Nebro has nothing to disclose.
Nina Thakur, DO	Dr. Thakur has nothing to disclose.
Rohan S. Joshi, MD	Mr. Joshi has nothing to disclose.
Ignacio J. Keller Sarmiento, MD	Dr. Keller Sarmiento has nothing to disclose.
Spencer D. Hall, DO	Dr. Hall has nothing to disclose.
Ayla Barakat, MD	Dr. Barakat has nothing to disclose.
Karim Borei	Dr. Borei has nothing to disclose.
Soumya Ravichandran	Ms. Ravichandran has nothing to disclose.
Sijia Tian, MD	Dr. Tian has nothing to disclose.
Rana Abushamma, MBBS	Dr. Abushamma has nothing to disclose.
Alex Cabe, DO	Dr. Cabe has nothing to disclose.
Sarah Westlake, DO	Mrs. Westlake has nothing to disclose.
Sana Iftikhar	Ms. Iftikhar has nothing to disclose.
Faraz Behzadi, MD	Dr. Behzadi has nothing to disclose.
Elia Barraza, MD	Dr. Barraza has nothing to disclose.
Justine Chee, MD	Dr. Chee has nothing to disclose.
Anne Taylor, MD	Dr. Taylor has nothing to disclose.
Yunji Seo	Ms. Seo has nothing to disclose.
Woo Sik Kim	Mr. Kim has nothing to disclose.
Gergis G. Altalab III, MD	Dr. Altalab has nothing to disclose.
Nidhi M. Patel	Miss Patel has nothing to disclose.
Mohamed F. Hemida Saleh	Dr. Hemida Saleh has nothing to disclose.
Adil Ahmed, MBBS	Mr. Ahmed has nothing to disclose.
Alex Casella, MD, PhD	Dr. Casella has nothing to disclose.
Rayyan Nabi	Mr. Nabi has nothing to disclose.
Bara M. Hammadeh	Mr. Hammadeh has nothing to disclose.
Chad Oh	No disclosure on file
Fiza Wali, MBBS	Miss Wali has nothing to disclose.
Ali Karimi	Mr. Karimi has nothing to disclose.
Angel Aledo-Serrano	Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke pharma. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharma. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB.
Binay Panjiyar, MBBS	Dr. Panjiyar has nothing to disclose.
Hemanth Kumar Arumugam, MBBS	Dr. Arumugam has nothing to disclose.
Obiadada Ugochukwu, MD	Dr. Ugochukwu has nothing to disclose.
Wendy Vera, MD	Dr. Vera has nothing to disclose.
Johny Tran, MD	Dr. Tran has nothing to disclose.
Ting Huai Shi, DO	Ting Huai Shi, DO has nothing to disclose.
Megan Coghlan, MD	Dr. Coghlan has nothing to disclose.
Armin Garcia, MD	Dr. Garcia has nothing to disclose.
Daniel Isaza Pierotti, MD, MCSO	Dr. Isaza Pierotti has nothing to disclose.
Divya Patel, MD	Dr. Patel has nothing to disclose.
Daniel Goldstein	Daniel Goldstein has nothing to disclose.
Michael Pennell, MD	Michael Pennell has nothing to disclose.
Anusha Sanivarapu, MD	Anusha Sanivarapu has nothing to disclose.
Lilla S. Simon, MD	Dr. Simon has nothing to disclose.
Phillip Regina, MD	Dr. Regina has nothing to disclose.
Tracey Nicole Webb, MD	Dr. Webb has nothing to disclose.
Kate Arner, MD	Dr. Arner has nothing to disclose.
Evan Mooney, MD	Dr. Mooney has nothing to disclose.
Emily Chea, DO	Ms. Chea has nothing to disclose.
Zoe Wilson	Miss Wilson has nothing to disclose.
Nikhil V. Avadhani, BA	Mr. Avadhani has nothing to disclose.
Arwaa Chaudhry, MBBS, Medical Student	Miss Chaudhry has nothing to disclose.
Henry L. Alvarez, MD	Dr. Alvarez has nothing to disclose.
Suryaa Gupta	Miss Gupta has nothing to disclose.
Yaritza Bautista Estrella, PhD	Dr. Bautista Estrella has nothing to disclose.
Dorisbel A. Grullon, Sr., MD	Dr. Grullon has nothing to disclose.
Jamila Mercedes, Sr., PhD	No disclosure on file
Diego Rodriguez, Sr., MD	No disclosure on file
Valentina I. Roa Forster	Miss Roa Forster has nothing to disclose.
Maria Pia Campagna, PhD	Dr. Campagna has nothing to disclose.
Kush Sehgal, MBBS	Dr. Sehgal has nothing to disclose.
Josephine Martin, DO	Dr. Martin has nothing to disclose.
Mehar Durah, DO	Miss Durah has nothing to disclose.
Jon Klein, MD	Mr. Klein has nothing to disclose.
Maria Clara M. de S. Lima, Medical Studant	Ms. de S. Lima has nothing to disclose.
Denisse Morales-Rodriguez	Ms. Morales-Rodriguez has nothing to disclose.
Deanna Sgambato, PA	Miss Sgambato has nothing to disclose.
Neha D. Mohite, Sr., MD	Dr. Mohite has nothing to disclose.
Bharati Hegde, PhD	Dr. Hegde has nothing to disclose.
Amer A. Alomari, MD, MBBS	Prof. Alomari has nothing to disclose.
Malik I. Allahham, MD	Dr. ALLAHHAM has nothing to disclose.
Dawn Meyer, PhD	Dr. Meyer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Dr. Meyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chiesi.
Lovella Hailey, NP	Mrs. Hailey has nothing to disclose.
Marcos M. Mota, Sr., Br	Mr. Mota has nothing to disclose.
Maria G. Munoz, Br	Mrs. Munoz has nothing to disclose.
Khiany Mathias, PhD	Miss Mathias has nothing to disclose.
Richard S. Machado, Sr., PhD	Dr. Machado has nothing to disclose.
Carla Damasio Martins, PhD	Ms. Damasio Martins has nothing to disclose.
Anita Dal Bó Tiscoski, Iniciação científica	Mrs. Dal Bó Tiscoski has nothing to disclose.
Natalia P. Piacentini da Silva, academic	Miss Piacentini da Silva has nothing to disclose.
Mohamed A. Zanaty	Mohamed A. Zanaty has nothing to disclose.
Larissa S. Joaquim, PhD	Dr. Joaquim has nothing to disclose.
Fabricia Petronilho	Prof. Petronilho has nothing to disclose.
Haneen Sabet, MD	Dr. Sabet has nothing to disclose.
Robert H. Scannevin, PhD	Dr. Scannevin has received personal compensation for serving as an employee of Verge Genomics. Dr. Scannevin has received intellectual property interests from a discovery or technology relating to health care.
Raquel Monegro Cordero, Estudiante	Mrs. Monegro Cordero has nothing to disclose.
Yihan Zhang	Mr. Zhang has nothing to disclose.
Meet Kachhadia, MBBS	Dr. Kachhadia has nothing to disclose.
Gregory Kurgansky, DO	Gregory Kurgansky, DO has nothing to disclose.
Jillian Scavone, PhD	Dr. Scavone has nothing to disclose.
Farhan Memon, MBBS	Mr. Memon has nothing to disclose.
Farah Barakat, MD, MBBS	Ms. Barakat has nothing to disclose.
Anosh John, MBBS	Dr. John has nothing to disclose.
Justin Huynh	Mr. Huynh has nothing to disclose.
Fiorella E. Rivas Sarmiento, Dra	Dr. Rivas Sarmiento has nothing to disclose.
Patrick Kirk, NP	Mr. Kirk has nothing to disclose.
Anne M. Islam	Ms. Islam has nothing to disclose.
NAMAN SAHU, Sr., MD	Dr. SAHU has nothing to disclose.
Aditi Agarwal	Aditi Agarwal has nothing to disclose.
Bahy El-din M. Saied, MBBS	Dr. Saied has nothing to disclose.
Neha Gregory	Miss Gregory has nothing to disclose.
Elana Goldenberg	Ms. Goldenberg has nothing to disclose.
Vitoria Palazoni Viegas	Dr. Palazoni Viegas has nothing to disclose.
Sana Desai, MD Student	Ms. Desai has nothing to disclose.
Tina Bastin	Miss Bastin has nothing to disclose.
Alexandra Bayer, PhD	Dr. Bayer has nothing to disclose.
Brian Spar	Mr. Spar has received personal compensation for serving as an employee of Praxis Precision Medicines.
Poppy Guest, Bsc	Mrs. Guest has received personal compensation for serving as an employee of Praxis Precision Medicines. Mrs. Guest has stock in Praxis Precision Medicines.
Brandon Bergsneider	Mr. Bergsneider has nothing to disclose.
Rayomand V. Kapadia	Mr. Kapadia has nothing to disclose.
Ginger Kwak, BS	Ms. kwak has nothing to disclose.
Maha Sajjad	Maha Sajjad has nothing to disclose.
Ali D. Marsool, MD	Dr. Marsool has nothing to disclose.
Lisett Castellanos	Miss Castellanos has nothing to disclose.
Jeancarlo Velazco Muñoz	Mr. Velazco Muñoz has nothing to disclose.
Thanuja Mora, MBBS	Dr. Mora has nothing to disclose.
Mitchell T. Dubaniewicz	Mr. Dubaniewicz has nothing to disclose.
Tobi N. Olajide, Student	Mr. Olajide has nothing to disclose.
Jose Maria Cabrera, MD	Dr. Cabrera has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. Cabrera has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB.
Marek Smilowski, MD, PhD	Dr. Smilowski has nothing to disclose.
Luiza Villarim	No disclosure on file
Xavier Grandes	Mr. Grandes has nothing to disclose.
Erum Habib, Optometrist	Miss Habib has nothing to disclose.
BIANCA ETELVINA S. OLIVEIRA, Sr.	Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVARTIS. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK.
Natanael Duarte, MD	Dr. Duarte has nothing to disclose.
Menno M. Schoonheim, PhD	The institution of Dr. Schoonheim has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. The institution of Dr. Schoonheim has received research support from Dutch MS Research Foundation. The institution of Dr. Schoonheim has received research support from Eurostars-EUREKA. The institution of Dr. Schoonheim has received research support from Amsterdam Neuroscience. Dr. Schoonheim has received research support from ZonMW. The institution of Dr. Schoonheim has received research support from Atara Biotherapeutics. The institution of Dr. Schoonheim has received research support from Biogen. The institution of Dr. Schoonheim has received research support from BMS. The institution of Dr. Schoonheim has received research support from Merck. The institution of Dr. Schoonheim has received research support from Cervomed/EIP. The institution of Dr. Schoonheim has received research support from ECTRIMS.
Kevin Soon Hwee Teo, MA, MB, BChir, MRCP	Kevin Soon Hwee Teo, MA, MB, BChir, MRCP has nothing to disclose.
Muhammad Fateh Alam Bhatty	Dr. Bhatty has nothing to disclose.
Christian C. Armijo, Jr., MD	Dr. Armijo has nothing to disclose.
Melika Arab Bafrani, MD	No disclosure on file
Joseph Yaria	Joseph Yaria has nothing to disclose.
Jorge Ginory-Perez	Jorge Ginory-Perez has nothing to disclose.
Rhani Pflaum	Rhani Pflaum has nothing to disclose.
Kin Mun Lau, MD	Dr. Lau has nothing to disclose.
Maryam Saghir, MBBS	Miss Saghir has nothing to disclose.
Dionysia Kontaxopoulou, PhD	Dr. Kontaxopoulou has received personal compensation for serving as an employee of Hellenic Foundation Research and Innovation.
Fahad Amin, MBBS	Mr. Amin has nothing to disclose.
Hassan Asif, MBBS	Dr. Asif has nothing to disclose.
Sarmad Chattha, MBBS	Mr. Chattha has nothing to disclose.
Sheina Emrani, PhD	Dr. Emrani has nothing to disclose.
Anastasiia Strelkova, MD	Dr. Strelkova has nothing to disclose.
Gelanys Castro Tejada, MD	Gelanys Castro Tejada has nothing to disclose.
Haya A. Al-Kuwari	Ms. Al-Kuwari has nothing to disclose.
Drusilla Tan, MD	Dr. Tan has nothing to disclose.
Muhammad Moiz Javed, MD	Dr. Javed has nothing to disclose.
Susanna Kwok, MD	Susanna Kwok has nothing to disclose.
Mayar N. Sinjilawi, Sr., MD	Miss Sinjilawi has nothing to disclose.
Alianis Tirado	Alianis Tirado has nothing to disclose.
Ruth Seleznick	Ruth Seleznick has nothing to disclose.
Sara Zakris	Mrs. Zakris has nothing to disclose.
Oscar E. Gutierrez Trevino, MD	Dr. Gutierrez Trevino has nothing to disclose.
Brigham Harrison	Mr. Harrison has nothing to disclose.
Hend Heikal	Ms. Heikal has nothing to disclose.
Gurunathan Srinivasan	Mr. Srinivasan has nothing to disclose.
Huzaifa S. Nawaz, MBBS	Dr. Nawaz has nothing to disclose.
Akshit Bararia, MBBS	Dr. Bararia has nothing to disclose.
Noorul Hidhaya S, MBBS	Miss S has nothing to disclose.
Veronica M. Andrade	Ms. Andrade has nothing to disclose.
AlDana J. Al-Khalaf	Ms. Al-Khalaf has nothing to disclose.
Jitendra Upadhyay, MBBS	Dr. Upadhyay has nothing to disclose.
Abirami Sivatharman	Miss Sivatharman has nothing to disclose.
Kaitlin Hanley, SLP	Ms. Hanley has nothing to disclose.
Nurit Omer, MD	Dr. Omer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis pharmaceutical. Dr. Omer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva .
ZAIN U. ABEDIN, MBBS	Mr. ABEDIN has nothing to disclose.
Anas Z. Nourelden, MD	Dr. Nourelden has nothing to disclose.
Safa Mazhar, MBBS	Miss Mazhar has nothing to disclose.
Sitki C. Parlar, BSc	Mr. Parlar has nothing to disclose.
Rey D. Nuez Lopez, MD	Dr. Nuez Lopez has nothing to disclose.
Hanzala A. Farooqi, MBBS	Mr. Farooqi has nothing to disclose.
Taylor Parks, MSc	Mrs. Parks has nothing to disclose.
Christina Banat	Miss Banat has nothing to disclose.
Ayushi Ambekar	Ms. Ambekar has nothing to disclose.
Jorgji Kerthi, PharmD	Dr. Kerthi has received personal compensation for serving as an employee of IntraBio, Inc. Dr. Kerthi has received personal compensation for serving as an employee of Amylyx Pharmaceuticals, Inc. Dr. Kerthi has stock in IntraBio, Inc. Dr. Kerthi has stock in Amylyx Pharmaceuticals, Inc.
Samaya Kallepalli	Ms. Kallepalli has nothing to disclose.
Daniel F. Guijo, MD	Daniel F. Guijo, MD has nothing to disclose.
Dasol Lee	Mrs. Lee has nothing to disclose.
Vania Amani, BSc Student	Miss Amani has nothing to disclose.
Chelsea Mae N. Nobleza, MD	Dr. Nobleza has nothing to disclose.
Charlene Bustamante, MD	Dr. Bustamante has nothing to disclose.
Pedro Bartkevitch Rodrigues, MD	Dr. Bartkevitch Rodrigues has nothing to disclose.
Radhika Patel	Miss Patel has nothing to disclose.
Sophia Rosin, college student	Ms. Rosin has nothing to disclose.
YASMIN NEGEDA, MD	Dr. NEGEDA has nothing to disclose.
Neil Nero, MLIS	Mr. Nero has nothing to disclose.
Reem A. Alwahsh, MD	Dr. Alwahsh has nothing to disclose.
Omar Bushnaq, MD	Mr. Bushnaq has nothing to disclose.
Bashar Abualsebaa, MD	Mr. Abualsebaa has nothing to disclose.
Chail Shah, MD	Dr. Shah has nothing to disclose.
Neveen M. Muqbel, MD	Dr. Muqbel has nothing to disclose.
Heba A. Aboeqab, MD	Dr. Aboeqab has nothing to disclose.
Mohammed Alkhateeb, MD	Dr. Alkhateeb has nothing to disclose.
Mandisa Keswa	Ms. Keswa has nothing to disclose.
Jasmine Zhang, BS	Ms. Zhang has nothing to disclose.
Joshua Hanlon, MS	Mr. Hanlon has nothing to disclose.
Emanuela Santoro, Medical student	Miss Santoro has nothing to disclose.
Blaine Foster	Mr. Foster has nothing to disclose.
Theres Alexander	Ms. Alexander has nothing to disclose.
Carlos A. Perez, MD	Mr. Perez has nothing to disclose.
Keara Kennedy	Miss Kennedy has nothing to disclose.
Lorenzo Malfer, MD	Dr. Malfer has nothing to disclose.
Daud Shah, MBBS	Dr. Shah has nothing to disclose.
Muhammad S. Saleem, MBBS	Dr. Saleem has nothing to disclose.
Farid Ullah, MBBS	Dr. Ullah has nothing to disclose.
Syeda Ayesha, MBBS	Miss Ayesha has nothing to disclose.
Prithvi Pillai, MBBS	Dr. Pillai has nothing to disclose.
Rimsha Adnan, MBBS	Miss Adnan has nothing to disclose.
Beatriz Gerente, Medical Student	Miss Gerente has nothing to disclose.
Amatul Aala, MBBS	Miss Aala has nothing to disclose.
Ameer Hamza, MBBS	Dr. Hamza has nothing to disclose.
Luis R. Vanegas, Jr., Medical Student (Intern)	Mr. Vanegas has nothing to disclose.
Peter Zhang, PhD	Dr. Zhang has nothing to disclose.
Amna Asif, MBBS	Dr. Asif has nothing to disclose.
Abdelrahman Nageh Ali Hafez, MD	Mr. Hafez has nothing to disclose.
Roberta Bovenzi, MD	Dr. Bovenzi has nothing to disclose.
Denise Vidal, MPH	Mrs. Vidal has nothing to disclose.
Lisa Kinsley, MS, CGC	Ms. Kinsley has nothing to disclose.
Bernabe I. Bustos, PhD	Dr. Bustos has nothing to disclose.
Greg Brunson, PharmD	Dr. Brunson has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Brunson has or had stock in Acadia Pharmceuticals.
Mary Montenegro, MD	Ms. Montenegro has nothing to disclose.
Simon Dang, Student	Mr. Dang has nothing to disclose.
Angela Tang	Miss Tang has nothing to disclose.
Yu Wu	Ms. Wu has nothing to disclose.
Lara H. Hamzeh, MD	Miss Hamzeh has nothing to disclose.
Soyoung Youm	Ms. Youm has received personal compensation for serving as an employee of Inventagelab.
Joo Young Cha	Mr. Cha has nothing to disclose.
Soonho Song	Mr. Song has nothing to disclose.
Slgirim Lee	Mr. Lee has received personal compensation for serving as an employee of Inventage Lab Inc..
Ju Hee Kim	Ms. Kim has received personal compensation for serving as an employee of Inventagelab.
Euna Kim	Ms. Kim has nothing to disclose.
Young Dai Seo	Mr. Seo has nothing to disclose.
Khader A. Abutawahina, MD	Dr. Abutawahina has nothing to disclose.
Abdulsalam K. Arebi, Sr., MD	Dr. Arebi has nothing to disclose.
Abdullah Obadi, MD	Dr. Obadi has nothing to disclose.
Said Alhassan, BS	Mr. Alhassan has nothing to disclose.
Divya Sudireddy, MD	Dr. Sudireddy has nothing to disclose.
Jessica Lamb, CRA	Ms. Lamb has nothing to disclose.
HAOCHENG LUO	Dr. LUO has nothing to disclose.
Yazan Nouh, MD	Dr. Nouh has nothing to disclose.
Mohannad Abd-Alhadi, MD	Dr. Abd-Alhadi has nothing to disclose.
Skylar Lewis, BA	Ms. Lewis has nothing to disclose.
Irogue Igbinosa, MD	Dr. Igbinosa has nothing to disclose.
Francesca D S Kamwa Dzukou, Medical Student, BS, MS	Mrs. Kamwa Dzukou has nothing to disclose.
Suhaib Alquraan, MD	Dr. Alquraan has nothing to disclose.
Eman Shazly, Resident doctor	Dr. Shazly has nothing to disclose.
Sara A. Elayan, MD	Ms. Elayan has nothing to disclose.
Manus Donahue, PhD	Prof. Donahue has nothing to disclose.
Shanza Abbasi, HO	Dr. Abbasi has nothing to disclose.
Maria D. Peralta Rosales, MD	Dr. Peralta Rosales has nothing to disclose.
William Zhang	Mr. Zhang has nothing to disclose.
Fahad S. Butt, FCPS (Pakistan)	Dr. Butt has nothing to disclose.
Sophie Nguyen	Miss Nguyen has nothing to disclose.
Ghassab E. Ababneh, MD	Dr. Ababneh has nothing to disclose.
jeffrey w. walter, PT	Dr. walter has received personal compensation for serving as an employee of education resources. Dr. walter has received personal compensation for serving as an employee of medbridge education. Dr. walter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for education resources inc. Dr. walter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medbridge Education.
Guillermo K. Pons Monnier, MD	Dr. Pons Monnier has nothing to disclose.
Muhammad Nabeel Saddique, MBBS	Mr. Saddique has nothing to disclose.
Muhammad Usman Iqbal, MBBS	Mr. Iqbal has nothing to disclose.
Saad Arsalan Wasti, MBBS	Mr. Arsalan Wasti has nothing to disclose.
Hammad Naveed, MBBS	Mr. Naveed has nothing to disclose.
Mohammad Waqas Bin Waheed, MBBS	Dr. Waqas Bin Waheed has nothing to disclose.
Ali Akram Qureshi, MBBS	Dr. Qureshi has nothing to disclose.
hellen g. mota, MS	Ms. mota has nothing to disclose.
Soraya P. Bussiki	Miss Bussiki has nothing to disclose.
Michele Hernandez, MD	Dr. Hernandez has nothing to disclose.
Zainab Alvi, MBBS	Dr. Alvi has nothing to disclose.
Wyllians V. Borelli, MD, PhD	Prof. Borelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Novo Nordisk. Prof. Borelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Prof. Borelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eli Lilly. Prof. Borelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Prof. Borelli has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for masima.
Syeda Vilay Z. Rizvi, MBBS	Miss Rizvi has nothing to disclose.
Usama Abbas, MBBS	Dr. Abbas has nothing to disclose.
Farid Khan, MD	Dr. Khan has received personal compensation for serving as an employee of Novartis. Dr. Khan has stock in Novartis.
Shikha Polega, PharmD	No disclosure on file
Elizabeth Duus, PhD	Ms. Duus has received personal compensation for serving as an employee of Diakonos Oncology.
Carolyn R. Lew, PhD	Dr. Lew has received personal compensation for serving as an employee of Merative.
Faraz Azhar, MBBS	Dr. Azhar has nothing to disclose.
Sajeela Chahat, MBBS	Dr. Chahat has nothing to disclose.
Mahmoud Afia, MBBCh	Dr. Afia has nothing to disclose.
Dalia Kamal Ewis, MD	Miss Ewis has nothing to disclose.
Aiza Ahsan, MBBS	Dr. Ahsan has nothing to disclose.
Raveen Mujeeb, MBBS	Dr. Mujeeb has nothing to disclose.
Sydney Hopkins	Ms. Hopkins has nothing to disclose.
Kristin Rose	Mrs. Rose has nothing to disclose.
Deepti Kewalramani, MD, MBBS	Dr. Kewalramani has nothing to disclose.
Didem Savasci, MD	Mrs. Savasci has nothing to disclose.
Ranjith K. Kumar Manokaran, MD	Dr. Kumar Manokaran has nothing to disclose.
Arjun Vijan, PhD	Dr. Vijan has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Vijan has or had stock in Jazz Pharmaceuticals.
Saeid Sadeghian, MD	Dr. Sadeghian has nothing to disclose.
Nicole J. Al Alam Rabie	Nicole J. Al Alam Rabie has nothing to disclose.
Maria Qadri, MBBS	Dr. Qadri has nothing to disclose.
Ethan Chang, MD Candidate	Mr. Chang has nothing to disclose.
Tolga Uz, MD, PhD	Dr. Uz has received personal compensation for serving as an employee of H. Lundbeck A/S .
Arham Kamil, MBBS	Mr. Kamil has nothing to disclose.
Mahmoud F. Alquraan, Psychology	Prof. Alquraan has nothing to disclose.
Elayaraja Sivaprakasam, MBBS, DNB (Ped), MRCPCH	Dr. Sivaprakasam has nothing to disclose.
Duaa Z. Khasawneh, MD	Dr. Khasawneh has nothing to disclose.
Ola Soudah, PhD	Dr. Soudah has nothing to disclose.
Sohaib A. Alomari, Jr., MD	Dr. Alomari has nothing to disclose.
Sarala Premkumar, MD	Dr. Premkumar has nothing to disclose.
Omar Abdullah Gill, MBBS	Mr. Gill has nothing to disclose.
Haley L. Miller	Miss Miller has nothing to disclose.
YI-HSUAN LIU, PhD	Dr. LIU has nothing to disclose.
Sahla Waqas, MBBS	Ms. Waqas has nothing to disclose.
Muhammad Izhan	Mr. Izhan has nothing to disclose.
Dorene Blum	Ms. Blum has nothing to disclose.
Arnold Corral Jr	Mr. Corral Jr has nothing to disclose.
Ariba Asif, MBBS	Dr. Asif has nothing to disclose.
Kennedy Guillen, BS	Mr. Guillen has nothing to disclose.
Muhammad H. Ansari, Sr., MBBS	Dr. Ansari has nothing to disclose.
Eshal Saghir, MBBS	Miss Saghir has nothing to disclose.
Diana M. Riaño, MD	Dr. Riaño has nothing to disclose.
Latha Ravichandran, MD	Prof. Ravichandran has nothing to disclose.
Areej Riaz, MBBS	Dr. Riaz has nothing to disclose.
Partab Rai, Jr., MBBS	Dr. Rai has nothing to disclose.
Afraah Mohammed Mouzzam, MBBS	Dr. Mohammed Mouzzam has nothing to disclose.
Elsayed S. Moubarak, MBBS	Dr. Moubarak has nothing to disclose.
Anshal Vyas	Mr. Vyas has nothing to disclose.
Tobias Kremsmayer, MS	Mr. Kremsmayer has nothing to disclose.
Tejaswin Mariappan, MBBS	Mr. Mariappan has nothing to disclose.
Abigail Biddix, BS	Mrs. Biddix has nothing to disclose.
Aleeza Habib, MBBS	Dr. Habib has nothing to disclose.
Martin G. McCandless, MD	Dr. McCandless has nothing to disclose.
Matthew Barrera, MD	Dr. Barrera has nothing to disclose.
Jeremy Weleff, DO	Dr. Weleff has nothing to disclose.
Nikita Rajbhandari, MD	Dr. Rajbhandari has nothing to disclose.
Sarah Chiavacci, Medical Student	Miss Chiavacci has nothing to disclose.
Iqra Aijaz, Student	Ms. Aijaz has nothing to disclose.
Vikrant Rai, MBBS, PhD	Dr. Rai has nothing to disclose.
Mahmoud Tablawy, MD	Dr. Tablawy has nothing to disclose.
Joan Cid, MD, PhD	Dr. Cid has nothing to disclose.
Charles Stout, MD, PhD	Dr. Stout has nothing to disclose.
PAOLA CHARRY ESPANA, MD	Dr. CHARRY ESPANA has nothing to disclose.
Bareera Wajahat, MBBS	Miss Wajahat has nothing to disclose.
Vishal deep, MD	Dr. deep has nothing to disclose.
Ahmad S. Hammouri, MS	Mr. Hammouri has nothing to disclose.
Husam Aldean Hussain, MD	Mr. Hussain has nothing to disclose.
Gabriel P. Costa, MD	Dr. Costa has nothing to disclose.
Al-Laith W. Ramadan, MD	Dr. Ramadan has nothing to disclose.
Basant Lashin, MD	Dr. Lashin has nothing to disclose.
Tarjani Shukla	Dr. Shukla has nothing to disclose.
Bishr M. Quwaider, MD	Dr. Quwaider has nothing to disclose.
Dennis J. Dlugos, MD	The institution of Dr. Dlugos has received research support from The Epilepsy Study Consortium.
Gabriel B. Rodriguez, PhD, MSPH	Dr. Rodriguez has received research support from American Public Health Association.
Laiba Jabeen, MBBS	Miss Jabeen has nothing to disclose.
Nilay McLaren	Mr. McLaren has nothing to disclose.
Tanya Baker, DO	Miss Baker has nothing to disclose.
Mawadda Abdelhai, MD	Miss Abdelhai has nothing to disclose.
Zhiyong Han, PhD	Dr. Han has nothing to disclose.
Kalli Kremer	Miss Kremer has nothing to disclose.
Ameer Afzal Khan, Final Year MBBS Student	Mr. Khan has nothing to disclose.
Alexander Yucht	Mr. Yucht has nothing to disclose.
Haran Srinivasan Saravanan, MBBS	Mr. Saravanan has nothing to disclose.
David M. Peereboom, MD	Dr. Peereboom has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anheart. Dr. Peereboom has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeOnc. Dr. Peereboom has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Peereboom has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orbus. Dr. Peereboom has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Peereboom has received research support from Nuvation. The institution of Dr. Peereboom has received research support from Anheart. The institution of Dr. Peereboom has received research support from Pfizer. The institution of Dr. Peereboom has received research support from NeOnc. The institution of Dr. Peereboom has received research support from Bristol-Myers Squibb. The institution of Dr. Peereboom has received research support from Genentech/Roche. The institution of Dr. Peereboom has received research support from Orbus. The institution of Dr. Peereboom has received research support from GCAR.
Ahmed A. Arif, MBBS, PhD	Dr. Arif has nothing to disclose.
Dhyey Sidhpura, MD	Dr. Sidhpura has nothing to disclose.
Camilla calomino, PhD	Miss calomino has nothing to disclose.
Maria J. Jaramillo-Arrazola, MD	Mrs. Jaramillo-Arrazola has nothing to disclose.
Robert M. Miller	Mr. Miller has nothing to disclose.
Jungshin Park, PhD	Dr. Park has received personal compensation for serving as an employee of SK Biopharmaceuticals.
Olivia Mihalek	Miss Mihalek has nothing to disclose.
Margarita I. Chuquin	Mrs. Chuquin has nothing to disclose.
Cliff Eskey, MD, PhD	Dr. Eskey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple law firms in multiple states.
Alyaa Ahmed Ibrahim, MBBS	Dr. Ibrahim has nothing to disclose.
Sai Zhang, PhD	The institution of Prof. Zhang has received research support from NIH. The institution of Prof. Zhang has received research support from Packard Center for ALS Research. The institution of Prof. Zhang has received research support from MND Association.
Qilong Jiang	Dr. Jiang has nothing to disclose.
Joshua Grube	Mr. Grube has nothing to disclose.
Yong Heui Jeon, PhD	Dr. Jeon has received personal compensation for serving as an employee of SK biopharmaceuticals.
Umika S. Paul	Ms. Paul has nothing to disclose.
Jiwon Jung, PhD	Dr. Jung has nothing to disclose.
Muneeb Saifullah	Dr. Saifullah has nothing to disclose.
Laya Krishnan, BS	Ms. Krishnan has nothing to disclose.
Amro Ali, MD	Dr. Ali has nothing to disclose.
Eunyeong Choe, RN	Ms. Choe has nothing to disclose.
Muhammad Ubaid U. Hussain, MBBS	Dr. Hussain has nothing to disclose.
Deepak Yadav, MD	Dr. Yadav has nothing to disclose.
Ihsan Qamar, MBBS	Mr. Qamar has nothing to disclose.
Fatima Rasool	Miss Rasool has nothing to disclose.
Hafiza Maheen Fatima, MBBS	Ms. Fatima has nothing to disclose.
Abdelrhman H. Mohamed, MBBS	Dr. H. Mohamed has nothing to disclose.
Sarim I. Nasir, MBBS	Dr. Nasir has nothing to disclose.
Huzaifa Nadeem, MBBS	Dr. Nadeem has nothing to disclose.
Ubaid Ur Rehman, MBBS	Dr. Rehman has nothing to disclose.
Rahman Syed, Medical student	Mr. Syed has nothing to disclose.
Anfal Khan, MBBS	Mr. Khan has nothing to disclose.
Mohsin Ali, MBBS	Dr. Ali has nothing to disclose.
Rita Nistico, MD	Prof. Nistico has nothing to disclose.
Rohama Rehman, MBBS	Dr. Rehman has nothing to disclose.
Muhammad Talha, MBBS	Mr. Talha has nothing to disclose.
Raja Aqib Ejaz, MBBS	Dr. Ejaz has nothing to disclose.
Sudheendra Lakshman Chintha, MD	Dr. Chintha has nothing to disclose.
Kyoung Heo, MD, PhD	Dr. Heo has nothing to disclose.
Rana S. Abdelhafiz	Miss Abdelhafiz has nothing to disclose.
Muhammad Ilyas, MBBS	Dr. Ilyas has nothing to disclose.
Ioannis Stamelos, MD	The institution of Mr. Stamelos has received research support from the Hellenic Foundation for Research and Innovation .
Amit Agarwal, MD	Dr. Agarwal has nothing to disclose.
Andrea Chicca, PhD	Prof. Chicca has received personal compensation for serving as an employee of Synendos Therapeutics. Prof. Chicca has or had stock in Synendos Therapeutics.
Blanca Albertí Vall, MD	Mrs. Albertí Vall has nothing to disclose.
Amirhossein Hajihosseini	Mr. Hajihosseini has received personal compensation for serving as an employee of UCB. Mr. Hajihosseini has stock in UCB.
Bhumi D. Patel	Ms. Patel has nothing to disclose.
FAYE A. SHAIKH III, MD	Dr. SHAIKH has nothing to disclose.
Kalliopi Vourou, PhD	The institution of Miss Vourou has received research support from Hellenic Foundation Research Innovation .
Evangelia Smaragdaki, PhD Candidate	The institution of Mrs. Smaragdaki has received research support from Hellenic Foundation Research and Innovation .
Aaron Burch, DO	Dr. Burch has nothing to disclose.
Oriana Tarabay, MD	Mrs. Tarabay has nothing to disclose.
Celine Maeder, PhD	Dr. Maeder has received personal compensation for serving as an employee of Synendos Therapeutics AG.
Ehsanullah Alokozay, MD	Dr. Alokozay has nothing to disclose.
txomin lalanne, PhD	Dr. lalanne has received personal compensation for serving as an employee of EphyX Neuroscience.
Winifred Trotman	Ms. Trotman has nothing to disclose.
Lucas D. Vital, Medical student	Mr. Vital has nothing to disclose.
Andrew Heaney	Mr. Heaney has received personal compensation for serving as an employee of Novartis. Mr. Heaney has stock in Novartis.
Yu Hong, Master of Science	Mr. Hong has received personal compensation for serving as an employee of Genesis Research Group.
Sandra Glasmacher, PhD	Mrs. Glasmacher has received personal compensation for serving as an employee of Synendos Therapeutics AG.
David R. Santiago-Dieppa, MD	Dr. Santiago-Dieppa has nothing to disclose.
Zhuolin Liu, PhD	Dr. Liu has nothing to disclose.
Madhuri S. Namekar, MS	Mrs. Namekar has nothing to disclose.
Lauren Cornell, PhD	Dr. Cornell has nothing to disclose.
Ana Hernando, RN	Mrs. Hernando has nothing to disclose.
Aqsa Amjad, Student	Ms. Amjad has nothing to disclose.
Connor Patterson	Mr. Patterson has nothing to disclose.
Matthew Phan, Medical Student	Mr. Phan has nothing to disclose.
Monika Gross	Ms. Gross has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with The Poise Project. Ms. Gross has a non-compensated relationship as a Executive Director with The Poise Project that is relevant to AAN interests or activities.
Muhammad Usman	Mr. Usman has nothing to disclose.
Zain A. Butt, MBBS	Mr. Butt has nothing to disclose.
Elena Faedo, MD	Mrs. Faedo has nothing to disclose.
Isabella Milejczyk, BS, MA	Miss Milejczyk has nothing to disclose.
Laura Greene, RN	Ms. Greene has nothing to disclose.
Aftab M. Merchant, MBBS	Dr. Merchant has nothing to disclose.
Graziella Mangone, Sr., MD, PhD	Dr. Mangone has nothing to disclose.
Maureen I. Ekwebelem	Ms. Ekwebelem has nothing to disclose.
Olivia Laun	Ms. Laun has nothing to disclose.
Fangxi Xu, MS	Ms. Xu has nothing to disclose.
Adam Ayoub	Mr. Ayoub has nothing to disclose.
Michael Alexander Feijoo Jaramillo	Dr. Feijoo Jaramillo has nothing to disclose.
Grace K. Cedeño, MD	Dr. Cedeño has nothing to disclose.
Madison Clemons, Clinical Research Coordinator	Ms. Clemons has nothing to disclose.
Ruben J. Mylvaganam, MD	Dr. Mylvaganam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for United Therapeutics. Dr. Mylvaganam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Mylvaganam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant Sciences. Dr. Mylvaganam has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Therapeutics. Dr. Mylvaganam has received personal compensation in the range of $500-$4,999 for serving as a Fellowship Director with United Therapeutics.
Naima Rahim	Miss Rahim has nothing to disclose.
Shariq M. Zaman	Mr. Zaman has nothing to disclose.
Aizhan M. Mengaliyeva, student	Ms. Mengaliyeva has nothing to disclose.
Dan Fogarty	Mr. Fogarty has nothing to disclose.
Amanda Salisbury, RN	Mrs. Salisbury has nothing to disclose.
Amanda Studnicki, PhD	Dr. Studnicki has received personal compensation for serving as an employee of The Geneva Foundation. Dr. Studnicki has received research support from National Institute of Health.
Suha Giselle Ghanem	Ms. Ghanem has nothing to disclose.
Elizabeth Metzger	Ms. Metzger has received personal compensation for serving as an employee of The Geneva Foundation. Ms. Metzger has received research support from University of Michigan .
Pablo Martinez-Martin, MD, PhD	Prof. Martinez-Martin has received personal compensation in the range of $500-$4,999 for serving as a Co-Director, Clinical Outcome Assessment Program with Movement Disorder Society.
Anas A. Alzyoud, MD	Dr. Alzyoud has nothing to disclose.
Priyanka Sinha, PhD	Dr. Sinha has nothing to disclose.
Eva Cifelli	Miss Cifelli has nothing to disclose.
Nada G. Abdelmaksoud, MBBS	Miss Abdelmaksoud has nothing to disclose.
Elizabeth Crevier, MPH	Mrs. Crevier has received personal compensation for serving as an employee of Avalere Health.
Brianna L. Poole, CCMA	Ms. Poole has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Ms. Poole has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Ms. Poole has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmeceuticals.
Ivana Kramarikova, PhD	Mrs. Kramarikova has nothing to disclose.
SAI VENKATA MANOJ KOTHARU, MBBS	Dr. KOTHARU has nothing to disclose.
Jules Skoda	Ms. Skoda has nothing to disclose.
Abdullah H. Maghrabi	Dr. Maghrabi has nothing to disclose.
Osama Hassan, MD	Dr. Hassan has nothing to disclose.
Krista Perez, MD	Dr. Perez has nothing to disclose.
Tien Kheng Khoo, MBBS, PhD	Prof. Khoo has nothing to disclose.
Ethan R. Cheraghpour	Mr. Cheraghpour has nothing to disclose.
Anna Brucker, NP	Miss Brucker has nothing to disclose.
Amanda V. Radtke, MD	Dr. Radtke has nothing to disclose.
Kilian Hett, PhD	Dr. Hett has nothing to disclose.
Sarah D. Boothby	Ms. Boothby has nothing to disclose.
Sandra Videmsky	Ms. Videmsky has received personal compensation for serving as an employee of International Parkinson and Movement Disorder Society.
Amanpreet S. Wasir, MBBS	Dr. Wasir has nothing to disclose.
Alberto Calvi, MD, PhD	Dr. Calvi has nothing to disclose.
Eman Elbayoumi	Dr. Elbayoumi has nothing to disclose.
Leonardo Ariello, MD	Dr. Ariello has nothing to disclose.
Alessia Cristofaro, Tecnico di neurofisiopatologia	Dr. Cristofaro has nothing to disclose.
Guillermo L. Rodriguez, MD	Mr. Rodriguez has nothing to disclose.
Daniel N. El Kodsi, PhD	Dr. El Kodsi has nothing to disclose.
Elizabeth Atkinson	Ms. Atkinson has nothing to disclose.
Richard W. Song	Mr. Song has nothing to disclose.
Luis G. Fontenele, MS	Mr. Fontenele has nothing to disclose.
Rachel E. Elam, MD	The institution of Dr. Elam has received research support from Rheumatology Research Foundation. The institution of Dr. Elam has received research support from National Institutes of Health. The institution of Dr. Elam has received research support from National Institutes of Health. The institution of Dr. Elam has received research support from Department of Defense.
Cezar Gammoh, MD	Dr. Gammoh has nothing to disclose.
Fabiana Novellino, MD	Prof. Novellino has nothing to disclose.
Hongwei Xue	Mr. Xue has nothing to disclose.
Sohail M. Dewain, MD	Dr. Dewain has nothing to disclose.
François-Jérôme AUTHIER, MD, PhD	Prof. AUTHIER has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARGENX. Prof. AUTHIER has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALEXION. The institution of Prof. AUTHIER has received research support from Ministry of Health. The institution of Prof. AUTHIER has received research support from French agency for research. The institution of Prof. AUTHIER has received research support from National agency for research on AIDS and transmissible disease.
Wen Huang, MD	Prof. Huang has nothing to disclose.
Guilherme Santos Marques da Silva, MD	Dr. Santos Marques da Silva has nothing to disclose.
Anastasia Kuzkina, MD	Dr. Kuzkina has nothing to disclose.
Usman Faisal, MBBS	Dr. Faisal has nothing to disclose.
Anya P. Gemos, Research Assistant	Miss Gemos has nothing to disclose.
Habib Nasir, BS	Mr. Nasir has nothing to disclose.
Christina L. Tamargo, MD	Dr. Tamargo has nothing to disclose.
Sarah Yang, MD	An immediate family member of Dr. Yang has received research support from NIH.
Ariv Vaidya, High schooler	Mr. Vaidya has nothing to disclose.
Anita Alizadeh	Ms. Alizadeh has nothing to disclose.
Simranjeet S. Nagoke, MBBS	Dr. Nagoke has nothing to disclose.
Andy Lu	Mr. Lu has nothing to disclose.
Varshini Thiruvadi, MD	Dr. Thiruvadi has nothing to disclose.
Ian Lee, MD	Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
Majid Alimohammadi, Sr., PhD	Dr. Alimohammadi has nothing to disclose.
Angela T. Remuzgo-Cabezas, Medical Student	Ms. Remuzgo-Cabezas has nothing to disclose.
Saifeldin Hossameldin, MD	Dr. Hossameldin has nothing to disclose.
Breelyn Gilbert	Miss Gilbert has nothing to disclose.
Priscilla Too, PhD	Dr. Too has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Aeon Biopharma.
Mark D. Johnson, MD, PhD	Dr. Johnson has nothing to disclose.
Marcos V. Lopes Penha	Mr. Lopes Penha has nothing to disclose.
João P. Nunes, Medical Student	Mr. Nunes has nothing to disclose.
Angeliki Pollatou	Dr. Pollatou has received research support from The Geneva Foundation.
Stephanie M. Hughes, PharmD	Dr. Hughes has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Hughes has received personal compensation for serving as an employee of Neurona Therapeutics.
Inmaculada Barrasa, PhD	Dr. Barrasa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Robigo.
Constance J. Mietus, MD, PhD	Dr. Mietus has nothing to disclose.
Omar Sayed, MD	Dr. Sayed has nothing to disclose.
Sumaiya Nazeen, PhD	Dr. Nazeen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dacapo Brainscience, Inc..
Shreyas Kuddannaya, PhD	Dr. Kuddannaya has nothing to disclose.
daniel vera grandez, MD	Dr. vera grandez has nothing to disclose.
Noor Elshinawy M. Noor Elshinawy	Ms. Noor Elshinawy has nothing to disclose.
Beatriz E. Perez-Martinez, MD	Dr. Perez-Martinez has nothing to disclose.
Amaara Wahid	Ms. Wahid has nothing to disclose.
Anna Nykonenko, MD	Ms. Nykonenko has nothing to disclose.
Bryan E. Rudas Sulca, Medical student	Mr. Rudas Sulca has nothing to disclose.
Daryna Khoptar, MD	Ms. Khoptar has nothing to disclose.
Saad Ali, MD	Dr. Ali has nothing to disclose.
Ritik Bhadana, MBBS	Dr. Bhadana has nothing to disclose.
Tara P. Menon, BS	Miss Menon has nothing to disclose.
Olukemi C. Ilori, Sr., MD	Dr. Ilori has nothing to disclose.
Mallikarjun Verma	Mr. Verma has nothing to disclose.
Yadira Tiburcio, MD	Dr. Tiburcio has nothing to disclose.
Aman Verma, MS	Mr. Verma has nothing to disclose.
Obinna Amaji, MBBS	Dr. Amaji has nothing to disclose.
Taras Ivanykovych	Mr. Ivanykovych has nothing to disclose.
ALAA M. ABDELRAHEAM, MD, MBBS	Dr. ABDELRAHEAM has nothing to disclose.
Majid Doroudi, PhD	Dr. Doroudi has nothing to disclose.
Thierry GENDRE, MD	Dr. GENDRE has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson & Johnson. Dr. GENDRE has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Fatima IKHETEAH, Study Coordinator	Miss IKHETEAH has nothing to disclose.
Valentine Perrain, MD	Dr. Perrain has nothing to disclose.
Martin T. Eicke, MD	Mr. Eicke has nothing to disclose.
Ismail Koubiyr, PhD	Dr. Koubiyr has nothing to disclose.
Iman TAHIRI, CRA	Miss TAHIRI has received personal compensation for serving as an employee of Excelya.
Hala Al Rayess, MBBS	Dr. Al Rayess has nothing to disclose.
Priyanka Deep	Miss Deep has nothing to disclose.
souvannanorath sarah, MD	Dr. sarah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for johnson and jonhson. Dr. sarah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. sarah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Argenx.
George Dong	Mr. Dong has nothing to disclose.
Giulia Sgro	Ms. Sgro has nothing to disclose.
Marianna Crasá	Miss Crasá has nothing to disclose.
Morounfoluwa P. Olalusi, MD	Dr. Olalusi has nothing to disclose.
Brenda Maura goncalves costa	Mrs. Maura goncalves costa has nothing to disclose.
Lahari Katta, MBBS	Dr. Katta has nothing to disclose.
Miguel A. Hernandez	Mr. Hernandez has received personal compensation for serving as an employee of UCB Pharma S.A.. Mr. Hernandez has stock in UCB Pharma S.A..
Evan Smith, PhD	Dr. Smith has nothing to disclose.
Holly Morrison, BS	Miss Morrison has nothing to disclose.
Ann L. Cleverly	Miss Cleverly has received personal compensation for serving as an employee of UCB. Miss Cleverly has stock in UCB.
Denise Maddox, RN	Ms. Maddox has nothing to disclose.
samanta diaz menai, MD	Ms. diaz menai has nothing to disclose.
Adolfo Del Bosque-Aguirre, MD	Dr. Del Bosque-Aguirre has nothing to disclose.
Camila M. Escobar, Sr., MD	Miss Escobar has nothing to disclose.
Ashis Das, MD, PhD	Dr. Das has nothing to disclose.
Jürg Gertsch, PhD	Prof. Gertsch has received intellectual property interests from a discovery or technology relating to health care.
jeffrey steinberg, MD	Dr. steinberg has stock in Clearpath Vascular.
Bashar F. Mohsen, MD	Dr. Mohsen has nothing to disclose.
Andrea Quattrone, MD, PhD	Prof. Quattrone has nothing to disclose.
Ziyad Elyamany	Dr. Elyamany has nothing to disclose.
Raiye Y. Hailu	Ms. Hailu has nothing to disclose.
Abigail Herbst	Ms. Herbst has received personal compensation for serving as an employee of Thermo Fisher Scientific.
Adam Renschen	Mr. Renschen has nothing to disclose.
Tricia Plumb, RN	Ms. Plumb has nothing to disclose.
Bridget A. Gaglio, PhD	Ms. Gaglio has received personal compensation for serving as an employee of Thermo Fisher Scientific.
Ahad Sabet, MD	Dr. Sabet has nothing to disclose.
Evrim Sude Con, Undergraduate Student	Ms. Con has nothing to disclose.
Mona Nada, MD	Prof. Nada has nothing to disclose.
Yashasvi Srivastava, MBBS	Ms. Srivastava has nothing to disclose.
Tony A. Torres Inuma	Dr. Torres Inuma has nothing to disclose.
Guido E. Alban Zapata	Dr. Alban Zapata has nothing to disclose.
Andrew Pickles, Medical Student	Mr. Pickles has nothing to disclose.
Koji I. Iida, MD, PhD	Prof. Iida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. Prof. Iida has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiich-Sankyo. Prof. Iida has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB Japan. Prof. Iida has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. The institution of Prof. Iida has received research support from Ricoh. The institution of Prof. Iida has received research support from UCB Japan. The institution of Prof. Iida has received research support from Zimmer Biomet.
Indraneel M. Deshpande, MA	Mr. Deshpande has nothing to disclose.
Arthur F. Vasconcelos, MD	Mr. Vasconcelos has nothing to disclose.
Chidinma Onweni, MD	Dr. Onweni has nothing to disclose.
Aine McConnon, PhD	Dr. McConnon has received personal compensation for serving as an employee of Novartis. Dr. McConnon has stock in Novartis.
liqing hu, DO	Dr. hu has nothing to disclose.
Muhammad Zohaib Qasim, MD	Dr. Qasim has nothing to disclose.
Naga Nyshita Veeramachaneni, MBBS	Dr. Veeramachaneni has nothing to disclose.
Jason P. Swindle, PhD	Mr. Swindle has nothing to disclose.
Hailey Modi	Ms. Modi has nothing to disclose.
Jiye Son, MD	Dr. Son has nothing to disclose.
Kwame A. McCain	Mr. McCain has nothing to disclose.
Sujith Madhavan	Dr. Madhavan has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Madhavan has or had stock in Jazz Pharmaceuticals.
Ji Hyun Kim, MD, PhD	Prof. Kim has nothing to disclose.
Michael Kogan, MD	Dr. Kogan has nothing to disclose.
Akhil Anand, MD	Dr. Anand has nothing to disclose.
Katheryn A. Cousins, PhD	The institution of Prof. Cousins has received research support from NIA. The institution of Prof. Cousins has received research support from DoD.
Grace Chen	Miss Chen has received personal compensation for serving as an employee of Analysis Group, Inc..
Ashley Audi, MD	Dr. Audi has nothing to disclose.
Hemant Luniwal, DM	Dr. Luniwal has nothing to disclose.
Krutika Katageri, MD	Dr. Katageri has nothing to disclose.
Abdul Rehman R. Nasir, MBBS	Mr. Nasir has nothing to disclose.
Trisha Chatterjee, MD	Dr. Chatterjee has nothing to disclose.
ANAND V, MD	Dr. V has nothing to disclose.
Yoomin Lee, Medical Student	Miss Lee has nothing to disclose.
Deya'a I. Alasmar, MD	Dr. Alasmar has nothing to disclose.
Areeb Amjad, MBBS	Dr. Amjad has nothing to disclose.
Minahil Zaheer, MBBS	Dr. Zaheer has nothing to disclose.
Muhammad Hassan, MBBS	Dr. Hassan has nothing to disclose.
Ali Zubair, MBBS	Dr. Zubair has nothing to disclose.
Abeera Amir, MD	Dr. Amir has nothing to disclose.
Danish Ali, MBBS	Dr. Ali has nothing to disclose.
Manahil Khan, MBBS	Miss khan has nothing to disclose.
Danyal Khan, MBBS	Mr. Khan has nothing to disclose.
Aleena Sharif, MBBS	Dr. Sharif has nothing to disclose.
Husnain Ahmad, MBBS	Mr. Ahmad has nothing to disclose.
Diya Rathi, MBBS	Miss Rathi has nothing to disclose.
Katherine Singh	Dr. Singh has nothing to disclose.
Noor Khan, Student	Miss Khan has nothing to disclose.
Hui Chen, MD	Dr. Chen has nothing to disclose.
Heather Smith, MD, PhD	Dr. Smith has nothing to disclose.
Yahn Alejandro Castro Rey, Physical and music therapist	Mr. Castro Rey has nothing to disclose.
Adolfo J. Valhuerdi Cepero, MD	Dr. Valhuerdi Cepero has nothing to disclose.
Rudbeckia Porto, MD	Mrs. Porto has nothing to disclose.
Shivani Iyer	Miss Iyer has nothing to disclose.
Luis Garegnani, PhD, PT	Prof. Garegnani has nothing to disclose.
Kristel Back Merida, MD	Dr. Back Merida has nothing to disclose.
Gargi Bhattacharya, MD	Dr. Bhattacharya has nothing to disclose.
Yufei Deng, MD	Ms. Deng has nothing to disclose.
YangLi YangLi	Mrs. YangLi has nothing to disclose.
Samuel I. Olawale, MBBS	Dr. Olawale has nothing to disclose.
Luis F. Quinones Olvera, MD	Mr. Quinones Olvera has received intellectual property interests from a discovery or technology relating to health care.
Anjana Sankar, MD, MBBS	Dr. Sankar has nothing to disclose.
muhammad F. Nazir, MBBS	Dr. Nazir has nothing to disclose.
alice dormeuil, MD	Dr. dormeuil has nothing to disclose.
Teresa Serna, NP	Ms. Serna has nothing to disclose.
Kevna Konduru	Ms. Konduru has nothing to disclose.
James Kim, BS	Mr. Kim has nothing to disclose.
Alejandro Lozano	Mr. Lozano has nothing to disclose.
Shradha Dave, MBBS	Dr. Dave has nothing to disclose.
Gina Forchelli, PhD	Dr. Forchelli has nothing to disclose.
Yaxel Levin-Carrion, Medical Student	Mr. Levin-Carrion has nothing to disclose.
Samata Kamireddy, MD	Dr. Kamireddy has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Kamireddy has stock in Praxis Precision Medicines.
Minao Tang	Mr. Tang has nothing to disclose.
Kimberly Crimin, PhD	Dr. Crimin has received personal compensation for serving as an employee of Praxis Precision Medicine. Dr. Crimin has received personal compensation for serving as an employee of Biohaven. Dr. Crimin has stock in Biohaven. Dr. Crimin has stock in Praxis Precision Medicine.
Maribel Hernandez, PA	Ms. Hernandez has received personal compensation for serving as an employee of Praxis Precision Medicines.
guanbiao liang, MD	Dr. liang has nothing to disclose.
Archis Patel, PharmD	Dr. Patel has nothing to disclose.
Maria Giovanna Bianco, PhD	Mrs. Bianco has nothing to disclose.
Jan Ilkowski, MD	Dr. Ilkowski has nothing to disclose.
Nicolas Meza, MD	Mr. Meza has nothing to disclose.
Hanya M. Qureshi, MD	Dr. Qureshi has nothing to disclose.
Brittany Owusu-Adjei, MD	Dr. Owusu-Adjei has nothing to disclose.
Adam Santaniello	Mr. Santaniello has nothing to disclose.
Mustafa I. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Elizabeth A. Fletcher, MD	Dr. Fletcher has nothing to disclose.
Diann George, MD	Dr. George has nothing to disclose.
Martina Orlovic, PhD	Dr. Orlovic has received personal compensation for serving as an employee of argenx. Dr. Orlovic has stock in argenx.
Maeve Curtin	Miss Curtin has nothing to disclose.
Vineetkumar Kharat, PhD	Mr. Kharat has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Mr. Kharat has stock in Novartis Pharmaceuticals.
Aldo Quattrone, MD	Prof. Quattrone has nothing to disclose.
Larysa I. Sokolova, PhD	Prof. Sokolova has nothing to disclose.
Ryan Bucco	Dr. Bucco has received personal compensation for serving as an employee of Acadia Pharmaceuticals.
Madelyn Rubenstein	Miss Rubenstein has nothing to disclose.
Steven Sherman, MPH	Mr. Sherman has received personal compensation for serving as an employee of Regeneron. Mr. Sherman has stock in Regeneron.
Xiaoshu Feng, PhD	Dr. Feng has nothing to disclose.
Tarik NORDINE, MD	Dr. NORDINE has nothing to disclose.
Madison Bangert, MD	Dr. Bangert has nothing to disclose.
Neha Arora	Ms. Arora has nothing to disclose.
Saurabh Nandwani, MD	Dr. Nandwani has nothing to disclose.
Jennifer Reihm	Ms. Reihm has nothing to disclose.
Caryn J. Ha, MD	Miss Ha has nothing to disclose.
Ashleigh Hansen, MSc, LCGC, Genetic Counselor	Ms. Hansen has received personal compensation for serving as an employee of Cedars-Sinai.
Joy Schmidt	Mrs. Schmidt has nothing to disclose.
Sameer Taywade, MD, MBBS, DNB	Dr. Taywade has nothing to disclose.
Yuelun ZHANG, PhD	Dr. ZHANG has nothing to disclose.
Virendra P. Singh, MD	Dr. Singh has nothing to disclose.
Maximilian U. Friedrich, MD	Dr. Friedrich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tovly LLC. Dr. Friedrich has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Portfolio. The institution of Dr. Friedrich has received research support from Jung Stiftung für Wissenschaft & Forschung. The institution of Dr. Friedrich has received research support from Manfred und Ursula Müller-Stiftung.
Beth Poirrette	Miss Poirrette has nothing to disclose.
Kelly F. Fischbein, RN	Ms. Fischbein has received personal compensation for serving as an employee of UCB Inc.. Ms. Fischbein has stock in UCB Inc..
Kathryn A. Keefer, Patient Education	Mrs. Keefer has received personal compensation for serving as an employee of Rush University Medical Center. Mrs. Keefer has received personal compensation in the range of $10,000-$49,999 for serving as a Program Manager with The Brain Health Center of the Rockies.
Jesse D. Hoffmeister, PhD	The institution of Dr. Hoffmeister has received research support from NIH. The institution of Dr. Hoffmeister has received research support from Uniformed Services University. The institution of Dr. Hoffmeister has received research support from Dr. Ralph and Mariak Falk Medical Trust.
Jenn Haw Fong, MBBS	Dr. Fong has nothing to disclose.
Shakthi Rave	Miss Rave has nothing to disclose.
Jean-Pascal J. Lefaucheur, MD, PhD	Prof. Lefaucheur has nothing to disclose.
Ibet Marie Sih, MD	Dr. Sih has nothing to disclose.
maurice smith, MD, PhD	The institution of Prof. smith has received research support from NSF. Prof. smith has received intellectual property interests from a discovery or technology relating to health care.
Stephanie Gelman, MD	Dr. Gelman has nothing to disclose.
hussein nasser, MD	Dr. nasser has nothing to disclose.
Alban GRAVIER, MD	Dr. GRAVIER has nothing to disclose.
Guadalupe Cecilia Aguilar-Domínguez	No disclosure on file
Sraavya Anne	No disclosure on file
Alexandra Chira	No disclosure on file
Jose A. Figueroa Sanchez	No disclosure on file
Nora Liss Gomez Dominguez	No disclosure on file
Luis Angel Haro-Santillan	No disclosure on file
Victoria Hardwick	No disclosure on file
Maksym Horiachok, MD	No disclosure on file
Muzammil Hussain	No disclosure on file
Jordan Larson	No disclosure on file
Ulla Nazzal	Ulla Nazzal has nothing to disclose.
Inés Reynoso-Moreno	Inés Reynoso-Moreno has nothing to disclose.
Francisco Rodriguez	No disclosure on file
Maria Salsone	No disclosure on file
Fiona Samson	Fiona Samson has nothing to disclose.
Sara Iris Santos	No disclosure on file
Peter Schloesser	No disclosure on file
Selim Tarabeah	No disclosure on file
Shahbaz Khan, Medical Student	Mr. Khan has nothing to disclose.
Khawaja M. Hassan	Mr. Hassan has nothing to disclose.
Claire M. Akard	Ms. Akard has nothing to disclose.
Muhammad Waleed	Mr. Waleed has nothing to disclose.
Argineh Shahbandari, MD	Ms. Shahbandari has nothing to disclose.
Pha S. Le, MD	Mr. Le has nothing to disclose.
Biura Markarian, MD	Biura Markarian has nothing to disclose.
Daniyal Sahto, MBBS	Mr. Sahto has nothing to disclose.
Muhammad Haziq Imran, MBBS	Mr. Imran has nothing to disclose.
Daniel Arizpe-Bravo	No disclosure on file
Ana Berta Arizpe-Bravo	No disclosure on file
David Blumenkron Marroquin	David Blumenkron Marroquin has nothing to disclose.
Eduardo Peña-Andrade	No disclosure on file
Armando Romero-Pérez	Armando Romero-Pérez has nothing to disclose.
Carlos Enrique Chávez-Donis	No disclosure on file
Veronica L. Torres, MD	Dr. Torres has nothing to disclose.
Chandler Gilgenbach	Chandler Gilgenbach has nothing to disclose.
Jessica Roland, PhD	Dr. Roland has received personal compensation for serving as an employee of Neurona Therapeutics.
Abdullah Serhan, MD	Dr. Serhan has nothing to disclose.
Andrea Robinson, PhD	Dr. Robinson has received personal compensation for serving as an employee of SK Life Science.
Jordan H. Larson, MD	No disclosure on file
Rhianne Scicluna, PhD	Dr. Scicluna has received personal compensation for serving as an employee of Synendos Therapeutics .
Syeda Safiya Hussaini, MD	An immediate family member of Syeda Safiya Hussaini, MD has received personal compensation for serving as an employee of HelloFresh. Syeda Safiya Hussaini, MD has or had stock in Eli Lilli.Syeda Safiya Hussaini, MD has or had stock in Abbvie.Syeda Safiya Hussaini, MD has or had stock in Apple.Syeda Safiya Hussaini, MD has or had stock in Nvidia.Syeda Safiya Hussaini, MD has or had stock in Amazon.Syeda Safiya Hussaini, MD has or had stock in Google.
Christopher Blaine, MD	No disclosure on file